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Abstract 
Life expectancy in cystic fibrosis (CF) has greatly improved, but as people live longer, they 
experience increasing symptoms. Literature indicates pain in CF is common and 
underreported, affecting quality of life, mental health and adherence to treatment. Pain 
is best explored in the context of the whole person, yet previous studies are almost 
exclusively quantitative.  
The aim of this research was to gain understanding of the experience of pain, within the 
context of the whole person with CF. Within a social constructivist framework, narrative 
methodology focused on the complex and unique experiences of individuals. Data were 
gathered through interviews with nine individuals and analysed using a method of 
narrative analysis to present findings in stanzas, a poetic form that preserves the 
narrator’s voice. Findings were interpreted through the lens of total pain theory.  
Three key narratives contributed to understanding pain: emerging awareness, social 
legitimacy and invisibility. Emerging awareness was the gradually increasing 
understanding of what it means to have CF. Social legitimacy was critical in the experience 
of total pain, appearing as participants struggled to conform to societal expectations. 
Total pain was ever-present in these stories, and when participants were isolated or 
marginalised and lost social legitimacy, they felt invisible.  
Total pain and suffering in CF are best understood as a singular experience happening to 
a whole person, encapsulating their very being. This deeper understanding highlights an 
opportunity to explore pain in the context of the whole person, to inform clinical practice 
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Chapter 1: Introduction 
1.1 Personal reflections 
I have spent most of my career as a registered nurse (RN) working in the areas of 
paediatrics, palliative care, and for the past 14 years, cystic fibrosis (CF). Working with 
pain has been a constant, but never has it felt more complex than pain in CF. In my clinical 
work, I found myself frustrated to hear some clinicians did not believe pain was an issue 
in CF, while people with CF told me they did not report pain because they believed nothing 
could be done. One of my core beliefs is that if I am not working to address an issue, I do 
not have the right to complain about it. I therefore sought others with similar concerns, 
and we formed a working group with a broad interest in palliative care in CF. To date, we 
have authored several publications and presented on a range of topics around CF and 
palliative care, including pain, advance care planning, barriers to palliative care, and 
education for palliative care in CF (Allgood, Kapnadak, Dellon, Goggin, & Lechtzin, 2018; 
Dellon et al., 2016; Dellon et al., 2018; Dellon, Hobler, Georgiopoulos, Chen, et al., 2019; 
Dellon, Hobler, Georgiopoulos, Goggin, et al., 2019; Goggin, 2017; Goggin & Cohen, 2016). 
The Cystic Fibrosis Foundation has supported many of these efforts.  
As I continued this work, it became clear that pain in CF was controversial. In discussions 
following sessions about palliative care in CF, the subject of pain inevitably arose. Much 
disagreement seemed centred around opioids. The phrases “drug seeking” and “not really 
in pain” were common. Some viewed opioids as absolutely contraindicated in people 
listed for transplant, while others believed pain medication should rarely, if at all, be 
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prescribed in CF. Still others relayed scenarios where they felt people with CF had been 
prescribed opioids for symptoms other than physical pain. These anecdotes and concerns 
are not unique to the CF community, as similar concerns have been reported in the pain 
management literature (Carvalho et al., 2018). During these discussions, clinicians 
expressed emotion at a level not usually seen at professional conferences, yet clearly 
longed for more information about pain and wanted to help people with CF. I understood 
this. I still recall people with CF who died following an overdose or struggled with 
addiction. Even many years later, thoughts of what could have been done differently are 
still with me.  
Around this time, having started the PhD program at Lancaster and begun thinking about 
research topics, a Facebook post from a young woman with CF caught my attention: 
“Does anyone else out there with CF have pain every single day?” (paraphrased). After 
reading the responses from people with CF talking about their pain, I knew this would be 
my research topic.  
A quick search of PubMed around this time yielded few studies, and most reported results 
from brief surveys or pain assessments. What was missing from the data, at first glance, 
was the people. Missing was the voice of those who matter most in the experience of pain 
in CF. Missing was their experience, their point of view, their stories. 
Some colleagues cautioned about embarking on a study in an area so controversial and 
complicated. I borrow this very caution as my own rationale for studying pain in CF, but 
poet Rich (1986, p. 111) may have expressed it best when she wrote: 
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 the body’s pain and the pain on the streets 
 are not the same   but you can learn 
 from the edges that blur  O you who love clear edges 
 more than anything   watch the edges that blur. 
 
Like Bourke (2014), I see the richness and complexity of human experience in Rich’s words 
and aspire to heed her advice to “watch the edges that blur”.  
1.2 Research overview 
The aim of this research study was to generate new knowledge through deeper 
understanding of the experience of pain in CF. This study is situated within the greater 
body of research in palliative care, and as such adopts an understanding of palliative care 
as holistic and whole person centred. As both pain and illness are known to be complex 
and highly subjective, this experience is best studied with an approach that encourages 
participants to describe and explore experiences in depth (Robson, 2011). A narrative 
form of qualitative research, set within a social constructivist epistemological framework, 
facilitated this in-depth exploration. See Chapter Five for additional details of the study’s 
philosophical paradigm.  
The narrative approach enabled exploration of the experience of pain in CF through 
unstructured interviews with nine adults. Data generated from these interviews were 
interpreted and findings presented in the form of stanzas, a poetic style of narrative 
analysis based on Gee (1991) that aims to preserve the narrator’s voice. Striving to 
maintain focus on the whole person and the many facets of the pain experience, findings 
were analysed through the lens of total pain, a theory introduced by Saunders that 
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attends to physical, emotional, social and spiritual pain, described further in Chapter Four 
(Clark, 2018a; Saunders, 1965). The research took place in the US, at a large CF program 
within an academic medical centre between 2015 and 2019. Interviews occurred between 
September 2016 and June 2017. 
1.3 Structure of the thesis 
Chapter Two provides background information for the research, beginning with an 
overview of expected illness trajectory, incidence and life expectancy in CF. Following this 
overview are descriptions of the usual model of care delivery, symptoms and treatment, 
and palliative care in CF. Chapter Two concludes with an introduction to pain theory. 
Chapter Three provides a summary of previous research about pain in CF. A description 
of how the literature search was conducted and an overview of findings are presented 
with key themes identified. The themes were (a) pain characteristics, (b) disease severity, 
(c) quality of life, (d) management of pain and (e) coping. Key to the literature review 
findings was that most research on pain in CF has been quantitative, and a gap exists in 
knowledge derived from a patient perspective.  
Chapter Four describes the methodology and methods employed in this study. A 
description is given of the research paradigm, rationale for qualitative research, narrative 
approach, and methods. Gee’s style of data analysis is introduced along with an 




Chapter Five presents the thesis findings in the form of stanzas, a poetic style informed 
by Gee (1991). Three narratives that seemed essential to understanding the experience 
of pain in CF are presented: emerging awareness of what it means to have CF, social 
legitimacy and invisibility.  
In Chapter Six, an overview of total pain theory, the theoretical lens employed in this 
study, is presented. A brief history of the development of total pain theory by Saunders 
(2006c) is followed by a critique of the theory and contemporary perspectives. Finally, 
thesis findings are discussed in relation to the literature and existing knowledge. The 
breadth and depth of pain and suffering in CF is viewed through the lens of total pain. 
Highlighted in the discussion are the relationships brought to light in this study between 
total pain, the gradual recognition of what having CF means to a person, social legitimacy 
and invisibility.  
Chapter Seven concludes the thesis with a summary of the study and reiteration of the 
contribution to knowledge. The conclusion also describes implications for clinical practice, 
limitations, and recommendations for future research.  
  
 6 
Chapter 2: Background 
This chapter will provide an overview of cystic fibrosis, including symptoms, treatment 
burden, and worsening illness.  An introduction to the model of care for CF in the US and 
internationally is then presented, followed by a description of palliative care in CF.  The 
chapter concludes with an overview of pain theory in the past fifty years. 
2.1 Cystic fibrosis overview 
CF is a life-limiting, multisystem, genetic disease affecting an estimated 30,000 people in 
the US and 70,000 worldwide (Cystic Fibrosis Foundation, n.d.-a). CF is most recognised 
for its effect on the respiratory system, characterised by chronic pulmonary infection, 
usually leading to respiratory failure and death (Chen et al., 2018; Philip et al., 2008). Once 
known as a paediatric disease due to short life expectancy, CF is now a chronic disease, 
with adults comprising more than half of those with CF in the US (53.5%) and the UK 
(56.2%) (Cystic Fibrosis Foundation, 2018; Cystic Fibrosis Trust, 2018).  
Clinical care in CF is complicated and usually delivered within accredited care centres in 
the US (Mogayzel, Dunitz, Marrow, & Hazle, 2014). Established by the Cystic Fibrosis 
Foundation in 1961, these care centres provide specialised care by multidisciplinary 
teams of physicians, nurses, social workers, dietitians and respiratory therapists 
(Mogayzel et al., 2014). Some teams also have pharmacists, psychologists, psychiatrists, 
physical therapists, child life specialists, or other specialists. The Cystic Fibrosis 
Foundation provides funding and accreditation to 130 care centres across the US and 
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recommends that people with CF are seen at least quarterly at the centres (Cystic Fibrosis 
Foundation, n.d.-b).  Accreditation of CF centres provides some level of standardization 
across centres; however, variation may exist related to differences in location, 
institutional or health systems. For example, although individuals living farther away from 
their centre may receive consultative care there, much of their day to day care is provided 
by a local primary physician. Additionally, people with CF without health insurance may 
not have access to an accredited care centre, especially if the institution does not provide 
robust charity care or the person does not have documented status as a US citizen or 
resident.  Others may have insurance that only allows one visit annually to an accredited 
care centre and requires other care to be provided within their network.   
Accredited care centres are part of a comprehensive network of care, support, research 
and quality improvement efforts of the Cystic Fibrosis Foundation. Another integral 
component of this network is the CF Foundation Patient Registry, established in 1966 to 
compile information on health status and outcomes of those with CF who have consented 
to participate (Mogayzel et al., 2014).  Collecting and analysing information from the 
Patient Registry has made significant contributions in creation of clinical care guidelines, 
research and quality improvement.  
Since the 1961 establishment of accredited care centres in the US, people with CF are 
living longer, with a median predicted life expectancy of 46.2 years for someone born in 
2017 (Cystic Fibrosis Foundation, 2018). Unfortunately, this organized model of 
multidisciplinary CF care provided through specialized care centres, although common in 
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higher income countries such as the US, is not consistent globally (Bell et al., 2020). In 
addition, although many countries now have national patient registries (Australia, 
Belgium, Brazil, France, Germany, Ireland, Italy, Netherlands, New Zealand, UK, US), other 
resource poor countries do not, across significantly large areas of the world (Africa, Asia, 
and the Middle East) (Bell et al., 2020).  Adding to the disparity in CF care is a lack of access 
to medications for both routine CF treatment and to treat infection; lack of access to 
specialists; and challenges related to economic and political systems. These issues, in 
combination with the relatively low number of individuals reported to have CF, likely 
contribute to the disparity in CF care and outcomes among countries (Bell et al., 2020; 
Seyed Bashir et al., 2017). Alarmingly, in some countries (Brazil, Soviet Union, El Salvador, 
India, Bulgaria) life expectancy in CF is only half (or less) than that of the US and UK (Bell 
et al., 2020; Cystic Fibrosis Worldwide, n.d.). 
Even in the US and UK, where infants with CF today are predicted to live longer, the reality 
is that CF remains life-limiting and people are still dying quite young, with a median age 
of death of approximately 31 years in 2017 (Cystic Fibrosis Foundation, 2018; Cystic 
Fibrosis Trust, 2018).  
2.2 Symptoms and treatment burden 
CF causes abnormally thick and sticky mucous that affects the respiratory, 
gastrointestinal, endocrine, reproductive and other body systems (Davis, 2006). The usual 
illness course in CF consists of repeated lung infections, known as pulmonary 
exacerbations, that lead to lung damage, eventual respiratory failure and death (Davis, 
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2006; Yankaskas, Marshall, Sufian, Simon, & Rodman, 2004). Most people with CF have 
pancreatic malabsorption (inability to absorb fats and protein), leading to weight loss and 
sometimes CF-related diabetes (CFRD) (Yankaskas et al., 2004). As they live longer into 
adulthood, people with CF experience increased complications and comorbidities 
(Simmons & Plant, 2015). 
Treatment of CF is primarily symptom-driven, aiming to improve symptoms and prevent 
or treat infection (Davis, 2006; Yankaskas et al., 2004). A primary goal of the daily 
treatment regimen is to help loosen and cough up the sticky mucous, often using a vest-
like device. Treatment usually includes medications to treat respiratory symptoms and 
infection, pancreatic enzymes to improve gastrointestinal symptoms and weight, and 
sometimes other medications to treat complications such as diabetes. The treatment 
regimen is often reported to be time-consuming and burdensome, requiring two to four 
hours of therapy daily (Sawicki, Sellers, & Robinson, 2009). Although there is no cure at 
this time, improved therapies, possibility of lung transplant, and recent development of 
CF transmembrane conductance regulator (CFTR) modulator medications addressing the 
underlying cause of CF all offer hope to some people living with CF (Dellon et al., 2018; 
Edmondson & Davies, 2016).  
As knowledge about CF has increased, infection control has become a significant 
component of treatment. Lungs in CF are usually colonised with various organisms, and 
people with CF may risk exposing each other to dangerous bacteria or other pathogens. 
Recently published guidelines recommend that people with CF avoid close proximity to 
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others with CF, recommending they stay a minimum of six feet apart at all times (Saiman 
et al., 2014). An unfortunate consequence of the guidelines is the potential for decreased 
interaction and social support between people with CF (Flewelling, Sellers, Sawicki, 
Robinson, & Dill, 2019).  
In addition to physical symptoms, people with CF experience a high rate of depression 
and anxiety (Quittner et al., 2016). Mental healthcare in CF has been emphasised through 
recent requirements for anxiety and depression screening and efforts to facilitate social 
support for people with CF and their families.  
2.3 Growing older and sicker  
As people with CF live longer, they transition between childhood and adolescence to 
adulthood.  This transition occurs within the context of expected growth and 
development but also advancing illness.  Rather than a clear delineation between states, 
there may be movement between states such as stages of growth and development or 
states of health and illness, sometimes referred to as liminality (Bruce et al., 2014; Lowton 
& Gabe, 2003).  A serious illness such as CF, may disrupt or at least complicate the usual 
state of identity formation that occurs across the life trajectory (Williams, Corlett, Dowell, 
Coyle, & Mukhopadhyay, 2009).  Referred to by Bury (1982) as biographical disruption, 
this theory describes how people respond to change and uncertainty and construct 




2.4 Palliative care in cystic fibrosis 
Despite innovations in treatment, CF is still a serious, life-limiting illness, and palliative 
care is applicable across the continuum from diagnosis to death. Although evidence on 
palliative care in CF is limited, the body of knowledge is growing (Chen et al., 2018).  
In the US, a large, multi-centre retrospective study examining end of life care patterns for 
adults with CF who died between 2011-2013, found people most often died in the 
hospital, often in intensive care (Chen et al., 2018). Palliative care services were utilized 
in 50% of patients, but this was inconsistent among US centres with some reporting that 
none of their patients received palliative care or hospice and others reporting all patients 
over this time received services (Chen et al., 2018; Dellon et al., 2016).  Information about 
timing of services was not reported and thus it is possible services may have been 
received only in the hours to days leading up to death.  
Dying in the hospital with limited utilization of palliative care services is not unique to the 
US. In a systematic review examining utilization of palliative care for adults with CF, with 
included studies reporting on deaths in the US, UK, Australia, and Canada,  Marmor et al. 
(2019) and colleagues reported that 62%-100% died in the hospital, with one-third dying 
in intensive care units. Even in a study at a single CF centre in the US that integrated a 
specialist palliative care nurse and physician within the CF care team, with the palliative 
nurse and physician attending CF clinics and team meetings over a three-year-period, only 
7% of patients died at home (Stephen J. Bourke et al., 2016).  Although Marmor et al. 
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(2019) reported that existing evidence supports that specialty palliative care is beneficial 
in CF, findings also indicated poor access to specialty palliative care. 
Challenges cited about palliative care in CF include unpredictable illness trajectory, 
difficulty with prognostication, lack of available palliative care services, and difficulties 
arising in the simultaneous pursuit of transplant and other types of aggressive care with 
preparing for possible end of life (Chen et al., 2018; Dellon, Hobler, Georgiopoulos, Chen, 
et al., 2019; Sands et al., 2011).  These perspectives on challenges or perceived barriers 
to palliative care in CF appear to be held not only in the US, but also in those who care for 
people with CF from Australia, Canada, and UK (S. J. Bourke et al., 2009; Chapman, Landy, 
Lyon, Haworth, & Bilton, 2005; Marmor et al., 2019). One of the greatest barriers to 
palliative care in CF may be rooted in misunderstanding palliative care as relating only to 
death, rather than as a model of care relevant across the entire continuum of illness 
(Aslakson et al., 2017; Lowton, 2002a). Robinson (2009) has suggested that CF physicians 
and care teams may not refer to palliative care due to their opinion that the care is best 
provided by the CF team as they have often provided care to an individual and family for 
many years. Other potential challenges in access to specialty palliative care in CF stem 
from issues with models of palliative care involvement at different CF centres or 
availability of palliative care.  
There are no accreditation requirements or standards for integration of specialist 
palliative care within CF care in the US, however, in a 2004 consensus guideline for adult 
care, the Cystic Fibrosis Foundation acknowledged that palliative care may be useful in 
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symptom management and more recently has provided funding for research to improve 
the delivery of palliative care in CF (Cystic Fibrosis Foundation, 2019; Linnemann et al., 
2016; Yankaskas et al., 2004). Furthermore, a committee for the Cystic Fibrosis 
Foundation has recently developed and submitted specific guidelines for palliative care in 
CF and these are pending publication. In the European Cystic Fibrosis Society Guidelines, 
Castellani et al. (2018, p. 167) similarly call for “attention to communication, symptom 
control and a multi-disciplinary approach to care, including expertise in palliative care”.  
Even in well-resourced countries, access to specialist palliative care is likely affected at an 
institutional level due to differences in size, scope and availability of palliative care.  For 
example, some CF centres may be located in an institution that only provides inpatient 
palliative care.  For those that have outpatient palliative care, access may be limited by 
diagnosis, for example cancer.  Other limitations may exist due to the makeup of the 
palliative care team with some teams only including a nurse and/or physician and others 
having social work, spiritual care, psychiatry, volunteers, child life and other specialists. 
Marmor et al. (2019) suggests that integration of palliative care within CF care is a 
challenge in the UK, Australia, and Canada, all well-resourced settings with organized 
systems of care for CF informed by national patient registries.  Unfortunately, in countries 
without an organized network for CF care and without patient registries, little is known 
about CF care in general and even less is known about specialist palliative care delivery in 
CF.  This is an area that would benefit from further research.  
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As part of a broader effort to improve palliative research and clinical care in CF, a working 
group of stakeholders, including experts in palliative care, CF and quality improvement, 
as well as people with CF and their caregivers, recently participated in a modified Delphi 
process to develop a definition of palliative care specific to CF. The definition created was: 
Palliative care focuses on reducing physical and emotional symptoms and 
improving quality of life for people with CF throughout their lives. Palliative care 
occurs alongside usual treatments and is individualised according to the unique 
goals, hopes and values of each person with CF (Dellon et al., 2018, p. 420). 
The definition was created for use as a tool to introduce the idea of palliative care to those 
living or working within the CF community. Additionally, the authors hoped the definition 
would support future research and clinical care in CF (Dellon et al., 2018). Addressing pain 
clearly falls within this definition and studying pain in CF will provide information for CF 
team members who report they feel unprepared for symptom management at end of life, 
and would like more education about palliative care in CF (Goggin & Cohen, 2016).  
Notably missing in the CF definition is suffering, a common concept in discussions about 
pain and palliative care and its relief a core part of the World Health Organization’s 
definition of palliative care (World Health Organization, 2019).  Suffering encompasses 
the whole person, comprised not only of physical pain, but all elements of a person's life 
(E. Cassell, 1982; E. J. Cassell, 1991).  Dellon et al. (2018, p. 419) noted in their study that 
during the Delphi process considerable difference of opinion existed among CF 
stakeholders in whether the word suffering would be perceived negatively or cause alarm 
or whether it was the only word “sufficiently broad to address the physical, emotional, 
and spiritual aspects of the illness experience” and the consensus definition did not 
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include it. Looking to literature around suffering in CF, a search of titles for “suffering” 
and “cystic fibrosis” through Lancaster Library OneSearch resulted in only 48 articles with 
all using suffering as a verb (i.e. suffering from cystic fibrosis) rather than a noun with 
suffering viewed as an experience.    
2.5 Pain theory in the past fifty years 
Pain is an ongoing subject of debate and theory in medicine and healthcare.  Throughout 
the 19th and early 20th centuries, theories of pain tended to be based around physiological 
pain, and significant advances were made in the understanding of nociception and 
perception of pain (Moayedi & Davis, 2013).  For example, the Specificity Theory of pain 
described sensory receptors receptive to specific stimuli and although there are hints of 
specificity in writings as early as the third century, it was tested and emerged as a 
developed theory in the 19th century through the work of von Frey, Sherrington and other 
researchers (Moayedi & Davis, 2013). Moayedi and Davis (2013) assert that despite the 
important contributions made through Specificity Theory and other earlier theories, they 
did not adequately consider the complexity of pain. 
As theories continue to evolve since the mid-20th century, pain has been increasingly 
described as complicated and multidimensional (Moayedi & Davis, 2013). Definitions 
have moved away from descriptions centred on physiology of perception and response 
to pain, towards recognition of pain as a complex phenomenon involving emotions and 
cognition (Loeser, 2005). In their widely accepted definition of pain, the International 
Association for the Study of Pain defines pain as “an unpleasant sensory and emotional 
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experience associated with actual or potential tissue damage, or described in terms of 
such damage” (Merskey, Bogduk, & International Association for the Study of Pain. Task 
Force on Taxonomy., 1994, p. 210). This move away from a “Cartesian” view of pain as a 
dualistic function of mind and body (that saw body and mind as separate) is seen in pain 
theories introduced throughout the last half of the 20th century. 
Conceived by Melzack and Wall (1965), the gate control theory of pain was one of the 
first theories to move away from a dualistic “Cartesian” view. Still taught in many schools 
of medicine, this theory proposed that the spinal cord acted as a gate to the brain by 
either letting pain in or keeping it out (Melzack & Wall, 1965). When later broadening this 
theory, Melzack and Casey (1968, p. 434) described pain as multidimensional, consisting 
of three components: sensory (sensation, intensity, quality), motivational (unpleasant 
experience), and cognitive (previous experience, cultural influences, context of 
experience), illustrated in Figure 1. This strengthened the existing model through 
integrating emotional aspects of pain and emphasising interaction between the 




Figure 1. Melzack and Casey’s model of pain. Reprinted from “Sensory, motivational, and central control 
determinants of pain: a new conceptual model” by Melzack and Casey (1968, p. 427).  
 
More an advocate than a theorist, Margo McCaffery, an RN and pioneer in the field of 
pain management, nevertheless holds an important role in the field of pain. McCaffery 
described pain in her 1968 UCLA class syllabus as “whatever the experiencing patient says 
it is, and exists whenever he says it does” (Pasero, 2018, p. 89). This understanding valued 
the subjective experience of the person in pain, viewing treatment of pain as an ethical 
imperative, and eventually became a core concept of pain treatment in the US (McCaffery 
& Ferrell, 1997).  
Building on models that envisioned pain as a complex experience, but recognising like 
McCaffery that pain is highly subjective, Loeser (1982) developed a nested or linear model 
of pain. Loeser (1982) described pain as consisting of four components: nociception (the 
ability to feel pain), pain, suffering, and pain behaviour. In his model, Loeser (2005) saw 
pain behaviour as the only component observable by others and all other components as 
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subjective, known only to the one experiencing it, as depicted in the nested model below 
(Figure 2). 
 
Figure 2. Loeser’s model of pain. Developed from “Pain, Suffering, and the Brain: a Narrative of Meanings” 
in Narrative, Pain and Suffering by Loeser (2005).  
 
Emphasis on the subjectivity of pain and recognition of the importance of each layer of 
the experience, including recognition that much of pain is invisible to all but the person 
experiencing it, provides a broader perspective of pain than the theories focused on the 
physical aspects of pain alone. 
This chapter has provided an overview of CF, a multisystem genetic disease that despite 
increasing life expectancy is still a life limiting illness with many people dying in young 
adulthood from respiratory failure.  A description of care delivery in CF was described as 
an organized network of care delivered by multidisciplinary teams for those in well-
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resourced countries with less known about CF care in other areas of the world.  An 
overview was provided of the worsening illness trajectory in CF and the treatment 
regimen and related burden usually beginning well before symptoms appear, with limited 
access to palliative care. In preparation to embark on this study of pain in CF, pain theory 
over the past 50 years was reviewed with Loeser’s nested model initially favoured for its’ 
inclusion of nociception, pain, suffering and pain behaviour and emphasis on the 
subjective nature of pain.  Chapter Three will review the literature on pain in CF.   
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Chapter 3: Literature review 
This chapter will introduce the concepts of pain in CF and describe the aim and methods 
of the review. The review findings will then be presented and discussed. 
As people with CF live longer, they experience an increased symptom burden resulting 
from disease progression, CF-related complications and comorbidities (Sawicki, Sellers, & 
Robinson, 2008). Pain is a common phenomenon in this increased symptom burden of 
advancing CF (Festini, Ballarin, Codamo, Doro, & Loganes, 2004; Hayes et al., 2011; 
Kelemen et al., 2012). Pain has been associated with negative outcomes in CF, such as 
decreased quality of life, decreased treatment adherence, increased pulmonary 
exacerbations, and decreased survival (Abbott et al., 2009; Hayes et al., 2011; Kelemen et 
al., 2012). Despite these adverse effects, Festini et al. (2004) stated that pain may be 
underreported, with less than half of CF patients in their study reporting pain to their 
physician. 
3.1 Aim 
This review aimed to determine how the experience of pain for people with CF is 
described and examined in the literature. Secondary questions were a) what is known 
about types of pain in CF and its assessment, and b) what is known about the association 
of pain in CF with other symptoms or outcomes, and c) what is known from the 





A systematic search of the literature was undertaken followed by a narrative synthesis of 
the findings to gain an understanding of what was already known about pain in CF.  
Aveyard and Bradbury-Jones (2019) report literature reviews usually lean towards either 
the highly structured ‘systematic review’ (such as developed by Cochrane or the Campbell 
Collaboration) or the more loosely structured ‘narrative review’.  Aveyard and Bradbury-
Jones (2019) also note that literature reviews are increasingly described by a myriad of 
different terms and thus a clear description of the chosen approach is important.  As more 
diverse evidence has been recognized as valuable and literature reviews have moved 
beyond assessment of intervention alone, approaches to undertaking literature reviews 
have evolved to encompass this heterogeneity (Aveyard, 2014; Aveyard & Bradbury-
Jones, 2019).   Approaches to literature reviews include systematic reviews, narrative 
reviews, scoping reviews, rapid reviews, and realist reviews (Aveyard, 2014; Popay et al., 
2006; University of York Centre for Reviews and Dissemination, 2009).  
Systematic reviews identify, critique, and synthesize empirical evidence to answer a 
specific question, often related to an intervention and whether it is effective (Aveyard, 
2014; Cronin, Ryan, & Coughlan, 2008).  Known to be rigorous and detailed, systematic 
reviews explicitly outline the methods followed to search, appraise, and analyse empirical 
evidence. Systematic reviews are often highly regarded, especially those published by 
reputable groups such as Cochrane and Campbell. A narrative review also brings together 
a body of literature, appraising and synthesizing the evidence but may not be as 
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transparent about the method of searches as is a systematic review (Aveyard, 2014; 
Cronin et al., 2008).   Narrative reviews are sometimes criticized as having little rigour, 
without clearly defined methods, and positioned as a polar opposite to the systematic 
review.  Although this perspective of a systematic review at one end of the quality 
spectrum with the narrative review at the opposite is correct at times, Aveyard and 
Bradbury-Jones (2019) found examples of less than rigorous reviews labelled as 
‘systematic” and high quality, rigorous reviews labelled as ‘narrative’ in their focused 
mapping review and synthesis, concluding that terms for literature reviews are poorly 
differentiated in practice and sometimes used interchangeably.   
A scoping review is used to assess the size and types of evidence available in a specific 
area, often in the planning stages for a future study.  Like systematic reviews, scoping 
reviews involve extensive searching for evidence but differ in that evidence is not 
synthesized (Aveyard & Bradbury-Jones, 2019; University of York Centre for Reviews and 
Dissemination, 2009). Rapid reviews are generally undertaken within a brief period (such 
as 90 days) and similar to a scoping review, are often used to inform a future study or 
policymakers when information is needed within a short time frame. With the limited 
time involved the breadth of evidence in a rapid review may be sacrificed but unlike the 
scoping review, evidence is synthesized (Aveyard & Bradbury-Jones, 2019). The realist 
review, like many systematic reviews, is focused on an intervention, but differs in looking 
beyond the question of whether an intervention works, seeking to answer why and it 
what context it works (Aveyard & Bradbury-Jones, 2019).  
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Within literature reviews, evidence from multiple studies is summarized, synthesized and 
presented in varying ways such as meta-analysis, meta-synthesis and narrative synthesis.  
Meta-analysis is a statistical method to combine quantitative data with similar properties 
to allow for greater statistical power and precision than can be achieved through the 
individual studies, while meta-synthesis is a non-statistical method to synthesize findings 
from qualitative studies (Cronin et al., 2008). Meta-analysis and meta-synthesis may be 
used separately or in parallel.  In narrative synthesis, findings are presented in a narrative 
style, commonly used when statistical methods for pooling data are not feasible or 
suitable, often due to variability in study designs (Ryan & Cochrane Consumers and 
Cummunication Review Group, 2013; University of York Centre for Reviews and 
Dissemination, 2009).  Synthesising data using a narrative style allows the main themes 
from heterogeneous studies to be identified and brought together (Mays, Pope, & Popay, 
2005).  Narrative synthesis is differentiated from the term narrative review, described 
earlier in this section as a term often used to describe a literature review that is not 
rigorous in approach (Popay et al., 2006). 
A literature review, conducted from a constructivist perspective, values multiple research 
methodologies, including qualitative methods and smaller case studies.  Evidence from 
diverse perspectives is important, and in health care evidence from the perspective of the 
person experiencing the phenomenon is especially important to enhance understanding 
of the individual’s experience, and to inform clinical practice, health policy and research.  
The constructivist researcher values these diverse perspectives and through the literature 




A systematic approach employing narrative synthesis was chosen for this study.  This 
approach aimed to help ensure the review was rigorous and transparent, with broad 
scope and depth; prioritizing critique, analysis, and synthesis of the evidence, whereas a 
scoping or rapid review was thought not appropriate as it risked sacrificing depth to 
facilitate rapid information.  Although primarily quantitative, the heterogeneity of the 
literature meant that meta-analysis was not feasible.  Narrative synthesis, using words 
and text to bring evidence together was selected as the best method to explain what was 
known about pain in CF. The process for narrative synthesis outlined by Popay et al. (2006) 
includes four primary elements: 1) theory development of how the intervention works, 
2) preliminary synthesis development, 3) exploring relationships in the data, and 4) 
assessing the robustness or quality of the synthesis. A modified version of this process 
was used, excluding theory development as the review is exploratory and evidence is not 
intervention based. The guidelines for Preferred Reporting Items for Systematic Reviews 
and Meta-Analysis (PRISMA) format were followed in this review (Moher, Liberati, 
Tetzlaff, & Altman, 2009). 
  3.2.1 Database searches 
The databases of AMED, CINAHL, PsycINFO, SCOPUS, Web of Science, and PubMed were 
searched in September 2015, without restriction on publication date. These databases 
were selected as they include a range of academic disciplines and research designs, and 
include journals that are known to publish articles about CF. An electronic “hand-search” 
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of the Journal of Cystic Fibrosis and Pediatric Pulmonology was performed. In addition, 
reference lists for all included articles were searched.  
In July 2019, the search was updated to identify highly relevant articles published since 
the initial search. The search terms and databases were unchanged from the original 
search; however, the inclusion and exclusion criteria were tightened to include only 
adolescent and adult participants and qualitative research. One highly relevant article was 
located through this search update and has been integrated within the narrative 
synthesis.  
The search was run a third and final time in January 2020 using additional search terms 
for cystic fibrosis (1. exp Cystic Fibrosis/ 2. cystic fibrosis.tw. 3. fibrocystic near disease 
near pancreas.tw. 4. mucoviscidos$.tw.5. (cystic$ adj10 fibros$).tw) and for pain (1. pain 
2. chronic pain 3. discomfort).  Like the 2019 search update, a tightened inclusion and 
exclusion criteria included only publications reporting qualitative research in adolescent 
and adults.  No further articles meeting the tightened search criteria were found. 
3.2.2 Database search terms 
A combination of MeSH and other search terms was used. For example, in PubMed, the 
following search terms were used in the titles and abstracts: ("Cystic Fibrosis"[Mesh]) 
AND ((("Pain Measurement"[Mesh]) OR "Pain Management" [Mesh]) OR "Pain"[Mesh]) 
Filters: Humans. In databases that did not incorporate MeSH terms, the words “cystic 
fibrosis” and “pain” were used. Subject librarians from Lancaster University and 
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University of California San Diego were consulted at various stages of the search. See 
Appendix A: Database summary for a list of databases and search results.  
3.2.3 Eligibility criteria 
Inclusion criteria for the narrative synthesis were a) studies with primary focus on pain in 
CF b) studies in people with CF of all ages c) studies published in English, and d) empirical 
studies reporting primary research. Articles were assessed for relevance through 
screening titles and abstracts using established eligibility criteria (see Appendix D: 
Inclusion and Exclusion Criteria). When suitability for inclusion was uncertain, a review of 
the article’s full text was performed. Any uncertainties were resolved by discussion with 
a second reviewer (AB or SGB).   
3.2.4 Data extraction 
Following guidelines recommended by Popay et al. (2006), a preliminary synthesis was 
performed followed by exploring relationships, before assessing the robustness of the 
synthesis. The preliminary synthesis consisted of extracting descriptive characteristics of 
the studies using a data extraction tool designed for use in reviews containing disparate 
data (Hawker, Payne, Kerr, Hardey, & Powell, 2002). Extracted data was then summarised 
in the data extraction table in Appendix B.  
Following extraction of participant and study characteristics, emerging themes were 
identified. An effort to manage existing knowledge and preconceptions related to insider 
status was an important part of the review process. An early tendency to pay more 
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attention to some aspects of findings than others, usually biomedical, was ameliorated 
through consciously staying in researcher role not clinician role as a way of reducing 
potential clinical bias.  Cross checking in which AB and/or SGB reviewed an article with 
color-coded themes addressed any uncertainty or overlooked emerging themes. After 
identification of themes, narrative synthesis moved towards examining the relationships 
within and between studies.  
3.2.5 Quality appraisal 
A quality appraisal tool by Hawker et al. (2002) was used to evaluate and assess the quality 
of the data in this review. This tool takes a broad approach to quality assessment that 
allows comparison of heterogeneous studies of both quantitative and qualitative design. 
See Table 1 for an example of quality appraisal of an article using the tool adapted from 
Hawker et al. (2002).  
Table 1 
Example of Quality Appraisal of Epker, Maddrey, and Rosenblatt (1999), adapted from 
Hawker et al. (2002). 
Category Score Category Score 
Abstract/Aims 2 Ethics/Bias 1 
Introduction/Aims 4 Findings/Results 3 
Method/Data 3 Transferability/ 
Generalisability 
2 
Sampling 2 Implications/ 
Usefulness 
3 
Data Analysis 3   
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Total Score  23 
Note: Scores range from very poor (1 point) to good (4 points) per category.  
Total available score ranges from 9-36. 
 
Appraisals using the Hawker tool resulted in ratings from 21–31 (total possible 9–36). The 
median score for the included studies was 27.5. In 11 of the 14 articles, ratings for ethics 
and bias were “poor” or “very poor”, indicating only a brief mention (or no mention) of 
potential ethical issues, ethical approval, or relationship between participants and 
researchers. Articles were rated highest in the area of results, indicating the findings were 
clearly stated and directly related to results, but in some cases would have benefitted 
from additional explanation. See Appendix B for total quality appraisal scores listed in the 




















Figure 3. Retrieval Strategy Adapted from PRISMA Flow Diagram (Moher et al., 2009). 
3.3 Literature review findings 
In total, 1108 potentially relevant articles were identified, from which 13 of these articles 
fulfilled the eligibility criteria and were synthesised and appraised (see Figure 3). An 
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additional highly relevant article published in 2018 and identified in the search update 
was included in the synthesis, thus 14 articles are included in the synthesis. 
3.3.1 Study characteristics 
Publication dates ranged from 1990–2018. Of the 14 studies, most were conducted in the 
US (n=9), followed by France (n=2), Australia (n=1), Canada (n=1), and Italy (n=1). Sample 
sizes ranged from 10–239. The study populations included adults (n= 6), children and 
adolescents (n=3), combined populations (n=4), and adolescents (n=1).  
Most participants were female (53%; n=598), with male participants comprising 47% 
(n=533). In studies of adults only (or combined studies that separated mean age of adult 
participants), the mean age ranged from 23–31.1 years. The mean age in the studies of 
children only (or combined studies that separated mean age for children) ranged from 
10.2–13.6 years. The adolescent-only study had a mean age of 15.8 years. Stenekes et al. 
(2009) included children, adolescents and adults, and reported a mean age of 19.9 years 
(range 7–60 years). Two studies did not report mean ages (Allgood, Kozachik, et al., 2018; 
Hubbard, Broome, & Antia, 2005). 
All but one of the identified studies were quantitative but were considerably disparate in 
data collection tools and study populations, including broad range of ages. Quantitative 
research designs included 13 observational studies (nine retrospective, three prospective 
and one chart review). Twenty-four different tools were used in the included studies. Only 
four tools were used in three or more studies, limiting statistical comparison of results 
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across studies. A single qualitative study, identified during the search update, employed 
a semi-structured interview design. 
Pain theories, further described in Chapter Four, were almost absent across included 
studies. Epker et al. (1999) mentioned a “biopsychosocial perspective” but did not 
actually employ this as a theoretical lens. Similarly, Kelemen et al. (2012) also made brief 
mention of pain as a “multidimensional phenomenon” in support of including a 
measurement of pain catastrophising. No other studies, including the single qualitative 
study, employed pain theory, at least not in a manner transparent to the reader. 
The concept of suffering was also absent from 10 of 14 studies with no mention of the 
word suffering in any context. Hubbard et al. (2005) and Kelemen et al. (2012) both used 
as a verb to indicate suffering from pain.  Only Festini et al. (2004) and Epker et al. (1999) 
used suffering as a noun, referring to it as an experience.  When suffering was mentioned, 
it was in background or discussion and not part of study findings.  
3.3.2 Thematic analysis 
The results of each study were coded according to common findings, and from these 
codes five themes were developed: pain characteristics, disease severity, quality of life, 
management of pain, and coping. Notation was made of differences in themes in relation 





3.3.3 Pain characteristics 
The most frequent reported locations for pain in adults were the head (n=4/8), chest 
(n=2/8) and back (n=2/8) (Festini et al., 2004; Flume, Ciolino, Gray, & Lester, 2009; Hayes 
et al., 2011; Kelemen et al., 2012; Ravilly, Robinson, Suresh, Wohl, & Berde, 1996; Sermet-
Gaudelus et al., 2009). The most frequent location of pain in children and adolescents was 
the abdomen (n=3/3) (Blackwell & Quittner, 2014; Koh, Harrison, Palermo, Turner, & 
McGraw, 2005; Sermet-Gaudelus et al., 2009). One study with a combined population of 
adolescents and adults reported the chest as the most frequent location of pain; another 
that combined children and adults reported the head as the most frequent site (Hubbard 
et al., 2005; Stenekes et al., 2009). Three studies did not report pain location. Although 
frequency was not reported by Allgood, Kozachik, et al. (2018) in their qualitative study, 
locations were consistent with the other studies.  
People with CF were most likely to report pain intensity in the moderate range (n=5) 
(Festini et al., 2004; Flume et al., 2009; Hayes et al., 2011; Hubbard et al., 2005; Sermet-
Gaudelus et al., 2009). Others with CF reported mild pain intensity (n=4) (Blackwell & 
Quittner, 2014; Epker et al., 1999; Kelemen et al., 2012; Koh et al., 2005). Four studies 
either did not report intensity or only reported it as a correlation with other variables 
(Munck et al., 2012; Palermo, Harrison, & Koh, 2006; Ravilly et al., 1996; Stenekes et al., 
2009). Participants in the qualitative study were included if they reported moderate to 
severe pain at least weekly for at least a month (Allgood, Kozachik, et al., 2018). When 
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examined by age group, adult participants reported higher pain intensity (moderate n=4; 
mild=2) than children and adolescents (moderate n=1; mild n=2).   
Tools used to assess pain intensity were all based on self-report. The tools were the 
Multidimensional Pain Inventory (MPI), Brief Pain Inventory (BPI), Faces Pain Scale/Faces 
Pain Scale-Revised, and ad hoc scales developed by the researcher, with frequency of use 
listed in Table 2 below  (Bieri, Reeve, Champion, Addicoat, & Ziegler, 1990; Hicks, von 
Baeyer, Spafford, van Korlaar, & Goodenough, 2001). The lack of consistency in tools used 
to measure pain intensity, and variation in how the questions were asked, made synthesis 
of severity challenging and limits interpretation of results. For example, Festini et al. 
(2004) asked participants only about the maximum degree of pain intensity, while 
Kelemen et al. (2012) inquired about both average and worst intensity.  
Table 2 
Pain measurement tools used in studies 
Pain Measurement Tool  Frequency 
Multidimensional Pain Inventory (MPI) 1 
Brief Pain Inventory (BPI) 3 
Faces Pain Scale & Faces Pain Scale-
revised 
3 




The reported prevalence of pain ranged from 64% to 94.1% of adults in the past one to 
two months. Ravilly et al. (1996) reported 84% prevalence in the posthumous group. 
Prevalence in children and adolescents ranged from 59% to 89%.  
Words used by adolescents to describe pain, selected from a list of terms, included “sore”, 
“aching”, “pounding”, “cramping”, and “stiff” (Blackwell & Quittner, 2014). Allgood, 
Kozachik, et al. (2018) reported similar words in adolescents, and also noted that adults 
tended to describe their pain more thoroughly rather than a single descriptive word. No 
other studies described words or language used to talk about pain. 
Most studies did not differentiate between acute, chronic and procedural pain. 
Procedural pain was assessed in two studies, with participants reporting procedural pain 
as mild (Koh et al. (2005) and common (Sermet-Gaudelus et al. (2009). Treatment-related 
pain was prevalent in adolescents, with airway clearance therapy the most common cause 
(Blackwell and Quittner (2014). Chronic pain, defined as pain most of the time for six 
months or more, was reported in 27% of adults according to Hayes et al. (2011). The 
qualitative study differentiated pain related to CF versus other causes (Allgood, Kozachik, 
et al., 2018). 
3.3.4 Disease severity 
Disease severity was most often assessed through pulmonary function measured by FEV1 
(forced expiratory volume in one second), a common measure of disease severity in CF. 
Other parameters used were clinician assessment and the Shwachman Rating of Illness 
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Severity (Shwachman & Kulczycki, 1958; Stollar, Adde, Cunha, Leone, & Rodrigues, 2011). 
Most studies reported FEV1 as a mean or median as depicted in Table 3.  In studies using 
FEV1 as a proxy for disease severity, there was no association with pain (Flume et al., 
2009; Hayes et al., 2011; Kelemen et al., 2012; Koh et al., 2005; Sermet-Gaudelus et al., 
2009). Epker et al. (1999) examined the relationship between pain severity and 
Shwachman Rating of Illness Severity, determining that pain was only associated with 
history and general activity level, and not associated with pulmonary physical findings and 
cough, nutritional status or chest x-ray findings.  
Table 3 
Pulmonary function as measured by Forced Expiratory Volume in 1 second (FEV1) and 
population in included studies. 
Author(s) 
 















   Mean/median not reported 
(range:  23.5%-102%) 
Blackwell, L S  
and Quittner A 
Adolescents   X Mean 80% 
Epker, J A, et al. Adults    FEV1 not reported 
Festini, FS, et al. Adults  X 
 
 Median 56.71% 
Flume, PA et al. Adults  X  Mean 58.4% 
Hayes, M et al. Adults  X  Median 63.6% 
Hubbard, PA et al. Adults    FEV1 not reported 
Kelemen, LA, et al. Adults  X  60.5% (unknown whether mean 
or median) 
Koh, JL et al. Children   X Mean 80% 
Munck, AA et al. Children   X Mean 85% 
Palermo, TM et al. Children 
Adolescents 
  X Mean 80.2% 
Ravilly, S et al. Adults  X  Mean 58% 
Sermet-Gaudelus 






X Mean 70% (children);  
Mean 50% (adults) 





   Mean/median not reported 
40% with FEV1>81%; 29% FEV1 
61-80%; 22% FEV1 41-60%; 4% 
FEV1 <40; 5% UNK 
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3.3.5 Quality of life 
In addition to examining potential physical correlates of pain, most studies also examined 
potential relationships between pain and psychological correlates or quality of life 
(Blackwell & Quittner, 2014; Epker et al., 1999; Festini et al., 2004; Hayes et al., 2011; 
Hubbard et al., 2005; Kelemen et al., 2012; Munck et al., 2012; Palermo et al., 2006; 
Sermet-Gaudelus et al., 2009; Stenekes et al., 2009).  
One of the most common tools used to measure quality of life was the Cystic Fibrosis 
Questionnaire–Revised (CFQ-R). The CFQ-R is a validated disease-specific questionnaire 
designed to assess various domains of quality of life in CF, including physical symptoms 
and functioning, social functioning and treatment burden (Quittner, Buu, Messer, Modi, 
& Watrous, 2005). Four studies used the CFQ-R, and two used the previous version, CFQ. 
Pain was found to be significantly related to CFQ-R domains for physical functioning, 
social life, treatment aspects, emotional response, and school or work (Blackwell & 
Quittner, 2014; Hayes et al., 2011; Kelemen et al., 2012; Munck et al., 2012; Palermo et 
al., 2006).  
There was some evidence of associations between sleep and pain. Flume et al. (2009) 
reported that the relationship of pain to impaired sleep quality was strongly correlated, 
and in another study 30.2% of those who experienced pain also reported sleeping 
disorders (Festini et al., 2004). Pain was also indicated as a cause of insomnia (Sermet-
Gaudelus et al., 2009).  
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Depression and anxiety were significantly related to pain, as measured by the Hospital 
Anxiety and Depression Scale (HADS) and the CFQ-R (Blackwell & Quittner, 2014; Hayes 
et al., 2011). Higher reported symptoms of depression or anxiety were associated with 
higher pain intensity (Blackwell & Quittner, 2014). Pain catastrophising, defined as a set 
of exaggerated and negative cognitive and emotional symptoms during actual or 
anticipated painful stimuli, was found to be associated with pain (Hayes et al., 2011; 
Kelemen et al., 2012; Sullivan, Bishop, & Pivik, 1995).   
Pain was associated with interference in daily activities, work and school (Festini et al., 
2004; Hubbard et al., 2005; Kelemen et al., 2012; Stenekes et al., 2009). Most studies 
found an association between pain and CF treatment (Epker et al., 1999; Festini et al., 
2004; Hayes et al., 2011; Hubbard et al., 2005; Kelemen et al., 2012; Koh et al., 2005; 
Palermo et al., 2006; Sermet-Gaudelus et al., 2009). Similar themes about pain negatively 
impacting education, work and social activities were reported in the qualitative study 
(Allgood, Kozachik, et al., 2018). 
3.3.6 Management of pain 
Only one study addressed medication use, reporting NSAIDS were most often used, while 
10 of 78 participants received opioids for more than three months (Ravilly et al., 1996). 




Non-pharmacologic management of pain included rest, physical activity, massage, 
acupuncture and chiropractic (Festini et al., 2004; Hayes et al., 2011; Koh et al., 2005; 
Ravilly et al., 1996). In two studies, some participants said they did nothing to treat their 
pain, an interesting finding given that pain has also been identified as underreported in 
CF (Blackwell & Quittner, 2014; Festini et al., 2004).  
Festini et al. (2004) reported that only 46.2% of participants talked to a physician about 
pain. In contrast, Allgood, Kozachik, et al. (2018) reported that all 10 interview 
participants indicated they spoke to their healthcare providers about pain, and most also 
felt able to talk about pain with friends, family, and school or work colleagues. Allgood, 
Kozachik, et al. (2018) reported adolescents felt supported during these discussions about 
pain, while adults felt stigmatised. 
3.3.7 Coping 
Hubbard et al. (2005) examined coping techniques in participants with CF and pain, 
finding most participants used active coping techniques such as problem-solving, 
acceptance and self-encouragement more than passive techniques such as minimising 
pain, self-isolation and behavioural disengagement. Coping type was not associated with 
the intensity or duration of pain (Hubbard et al., 2005). Interpretation of coping 
mechanisms varied across studies, with Blackwell and Quittner (2014) reporting most 





The aim of this narrative synthesis was to identify what is known about pain in CF, and 
what is known about associations between pain and other symptoms or outcomes in CF. 
All included studies but one were quantitative. Although several studies did include 
quality of life measurements, most were quantitative and did not provide (or at least did 
not report) an opportunity for participants to provide information from their perspective 
and in their own words. The lack of experiential qualitative knowledge in the literature is 
reflective of a research environment that values quantitative evidence over qualitative. It 
also reflects the perception of pain as a singular symptom to be assessed and treated in 
isolation, rather than a complex phenomenon best suited to a qualitative approach to 
explore personal experience and increase understanding. 
The quality of included articles was assessed as between poor and fair, indicating 
improved research design in this area would be beneficial. Studies were rated the lowest 
on ethics and bias, with some studies not mentioning ethics at all (n=4) and others with 
only a minimal mention (n=7). The quality of future studies can be improved through 
clearly stating information about ethical issues and how they have been, or will be, 
addressed. Consideration of the relationship between researchers and participants 
should also be clear, with the researcher demonstrating awareness of potential bias.  
Despite some issues with quality, evidence does suggest that pain is a common issue in 
CF, with prevalence ranging from 59% to 94.1%. This finding is especially interesting given 
at least two studies revealing that participants with CF were not reporting pain to their 
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clinicians. If pain is prevalent in the CF population, then why is it not reported in some 
cases? This area should be further investigated, preferably in a qualitative study that 
allows more in-depth exploration.  
Pain was reported to be significantly related to quality of life, including physical 
functioning, social life, treatment aspects, emotional response, and school or work, and 
these relationships should be further explored. As adults with CF live longer and 
experience the usual activities of life including education, careers and relationships, 
impact of pain on these developmental activities is important to study. Similarly, the 
impact of pain on other quality of life indicators, anxiety and depression should be further 
studied. With evidence suggesting pain impacts daily activities, especially usual CF 
treatment, this may create a cyclical effect with increased pain causing decreased 
adherence to routine therapies, which in turn may lead to increased pain and so on.  
Pain management was not a primary focus in most studies, as they focused more on pain 
characteristics and impact on quality of life, at least in part because this review excluded 
pharmacological RCTs. Although also limited, more information was available about non-
pharmacological management of pain with participants using rest, massage, acupuncture 
and chiropractic. Some participants reported doing nothing to treat their pain and this 
should be further explored. 
Coping was also studied in relation to pain in CF. As most studies were quantitative, the 
possible coping mechanisms reported were chosen from an established list and may not 




There are several limitations identified in this review. First, most studies had a small 
sample size, but this is at least in part due to low prevalence of CF.  Studies were primarily 
retrospective, and participants may not have had adequate recall of their pain. In 
addition, studies performed in a CF clinic setting may have included more outpatients and 
therefore weighted the sample towards a healthier population, but this information was 
not consistently described.  
Multiple tools are used to measure pain in CF, many of which are ad hoc tools that lack 
validation and allow little ability to reliably compare results across studies. Notably, the 
tool developed by Hawker et al. (2002) for quality appraisal has been criticised for lack of 
sensitivity, but its purpose in this review is to provide a general assessment of quality 
rather than to exclude studies.  
Another limitation was lack of consistency in definitions for concepts including pain, 
functioning, quality of life, and disease severity. Finally, all but one study that met the 
inclusion criteria were of quantitative design and engagement with literature on pain 
theory was virtually non-existent.  Despite these limitations, the review was systematic 
and thorough, enabling an adequate answer to the question of what is known about the 






This review has demonstrated that pain is an important issue in CF that may affect quality 
of life, mental health and adherence to treatment. Both pain and CF are recognised as 
complex phenomena, yet existing research about pain within CF is almost exclusively 
quantitative in design. Of the 14 included studies, 13 employed pain assessment tools and 
surveys and one was a retrospective chart review and thus did not include assessment or 
surveys. The tools demonstrated in these studies tended to only provide information on 
clinical aspects of pain as deemed important by the tool’s developer or researcher.  Only 
one pain-based study also sought the perspective of the person with CF; a significant gap 
in the evidence that provides rationale for undertaking this study.  
The literature review findings suggest a gap in knowledge about pain in CF from the 
experiential perspective of the person.  There is a case to explore these experiences and 
using a qualitative approach provide an opportunity for people with CF to share their 
personal stories about pain. Qualitative research is a valuable way to deepen 
understanding about the experience of pain in CF and provide a foundation of knowledge 
to inform future studies, both quantitative and qualitative. The existing literature on pain 
in CF was found to lack engagement with theory.  
The rationale underpinning selection of a qualitative approach, characteristics of 




Chapter 4: Methodology 
In Chapter Three, the literature review revealed pain is a key issue in CF and may affect 
many aspects of quality of life yet seems underreported to CF clinicians. In reviewing the 
literature, existing research about pain in CF was found to be chiefly quantitative. Pain 
theorists within the last fifty years have incorporated multidimensional aspects of pain 
within their models to address complexity of the pain experience, but these models are 
underrepresented in current evidence about pain in CF. This gap in the literature 
confirmed the need to better understand the experience of pain in CF.  
The aim of this research study is to explore the complex experience of pain in cystic 
fibrosis from the perspective of those living with it. Next, Chapter Five will describe the 
philosophical assumptions, methodology and methods for the study, along with the 
rationale for their selection. 
4.1 Research paradigm 
Research paradigms, described by (Guba & Lincoln, 1994, p. 107) as a “set of basic 
beliefs”, are closely connected to all phases of research and provide a foundation or 
framework for key decisions made by the researcher. Research paradigms attend to 
ontological positions (the nature of reality and its characteristics), epistemological 
positions (nature of knowledge), axiological positions (values), and methodological 
positions (how knowledge is obtained) (Creswell, 2013). The particular paradigm, and 
how it guides a researcher’s approach, should be transparent (Guba & Lincoln, 1994). The 
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aim of this study is to better understand the experience of pain in CF, and the research 
paradigm must therefore support exploration of these experiences. 
Historically, paradigms in health research have been largely positivist (Pope & Mays, 
2006; Saks & Allsop, 2013). In a positivist paradigm, reality is understood as an objective, 
single reality that can be measured and known (Guba & Lincoln, 1994; Saks & Allsop, 
2013). Positivist researchers usually adopt quantitative methodologies such as RCTs or 
surveys, and look to identify relationships between variables such as cause and effect 
(Bryman, 2012). While valuable information is gained through positivism, this paradigm 
does not best recognise multiple, unique realities of experience and therefore another 
paradigm, social constructivism, will be considered.  
In social constructivism, individuals are understood to learn and develop meaning 
through social activities, sometimes called social construction (Creswell, 2013; Crotty, 
1998). The ontological perspective in social constructivism is that reality is relative – that 
rather than one true reality, there are multiple realities subject to interpretation (Guba & 
Lincoln, 1994). In other words, reality in social constructivism is socially negotiated. As 
individuals experience the world and interact within it these subjective realities 
continually evolve (Bryman, 2012; Moen, 2006). By adopting a social constructivism 
paradigm, evolving and varied perspectives are valued in understanding unique pain 
experiences in CF.  
Epistemological assumptions within social constructivism hold knowledge as socially 
constructed, with a close relationship between the knower and the known (Crotty, 1998; 
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Guba & Lincoln, 1994). Knowledge stems from subjective experiences of participants and 
in this construction of knowledge, researcher and participant are inextricably connected. 
This connection occurs through interaction between researcher and participant; which 
stories the participant chooses to tell, and how the researcher subsequently reacts to 
these stories, ultimately create knowledge (Guba & Lincoln, 1994).  
Where ontological and epistemological assumptions are concerned with reality and 
knowledge, axiological assumptions are related to values (Creswell, 2013). Social 
constructivists recognise that values influence almost all aspects of research. 
Researchers’ values are expressed through which topics are chosen as worthy of research, 
whose voices are heard, what communications are encouraged or discouraged, and what 
data are chosen for the findings. Similarly, participants choose what information to 
communicate, what details are deemed more or less important, and what they choose to 
leave out entirely.  Finally, editors and publishers decide what is worthy of publication, 
and readers choose what to read and pay more or less attention to.  
Just as social constructivist researchers believe research paradigms should be 
transparent, they also strive to recognise their values and biases and clearly communicate 
them (Guba & Lincoln, 1994). Through communicating their own values and biases, they 
position themselves to show how their interpretation may be influenced by their unique 




4.2 Qualitative rationale 
Underlying assumptions related to ontology, epistemology and axiology suggest 
particular research approaches as more or less congruent with social constructivism. 
Through recognition of multiple realities as socially negotiated and knowledge as socially 
constructed, social constructivist researchers seek complexity of experience and rely on 
an individual’s view of their experiences (Guba & Lincoln, 1994). In seeking this 
complexity, social constructivist researchers also examine the interaction and knowledge 
formed between researchers and participants. For this study, the selected approach must 
then provide a format for participants to describe their experiences in depth, facilitate 
understanding of these experiences and explore how they construct and make meaning 
with these experiences (Robson, 2011).  
There are two primary research approaches, quantitative and qualitative. In a 
quantitative approach, data are usually expressed in numerical form and then 
categorised, ranked or analysed in relation to other variables using statistical analysis. In 
contrast, data in a qualitative approach are non-numerical in form, such as interview 
transcripts or observations.  
A qualitative approach was chosen for this study to facilitate a more complex and deeper 
understanding of experience than would be gained through quantitative means (Braun & 
Clarke, 2013; Creswell, 2013). Having decided that a qualitative approach was ideally 
situated to answer the research question, determination of which specific qualitative 
methodology is most appropriate was considered next.  
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In a social constructivist qualitative approach, methodology should be interaction- and 
discussion-based (Guba & Lincoln, 1994). Several qualitative methodologies facilitate 
exploration of experiences and meet the criteria of being interaction- and discussion-
based, including phenomenology, grounded theory, ethnography and narrative (Creswell, 
2013). Phenomenology aims to describe the meaning of lived experience (phenomenon) 
shared by several individuals, focusing on shared aspects, or essence of the experience 
(Creswell, 2013, p. 76). Grounded theory methodology moves past description and 
application of current theory and aims to generate new theories (Creswell, 2013). A key 
feature of grounded theory is that the theory emerges or is grounded in the data. 
Although grounded theory may involve interviews, the focus is usually on factors that 
affect social processes in a particular phenomenon (Braun & Clarke, 2013). In 
ethnography, the researcher describes and interprets behaviour of a group that shares a 
culture, primarily through participant observations in a natural setting. Analysis in 
ethnography often provides interpretations of how groups work or function, language, 
values, behaviours, and institutional patterns (Hammersley & Atkinson, 2007). Narrative 
methodology recognises the importance of stories people construct and how they make 
meaning through these stories (C. K. Riessman, 2008). In a narrative approach, 
researchers aim to explore participants’ unique experiences, how they tell stories of their 
experience, and their relationship with an experience over time.  
With limited evidence available in the literature review, any of these qualitative 
methodologies could make a meaningful contribution to understanding the experience of 
pain in CF. However, not every qualitative methodology is ideally situated to meet the 
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aims of this particular study. After careful consideration, narrative methodology was 
identified as most congruent with the aim, epistemological, ontological and axiological 
assumptions of this study. With a focus on the unique and evolving experiences of 
individuals, narrative is particularly congruent with the ontological perspective of this 
study, social constructivism, in which reality is multiple and subjective, which has been 
discussed in section 5.1. The co-construction that occurs through narrative research 
further situates it in the epistemological perspective of knowledge as socially constructed. 
Finally, the axiological positioning of narrative with an emphasis on participants telling 
the stories they choose to tell in the way they choose to tell them, and the transparent 
positioning of the researcher further support the positioning of narrative within social 
constructivism.    
4.3 Narrative research methodology 
4.3.1 General description 
Narrative research has origins in multiple disciplines including literature, history, 
linguistics, sociology and anthropology (Andrews, Squire, & Tamboukou, 2013). As a 
research methodology, narrative has been developed as a means of exploring experience 
over the past three decades, and is increasingly used in health and social research (Elliott, 
2005; Margarete Sandelowski & Barroso, 2006). Narrative research has been reported as 
useful in nursing research around health and illness (Haydon & van Der Riet, 2017; Wang 
& Geale, 2015).  Using narratives exploring an individual’s experience with illness 
contributes to understanding and subsequently informs both health policy and clinical 
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care.  The particular attention to relationship in the co-construction of narrative is equally 
important in partnerships in healthcare between patients and families with nurses and 
other clinicians and is at the core of conveying compassion and building trust.  
Additionally, narrative is reported as beneficial to illuminate patient experience in 
palliative care, whether to accompany quantitative methods or as a stand-alone method 
for qualitative research (Thomas et al., 2009).  Individual nuances in the experience of 
patients and clinicians, and in the relationships and interactions that occur between them 
come forth through narrative. These nuances of experience further understanding, 
leading to insights in clinical care, and future directions for research, health policy, and 
education (Bingley, Thomas, Brown, Reeve, & Payne, 2008). In this study, narrative 
methodology was chosen to facilitate insight into the experience of pain in CF. 
The term “narrative” is used in different ways and meaning may vary depending on who 
is speaking. It is therefore difficult to come to a consensus on a precise definition 
(Andrews et al., 2013; C. K. Riessman, 2008; Smith & Sparkes, 2009). Although narrative 
may be used as a synonym for story, narrative as a methodology encompasses more than 
just the stories or narratives themselves (C. K. Riessman, 2008). According to Clandinin 
and Connelly (2000, p. 18) ”narrative is both the phenomenon and the method of the 
social sciences”. To gain insight into serious illness when facing end of life, Bingley et al. 
(2008) recommends that researchers not only engage with the narrative itself, but employ 
narrative methodology to do so. Although Bingley et al did not include CF illness narratives 




In perhaps the simplest description, narrative is defined as a way to understand 
experience (Smith & Sparkes, 2009). C. K. Riessman (2008, p. 6) further describes narrative 
methodology as having three important distinctions: “the practice of storytelling (the 
narrative impulse – a universal way of knowing and communicating…); narrative data (the 
empirical materials, or objects for scrutiny); and narrative analysis (the systematic study 
of narrative data)”. This comprehensive understanding described by C. K. Riessman (2008) 
informs the present study, along the continuum from planning to data collection and 
analysis. 
4.3.2 Importance of stories 
A key assumption in narrative is that of story as the basic unit through which experience 
is communicated and a fundamental way that people make sense and meaning of these 
experiences (Elliott, 2005; Mishler, 1986; C. K. Riessman, 2008; M. Sandelowski, 1991). In 
the words of Polkinghorne (1988, p. 1), narrative is “the primary scheme by which human 
existence is rendered meaningful”. Narrative researchers seek to explore experiences and 
their meanings through the rich data found within stories (Clandinin & Connelly, 2000). 
Mishler (1986) drew attention to the importance of listening to people’s stories when 
conducting qualitative interviews, taking active efforts to encourage rather than silence 
these stories. Narrative researchers assert that facilitating these stories through narrative 
approaches makes sense since people are naturally storytellers (Charon et al., 2016; 




4.3.3 What counts as narrative? 
Narrative stories may be constructed from different types of data including interviews, 
observations, written documents, and visual data such as paintings or photographs 
(Andrews et al., 2013; C. K. Riessman, 2008). Stories may encompass a single experience 
or phenomenon, or an entire life (Elliott, 2005). Although narratives can be constructed 
from different sources, much narrative research uses data constructed through 
interviews, as is the case in this study (C. K. Riessman, 2008).  
4.3.4 Co-construction of narratives 
A key concept in narrative methodology is that of narratives as co-constructed (A. W. 
Frank, 2010; Mishler, 1986; C. K. Riessman, 2008). Narratives are created through 
interaction when narrative researchers co-construct and analyse the stories individuals 
tell about their experiences. In this study, narratives are co-constructed through the 
research interview.  A narrative research interview facilitates storytelling, something C. K. 
Riessman (2008, p. 23) called a “narrative occasion”. A narrative interview has a 
conversational style, allowing the participant to freely tell their story with fewer 
interruptions than seen in other styles of interviewing or everyday conversation (C. K. 
Riessman, 2008) . The goal in a narrative interview, through this conversational style, is 
to construct a detailed account rather than the more familiar brief response seen in other 
types of qualitative interviews (C. K. Riessman, 2008). In practice narrative interviews 
require the same level of preparation and adherence to high research and ethical 
standards (Beuthin, 2014; Pederson, 2013). 
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Narratives do not literally represent reality but rather present constructions of an 
individual’s experience within a social context or community (Crotty, 1998). This 
perspective of narrative as co-constructed is aligned with underlying assumptions of 
social constructivism, where meaning is constructed through a person’s interaction with 
the world (Crotty, 1998). Co-construction highlights the dialogical nature of narrative, 
regarding the participant as an important aspect of the co-constructed narrative (A. W. 
Frank, 2010).  In creating a narrative, both researcher and participant are working with 
the story, exploring and creating it together.  The personal account of illness experience 
and how it has affected one’s life is known as an illness narrative (Kleinman, 1988). Illness 
narratives have become an influential area of study over the past several decades  
(Charmaz, 1999; A. Frank, 2009; A. W. Frank, 1998; Mishler, 1995; Smith & Sparkes, 2005). 
According to Cardillo (2010), one can gain a greater awareness and understanding by 
focusing closely to the illness narratives of those who have grown up with chronic 
conditions, such as CF.  
4.3.5 Why narrative? 
A key consideration in selecting a methodology is looking at what the specific approach 
does. In other words, what does narrative help discover about pain in CF that other 
methodologies may not? Narrative methods allow researchers to discern how 
participants understand their lives across the life course, accounting for temporality of 
experience (Clandinin & Connelly, 2000; C. K. Riessman, 2008). This aspect of time, to hear 
through stories how an individual reflects on their past, considers their present and 
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anticipates the future, is a valuable characteristic of narrative. People make meaning 
through storytelling, and these stories can help shed light on how meaning may evolve 
over time or differ even within the same conversation (Clandinin & Connelly, 2000). 
Sometimes, narratives may provide insight into why some stories are silenced and others 
are heard, identifying opportunities for improvements in care (Andrews et al., 2013).  
Although they use varying approaches, narrative researchers share in common an interest 
in improving understanding of the illness experience through the stories that people tell. 
For example, Ahlsen, Mengshoel, and Solbrække (2012a, p. 317), in their study of men 
with chronic pain, used narrative methodology based on typologies such as “being 
comforted” and “being connected”, similar to the quest, chaos and restitution narratives 
depicted by  A. W. Frank (2000).  Through narrative, they learned that men found meaning 
beyond physical recovery at the rehabilitation clinic, men spoke of finding social 
connection and rebuilding the self (Ahlsen et al., 2012a).  In another study on chronic 
pain, Ahlsen, Mengshoel, and Solbrække (2012b) employed narrative methodology with 
attention to both content and structure.  This approach, also with men who are receiving 
rehabilitative care, facilitated recognition that below the surface in accounts on their 
objective experience with pain, the men shared vulnerability in their suffering and 
struggles with losing control (Ahlsen et al., 2012b). Dysvik, Sommerseth, and Jacobsen 
(2011) applied a traditional thematic analysis to a case study about a woman with chronic 
pain but did not use narrative methodology. While the case study provided details of 
experience a narrative approach may have yielded additional understanding such as the 
social context and temporal aspects of experience. In young adults with CF, Oddleifson 
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and Sawicki (2017) used thematic narrative analysis, including attention to the context in 
which stories were told. This shed light on the social world of the young adult with CF and 
the connections between this social world, adherence to the CF treatment regimen, and 
sense of self (Oddleifson & Sawicki, 2017). Moola and Faulkner (2014) analysed illness 
narratives of two children with CF.  Their approach includes robust narrative methodology 
attending to content, structure, dialogic and performance aspects of narrative 
methodology. Through this approach they reveal the complexity of the child’s experience 
with CF, illuminating how life-threatening illness, a child’s developmental stage, social and 
cultural background may influence the stories they tell (Moola & Faulkner, 2014). Using 
narrative in a form that leans towards the traditional qualitative thematic analysis, Bruce 
et al. (2014) explored stories of those with life-threatening illness, uncovering nuances of 
invisibility in life threatening illness but attending to content only. Gatti et al. (2018) used 
a different style of narrative analysis, a quantitative form that counted words and phrases, 
as well as exploring metaphors, a less common method in narrative. Wicks, Berger, and 
Camic (2019) used an extensive narrative methodology attending to structure, content, 
literary elements and social context in her study of chronic illness in adolescents, enabling 
the relationship between adolescent development, physical and emotional health to 
come into focus. 
Carr, Loeser, and Morris (2005); Lipman (2011); Rajagopal (2011) are all researchers who 
have recommended narrative as a good approach to the study of pain, given that it is 
exploring experience of pain over time in people with CF. As they have a lifelong life 
limiting illness it seems especially relevant to explore their experience over their lives.  
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With experience being so subjective “pain remains elusive, difficult to grasp, and hard to 
address” and narrative offers a way to better understand pain, through the stories of 
those that are experiencing it (Carr et al., 2005, p. 3; Lipman, 2011). These stories about 
pain facilitate rich description and exploration of these experiences. Through listening to 
stories participants choose to tell, how they tell them, and the context of telling, a deep 
understanding of complicated experience can be gained. This provides insight into how 
pain should be treated and studied (Rajagopal, 2011).  Narratives may also encourage 
others to act. In the case of the researcher-clinician, it is recognised that participants may 
view the interview occasion as an opportunity to be heard, to ensure that their unique 
perspectives about pain are heard, and in some cases may hope the researcher takes 
some kind of action. Through sharing their experiences, participants may also encourage 
others with similar experiences to also speak out, thereby creating movement or even 
social action.  
4.3.6 Empowerment through narrative 
With so little known about pain from the perspective of individuals with CF, and 
indications that pain is underreported in CF, empowering individuals to share their stories 
is critical. Narrative interviewing begins with the researcher empowering the participant 
to tell their own story in their own way (C. K. Riessman, 2008). This results in a shift of 
power from researcher to participant as the researcher gives up some degree of control, 
encouraging participants to provide extended accounts of experiences (Elliott, 2005; C. K. 
Riessman, 2008). By the researcher listening carefully and avoiding interruption, 
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participants are empowered to tell their own stories, whereas doing otherwise may 
inadvertently train the participant to discuss only topics the researcher finds relevant or 
only provide brief responses (C. K. Riessman, 2008).  The researcher inevitably does exert 
control through their leading the research enquiry, even in narrative research, by deciding 
which aspects of a story are included, and how it is presented and interpreted.  It has 
been noted, for example by Esin, Fathi, and Squire (2014), that it is important to be aware 
of the differential in power between researcher and participants, particularly in a 
constructionist approach to narrative.  This attention to power helps the researcher and 
reader to see how the power relationship influences which stories are told and which 
ones may be suppressed.  The interest in the power relationship is not only concerned 
with that between participant and researcher, but also with each party in the context of 
their other unique positions, cultural and social environments (Esin et al., 2014).  There 
are power differentials that occur in all types of qualitative work and narrative is no 
exception.  But it is in the way that the narrative researcher stays alert to the power in 
the relationship and its influence on co-construction that is important in honouring the 
story. 
4.3.7 Narrative analysis 
Narrative studies differ from other qualitative studies in how narrative accounts are 
treated analytically. In contrast to other forms of qualitative analysis which fragment data 
into themes, narrative research treats the extended narrations as units (C. K. Riessman, 
2008). By keeping narratives relatively intact, researchers honour the individual’s unique 
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voice and way of telling their story, allowing characteristics such as sequence and 
structure to remain visible (C. K. Riessman, 2008).  
Just as there are different perspectives about what is accepted as narrative, researchers 
may align with particular approaches to analysis. Mishler (1995) published a useful 
framework for understanding these different approaches to narrative analysis. In his 
framework, Mishler (1995) described different approaches to narrative as focused on 
content (events and experiences described), structure (how the story is told), or 
performance (context of how a story is produced). In addition to these approaches, C. K. 
Riessman (2008) adds visual analysis, which examines how people communicate with 
images. Selection of a particular approach to narrative analysis can have a significant 
impact on presentation of data and findings, and their interpretation, demonstrated 
through re-presenting narratives by Poindexter (2002). Through detailed descriptions of 
using five different narrative transcription methods, Poindexter (2002) provided an 
insightful illustration of how different methods can influence interpretation and meaning.  
Transcripts of the same narrative in different styles focused on 1) content informed by 
Catherine Kohler Riessman (1993), 2) structural elements of the stories by Labov and 
Waletzky (1967), 3) linguistic approach attending to emphasis, pitch, pauses and 
presenting the story in the form of idea units, lines, and stanzas by Gee (1991), 4) an  
iteration combining Gee (1991) with Mishler (1995) emphasizing co-construction and 5) 
a poetic style informed by Gee (1991), but with more liberty taken to reduce to a poetic 
style. Each of these methods of transcription led to different nuances of analysis, for 
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example, Poindexter (2002) found that using Gee (1991) approach conveyed emotion in 
a way that others did not. 
Most narrative researchers use thematic or content analysis or structural analysis (C. K. 
Riessman, 2008). Rather than a clear delineation between these approaches, C. K. 
Riessman (2008) describes the boundaries as blurred, with many researchers modifying 
the approach or combining different approaches together.  This combined approach 
focusing on both content and structure is adopted in this study to examine the stories 
about pain in CF. A thematic or content analysis informed by C. K. Riessman (2008) and 
structural analysis based on discourse analysis by Gee (1991) was undertaken to closely 
examine how the stories are told. Looking closely at how the stories are told strengthens 
the findings as new insights may be found that were not visible when focusing on content 
alone (C. K. Riessman, 2008).  
In the approach to structural narrative analysis and content informed by Gee (1991), 
interpretation begins with the units that make up speech. Units of speech include idea 
units, lines, stanzas, strophes, and parts, outlined in Table 4 (Gee, 1991). Stanzas, 
purported by Gee (1991) as a universal component of language, are made up of a group 
of lines about a single topic, relatively short and spoken at about the same pace. When a 
narrative interview is represented in lines and stanzas it may appear as a poetic-like form, 
communicating the essence of the story. Identification of these units of speech and 
subsequent application of this method requires close attention to both structure and 
mechanics of how a story is told, including pauses, utterances, emphasis, and intonation 
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or pitch (Gee, 1991). The close attention required is achieved through listening to the 
recorded interview multiple times during and following transcription.  Poindexter (2002), 
whose comparison of five different narrative methods was described earlier in this 
section, found that Gee’s method facilitated attention to pace and pattern of speech, 
word usage and emphasis on different words, resulting in identification of meaning that 
was not realized through other approaches.   
 
Table 4 
Structure of narrative as described by Gee (1991). 
Unit Description 
Idea units A single idea, single pitch glide, often noted by a 
preceding pause. The basic unit of speech. 
Lines A line is made up of several idea units, appears similar to 
a sentence, often identified through pitch and pauses. 
Stanzas Several lines about a single topic, often four lines in 
length, relatively short, spoken at same pace.  
Strophes Comprised of two related stanzas. 
Parts Larger units made up of stanzas and strophes which when 







This section outlines in detail the specifics of how this study was conducted.  
4.4.1 Participant selection 
This study was conducted at an adult CF centre in the US accredited by the Cystic Fibrosis 
Foundation. Approximately 260 people with CF receive their care at this centre, with ages 
ranging from 18-72. The centre has an active research program consisting primarily of 
pharmaceutical trials. 
Purposive or criterion-based sampling was used for recruitment in this study. This 
sampling strategy involved selecting participants who could provide “insight and in-depth 
understanding” of the phenomenon to be studied (Patton & Patton, 2002, p. 230). 
Purposive sampling is commonly used in qualitative research to ensure that the 
participants represent the criteria of interest in the study and to attempt to include 
diverse representation (Creswell, 2013; Ritchie & Lewis, 2003). Purposive sampling also 
common in narrative studies, for example,  (Pooler, Richman-Eisenstat, & Kalluri, 2018; 
Sheilds et al., 2015; Wicks et al., 2019). 
The target population was adults with CF who endorsed experience with pain. Since 
previous studies indicated many with CF underreport pain, it was decided not to limit the 
study to individuals with a diagnosis of pain in the medical record. Instead, potential 
participants were eligible if they self-identified as having experience with pain in CF as 
described on the study information sheet.  
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Potential participants were identified through members of the CF multidisciplinary team 
(nurse coordinator, research coordinator, and physician) who served as gatekeepers. The 
gatekeepers provided a participant information sheet (Appendix H) to potential 
participants during scheduled CF clinic visits, and if they were interested, requested their 
preferred method of contact (telephone and/or email).  
Participants were contacted to explain the study’s purpose and what participation 
included, including potential risks and the ability to withdraw. When possible, they were 
given a copy of the informed consent (Appendix G) before the interview. A total of 23 
people with CF were invited to participate, and 16 expressed interest. Reasons stated for 
not wishing to participate (when given) were reported by gatekeepers to be primarily 
related to the time required for the interview. Of the 16 participants who expressed 
interest, seven did not participate for reasons that included interview cancelled with no 
reason stated (1), interview cancelled due to hospital admission (1), participant died 
before interview (1), participant changed mind (1), interview cancelled due to wildfire (1), 
or lost to follow-up (2). A total of nine participants were interviewed.  
The primary barrier to recruitment was reliance on gatekeepers to provide study 
information sheets, and notes placed on the clinic packets were helpful reminders. 
Diversity in gender, age, and disease severity was an aim, but notably in this size and type 
of in-depth qualitative study, a representative sample is not possible. Originally the aim 
was to recruit 10-20 participants, however, only 9 were recruited. Relatively small 
numbers of participants is comparable with other narrative studies as the focus in 
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narrative research is on  rich and unique experiences communicated through individual 
participant stories (Braun & Clarke, 2013; C. K. Riessman, 2008). Because of the depth of 
data collection and depth of the method it is not unusual to find smaller sample sizes of 
4-6 participants, for example Haydon, Browne, and van Der Riet (2018). The flexibility of 
narrative methodology to be applied to various sample sizes was illustrated by Elliott 
(2005) in her book about narrative in social research.   Narrative approaches and their 
focus on individual participant stories (or cases) can be especially time intensive in 
comparison to other qualitative methods (Thomas et al., 2009). This focus on individual 
stories does not indicate disinterest in the sociological, rather it can illuminate the 
individual within society (Elliott, 2005). 
4.4.2 Setting 
Participants selected where to have the interview. Four preferred to meet in their homes 
and five chose to meet in an office building conference room at the university campus. 
Attention was paid to ensuring the participant’s comfort, including physical environment 
and privacy in both locations. In seven interviews, only the participant and the researcher 
were present during the interview. In two interviews, family members were present or 
nearby at the participant’s request. 
4.4.3 Data collection 
Primary data collection consisted of unstructured or in-depth interviews, conducted in a 
conversational manner (C. K. Riessman, 2008; Rubin & Rubin, 2012). Participants were 
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invited to explore their stories with pain and had some control in the direction and pace 
of the interview (Offredy & Vickers, 2010) .  
An interview guide (see Appendix E) was developed with a list of topics, and examples of 
open-ended question styles, prompts and probes, but this guide was used infrequently 
and usually at the end of the interview to see if any topic areas had not already been 
covered. Topics included in the guide were past and current experiences with pain, quality 
of life, reporting pain to others, treatment, self-management, fears and concerns, and 
types of pain. Interview duration ranged between one hour and one hour 20 minutes. All 
interviews were audio recorded with participant permission. Emotional responses, 
silence, reflections and other details not easily identified in later reviews of the transcript 
were noted in the field journal.  
I began each interview by explaining that I was interested in the participant’s experience 
with pain in CF. I explained that the style of interview was unstructured and explained 
briefly what that meant. Initial questions and probes invited participants to “tell me about 
yourself” to learn background information that may not be related to pain and to begin 
to establish comfort in the interview.  
Following this initial question, I asked the participant to tell the story about their 
experience with pain in CF, although this question did not immediately follow the initial 
prompt in all interviews. I tried to allow the stories to flow in as natural a style as possible, 
and minimised interruptions except to ask for clarification or further description. At the 
end of each interview, I reviewed the interview guide and asked additional questions if 
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needed. Participants were asked if there was anything they were surprised we did not 
talk about or would like to add to our discussion. I offered each participant the 
opportunity to contact me if they would like to add additional information to their 
interview, but none did so.   
4.4.4 Ethical considerations 
This study was approved through the Human Research Protections Program (HRPP) at 
University of California San Diego and through the Faculty of Health and Medicine 
Research Ethics Committee (FHMREC) at Lancaster University. Annual research updates 
and renewals were submitted as required. See Appendix F for complete ethics approval 
documentation.  
It is worth noting in regards to ethical considerations my position as an insider, in that I 
conducted research within a population that I also work with in the role of nurse manager 
(Hammersley & Atkinson, 2007). Recognising the possibility that people might feel 
pressure to participate given my role in the CF program, I took several steps to minimise 
this possibility. First, I used gatekeepers for initial contact with potential participants. 
Next, when contacting potential participants who had expressed interest, I directly stated 
that the decision to participate or not would not affect clinical care in any way and 
emphasised that I was inviting them to participate if they wanted to. I further stated that 
anonymity and confidentiality would be maintained in accordance with the informed 
consent and emphasised that this included the CF team as well. When talking in person I 
avoided wearing a lab coat or business suit to decrease any perception of power that 
  
 65 
might be reinforced through this attire commonly associated with clinicians or executive 
leaders.  
4.5 Data analysis 
 A staged narrative analysis approach was undertaken to analyse the participant 
narratives. The first stage of analysis was to transcribe the interviews. This initial 
transcription of the interview was done verbatim with notation of pauses, sighs, emphasis 
placed on words or syllables, or any verbal utterances such as um, ah, hmm and similar. 
Also notated were any emotions such as laughing, crying or nervousness. Including these 
details in the transcript was important for providing vital information needed for Gee’s 
(1991) method of structural and content analysis, about which further details are included 
below. I transcribed all of the interviews myself, and although it required a large amount 
of time, it enabled me to become very familiar and begin to immerse myself in the data.  
During transcription, all identifiers were removed such as names of family members or CF 
care team members. Participants were assigned an alias from the list of most common 
baby names in the US in 1990, starting with the most common name (BabyCenter, n.d.). 
Following initial transcription, the audio recording was played again while reading the 
transcript, and any errors or omissions were corrected.  
In the next stage of analysis, I began to interact with the data through close reading and 
notation of areas of interest in the transcripts. Using paper copies of transcripts, I 
annotated interesting sections of text by highlighting or making notes in the margin. I also 
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used the process of mind-mapping to engage further with the data and begin to identify 
relationships to Saunders (1965) theory of total pain. See Appendix I for an example of 
this initial stage of analysis on paper transcripts and for an example of mind-mapping. 
I then used an approach to structural narrative analysis and content informed by Gee 
(1991), where interpretation begins with the units that make up speech. Transcribing that 
included these details and close repeated listening to the recording helped to identify 
these units of discourse within the transcript, specifically lines and stanzas. As Gee (1991) 
did in his research, each stanza was given a title using the participant’s own words. 
Identification of these stanzas was a subjective process and it could be said that another 
researcher working with the same material might identify different stanzas. In this way, 
application of structural analysis is a highly interpretive process and demonstrates the co-
construction of knowledge inherent in qualitative analysis. An example that clearly 
demonstrates this co-construction in a full text excerpt and the associated stanza is 
included in Appendix J. 
4.6 Public involvement in research design 
As recommended by Hammersley and Atkinson (2007), I aimed to empower participants 
and other individuals with CF through involvement in the research planning process, 
providing some degree of control in the interview process itself, and participation in 
providing feedback on transcripts and analysis. In CF and other pulmonary diseases, 
patient and public involvement has been encouraged in both research and clinical care 
(Chalmers et al., 2017; Cystic Fibrosis Foundation, n.d.-c; Cystic Fibrosis Trust, n.d.). 
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Through Community Voice, the Cystic Fibrosis Foundation actively seeks patient and 
family involvement, expressing that because each person’s experience is different hearing 
from as many people as possible is critical to identifying needs and planning present and 
future initiatives (Cystic Fibrosis Foundation, n.d.-c).  During the early planning phase, 
three individuals with CF volunteered to provide feedback on the planned study. These 
individuals reviewed the interview guide and provided feedback. Two of these individuals 
also participated in a brief pilot interview which helped to develop interview skills and 
comfort using the interview guide and audio recorder.  
During the pilot interviews, a need to provide tissues, wastebasket and water was 
identified (due to coughing up sputum). Also, during pilot interviews, there was an 
opportunity to practice listening more, talking less, and become aware of the impulse to 
want to speak up to solve problems. Conducting pilot interviews aided in the transition 
from the role of clinician to that of clinician-researcher for this study.  
The unstructured interview style provided participants some control over the interview 
process, particularly which stories received more attention than others. Each participant 
was offered an opportunity to review their interview transcripts but only one did so. This 
individual commented that they were surprised by the depth of pain they were holding 
in and expressed gratitude for the opportunity to talk about it. Similarly, participants were 
provided an opportunity to view the interview segments that were formatted into 
stanzas. Five participants elected to review stanzas, and none requested changes. Rather, 
all five expressed satisfaction with the transformation to stanzas and felt representations 
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were accurate. Several commented on the “power” or “essence” present in this poetic 
form, and one participant tearfully asked if he could have a copy to share with his wife as 
“this is my heart in raw form”.  
4.7 Conclusion 
This chapter has outlined a research paradigm concerned with how individuals learn and 
develop meaning through social activities or social constructivism. In this paradigm, there 
are multiple realities subject to individual interpretation (Guba & Lincoln, 1994). Adopting 
social constructivism demonstrates value for varied perspectives in striving for a deeper 
understanding of unique pain experiences in CF and narrative research methodology is 
ideally situated for this study. Findings, analysed thematically as informed by C. K. 




Chapter 5: Findings 
This chapter presents the study findings. First, a summary of participant socio-
demographics, data collection and analysis are presented. Next, the three key narratives 
and associated sub-stories identified during analysis are described. The narrative of 
emerging awareness of having CF is presented through the sub-stories of diagnosis, 
disease progression and limited life expectancy. The social legitimacy narrative is 
presented through the sub-stories of pushing through and independence. Finally, the 
narrative of invisibility is presented through the sub-stories of feeling misunderstood, 
choosing to be invisible, and becoming visible. 
5.1 Sociodemographics, data collection and analysis 
Ten individuals agreed to participate in the study, of whom nine were interviewed; one 
died before the interview could occur. Participants were aged 26–44 years, and all 
Caucasian but one. Gender distribution was six females and three males. The ethnic 
distribution of participants was consistent with the reported ethnic distribution nationally 
(Cystic Fibrosis Foundation, 2018).  One third of participants had advanced lung disease 
with an FEV1 of £40%. Participant demographics including age, gender, ethnicity, lung 







Table 5  
Demographics 
Age Median 29.5 (26–44) 
Gender  Female: 6 
Male: 3 
Ethnicity Caucasian: 8 
Latino: 1 
Other: None 
Lung function FEV1 £40%: 3 
FEV1 >40%: 6 
Marital status Married: 5 
In a relationship: 1 
Divorced and in relationship: 1 
Single: 2 
Lung transplant status Received transplant: 2 
Listed or undergoing evaluation: 1 
Not applicable: 6 
 
Four interviews were conducted in participants’ homes and five in a university office 
conference room. Interviews, lasting between 55 minutes and 75 minutes on average, 
were conducted between October 2016 and June 2017.  
Interviews started with an invitation for participants to share a little about themselves, 
usually phrased: “How would you describe yourself and your CF to someone who doesn’t 
know you, a kind of [participant name] 101?” This prompt was given to help participants 
feel comfortable as the interview began. Initially an attempt to ease into the interview, 
these initial stories became a significant element of the findings.  
After sharing about themselves, participants were asked to describe their experiences 
with pain. Some participants immediately asked if emotional pain was included, while 
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others simply assumed it was. All participants shared different types of pain, and most 
labelled their experiences as physical or emotional pain. Although many stories included 
elements of social and spiritual pain as well, these were not overtly identified by category, 
and often labelled as emotional pain, if labelled at all. When they described their 
experience with pain in CF, participants shared a narrative journey of their lives, 
incorporating their experiences with pain into these stories.  
A narrative approach to analysis, conducted according to the description of methods in 
Chapter Five facilitated identification of overarching narratives and sub-stories. Inspired 
by Gee (1991), analysis focused on both content and structure. Through analysis, three 
key narratives were identified: emerging awareness of having CF, social legitimacy, and 
invisibility. They are presented here in the form of stanzas. These narratives, each 
composed of several storylines, expressed the essence of participants’ all-encompassing 
experience with pain.  
5.2 Emerging awareness of having cystic fibrosis 
Throughout their interviews, participants shared how CF has increasingly affected their 
lives. As CF progressively worsened, participants experienced an emerging awareness of 
what having CF means. As they became sicker, participants were more aware of how CF 
was affecting them and expressed different types of pain. Pain was a constant presence 
and affected every sphere of their lives.  
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While increasing awareness occurred gradually, some memories stood out more than 
others, and it is these recollections that facilitated the emerging awareness narrative. For 
discussion purposes, the emerging awareness narrative is divided into three sub-stories: 
diagnosis and early years, disease progression, and limited life expectancy; however, 
these actually comprise more of a single, narrative journey through participants’ lives. 
Participants shared this narrative as a chronological retelling of their experiences with 
pain from diagnosis and early years to the present, a style consistent with temporal 
structuring of illness narratives and other forms of life stories (C. K. Riessman, 2008).  
5.2.1 Diagnosis and early years living with cystic fibrosis 
All participants began with stories about diagnosis. In the first four interviews, these were 
elicited by an initial prompt requesting they talk a little about themselves and their CF, 
then adding an inquiry about diagnosis and disease course. This part of the initial prompt 
was later dropped to decrease interviewer influence on what they chose to share, but 
participants began with diagnosis stories regardless of which prompt was given.  
For most participants, these stories were brief and factual in nature, coming from those 
diagnosed as infants or young children. For these participants, CF had always been a part 
of their lives, and information about diagnosis was relayed through parents rather than 
personally experienced. When diagnosed in infancy or early childhood they did not have 
the intellectual capacity or maturity at the time to understand the implications of 
diagnosis. However, participants diagnosed later (Amanda and Matthew) relayed more 






Stanza 2: They did a sweat test on me 
 
5. I would cough in the mornings 
6. I would cough so much I would vomit right when I woke up  
7. and then throughout the day I’d be a little bit better 
8. so, they did a sweat test on me 
 
Stanza 3: I was in denial 
 
9. I had never even heard of the disease before, so I was in denial  
10. because I thought for years  
11. I thought that they had did something wrong with the test  
12. and that I had some other something. 
 
Stanza 4: I thought eventually they would say we made a mistake 
 
13. I thought eventually they would say we made a mistake 
14. here’s an antibiotic you’re going to be better 
15. I’m sorry to put you through this 







Stanza 2: Before I got diagnosed it didn’t really affect me that much 
 
1. Before I got diagnosed, it didn’t really affect me that much  
2. I was doing everything a normal 16-year-old was doing  
3. I was playing soccer, I was playing sports at school,  
4. like a normal 16-year-old 
  
Stanza 3: But after I got diagnosed it did affect me emotionally 
 
5. But after I got diagnosed it did affect me emotionally 
6. knowing that I was sick 
7. and that there wasn’t a cure for it 
8. it affected me a little bit 
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These participants who were older at diagnosis did not describe themselves as “sick”, 
despite having symptoms. Instead, they described themselves as normal, with diagnosis 
presenting a tremendous disruption as they wondered what it meant and if perhaps it 
was a mistake. Figuring prominently in their stories was how diagnosis affected them 
emotionally. Their stories expressed pain around diagnosis that was not present in stories 
of participants who always knew they had CF. Although they mentioned physical 
symptoms, the dominant type of pain in these stories was emotional. Emotional pain was 
seen through denial of the diagnosis and in recognition that there was no cure.  
For every participant, and throughout their interviews, laughter and sometimes 
whispering accompanied expression of their most painful experiences. Diagnosis stories 
seemed well rehearsed as if told many times before, especially for those diagnosed as 
infants. In contrast, the pain expressed in these stories seemed raw, less rehearsed than 
the factual information. As participants continued their narratives of emerging 
awareness, they moved from stories centred on diagnosis and early years to stories about 
getting sicker.  
5.2.2 Disease progression: Harder to stay healthy 
Similar to the overarching narrative of emerging awareness, disease progression stories 
were told chronologically, beginning with describing how it became harder to stay 
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healthy. Participants recalled different milestones as indicators of disease progression, 
such as Brittany in Box 3, who viewed her first hospitalisation as a turning point.  
Box 3 
 
Stanza 1: It just got harder and harder for me to stay healthy 
 
1. When I turned 17, I had my first hospitalisation, my first IV, my PICC line 
2. and after that it just got harder and harder for me to stay healthy 
3. so ever since then the progression is just 




As these stories progressed, realisation of how CF was affecting participants became 
increasingly evident, and they worked harder to maintain the same level of health. Every 
participant told these stories of working harder, whether seen through increased time 
and intensity required daily to clear their lungs, needing more medications, or more 
frequent and longer hospital admissions. As they worked harder to stay healthy, 
awareness of what having CF means, and how it was affecting their lives, became more 
apparent. Every participant referred to the treatment burden caused by hours of therapy 
daily, seen through Christopher in Box 4 when asked about his experience with pain. 
Box 4 
 
Stanza 6: It’s very slow repetitive 
 
1. I would consider almost everything I’ve experienced with cystic fibrosis  
2. It’s very, slow, repetitive 
3. kind of like how a drop of water on your forehead isn’t uncomfortable  




Stanza 8: It’s just the frustration of having the same, slightly discomfort feeling 
 
8. So, it’s not something where you can take it in five seconds  
9. and feel it and go yeah that’s painful – you know 
10. it’s just the frustration of having the same, slightly discomfort feeling  
11. for such a long period of time.  
 
Stanza 9: Just the constant beat down that you kind of feel 
 
12. The most prevalent thing just being just the consistency of it 
13. the consistency of the discomfort 
14. the consistency of the time management and the lifestyle 
15. just the constant beat down that you kind of feel for having all those things at one 
time. 
 
Stanza 10: It’s the most unfair thing in the world 
 
16. and then you feel like you’re doing everything right  
17. and then you start to get sick  
18. and you’re like what in the world? 




Although all participants described treatment burden, notable in Christopher’s interview 
is the way that his visual style of speech and use of metaphors illuminates the experience. 
Repetition of “consistency” provides a rhythmic depiction to reinforce the “constant 
beatdown”. Participants viewed increasing treatment burden as an important component 
of their experience with pain. Even the language Christopher chose (“constant 
beatdown”) was reminiscent of pain. 
While at first participants could avoid getting sicker by increasing therapies, eventually 
this no longer worked. As in their first hospitalisations, participants recalled not 
responding as well to treatment as a milestone or marker of disease progression. 
  
 77 
Christopher’s story in Box 5 represents this turning point when participants began not 




Stanza 3: I got on the IV and just a couple days later I started to feel this lift 
 
10. What I remember from last time being on IVs  
11. not this time – the time before which I believe was 6 years ago 
12. I remember I got on the IV and just a couple days later I started to feel this lift 
13. and about 4 days later I felt like Superman 
14. I felt like I could do anything. 
 
Stanza 4: I feel like Superman – is this what normal people feel like? 
 
15. I remember specifically I was on a run with my wife on a trail  
16. and we’re running and she’s having trouble keeping up with me  
17. which is not usually the case 
18. cause I’m usually either with her or a little bit behind her 
19. and I remember running and turning around going I feel like Superman 
20. is this what normal people feel like – this is crazy!  
 
Stanza 5: But this time… it was a little more slow going 
 
21. But this time, which I just recently got off IVs  
22. it was a little more slow going than I thought it was going to be 
23. I think it was about 6 or 7 days until I started feeling good 




Like Christopher, most participants used metaphors associated with power, such as 
Superman, battle and war; they compared CF to a lengthy battle, one that is both 
frustrating and exhausting. This frustration and sense of overwhelm is echoed in all 
participant stories. In these stories about increasing difficulty of staying healthy, 
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participants still responded to treatments, albeit not as well as before. Within these 
stories is an initial glimpse of what having CF means, but participants became even more 
aware as they grew even sicker. Described in these stories, pain had a gradual, insidious 
presence. 
5.2.3 Disease progression: Getting sicker 
As CF progressed, emerging awareness figured prominently in participants’ stories. 
Participants described getting sicker and sicker, regardless of their efforts to prevent or 
treat their symptoms. They spent more time in the hospital and pain took a more 
pronounced role in their narratives. Participants such as Samantha, who had previously 
been in denial about CF, described a breaking down of denial as they became increasingly 
aware of the impact CF was having on their lives.   
Box 6 
 
Stanza 1: Emotionally that was rough 
  
1. So, there was a really hard learning curve for me when I became an adult 
2. I mean if 18 can be considered an adult 
3. So, I mean that was – I mean emotionally that was rough – or painful 




Notably, Samantha’s depiction of emerging awareness was told in the past tense as she 
was clearly recalling a past event. Other participants changed to the present tense in 
these stories. For these participants, they were still in the midst of these experiences, as 
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when Brittany referred to pain as a reminder that she is sick. Participants viewed both the 
treatment regimen and their physical symptoms as reminders of CF.  
Box 7 
 
Stanza 1: Like a chink in the armour 
 
1. It’s like a milestone (pain) – isn’t that great 
2. A milestone in my cystic fibrosis progression 
3. like a chink in the armour 
4. it’s a tangible reminder of everything else 
 
Stanza 2: You know coughing is exhausting 
 
5. and coughing – just the coughing 
6. you know coughing is exhausting 
7. you wake up and you feel like you have to cough 
8. and automatically you’re reminded 
 
Stanza 3: It’s a reminder that you like you have this thing 
 
9. when you are in class and you need to cough  
10. and you already coughed five times 
11. it’s a reminder that you like 




As her story unfolds, Brittany repeatedly returns to physical reminders of illness. 
Referencing the progressive nature of CF, pain is described as a milestone, a symbol that 
she is getting worse.  
For most participants (seven), as they delved deeper into this emerging awareness 
narrative, pain became more apparent, notably expressions of emotional and spiritual 
pain. Pain was not portrayed as separate and distinct, but was woven throughout, and in 
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a way inseparable from the greater experience of CF. Participants struggled to talk about 
pain as a distinct entity, and yet pain was present throughout the entire interview.  
This depiction of pain as enmeshed in the life experience is seen in Brittany’s continued 
narrative of emerging awareness as she moved out of her parents’ house, then stopped 




Stanza 2: So now I live at home with my mom and dad 
 
5. So now I live at home with my mom and dad. 
6. I moved out a year and a half ago  
7. which was a big thing for me 
8. because when I was 18, I always thought I would be out 
 
Stanza 3: This has been very hard for me the past few years 
 
9. I always wanted to be very independent 
10. I graduated school – I got my diploma early 
11. I wanted to work, and I just wanted to – you know 
12. so, this has been very hard for me the past few years  
 
Stanza 4: This is not going the way that I thought it would go 
 
13. Because I feel like my whole life has just like been completely different 
14. As to what I thought I would be – obviously  
15. it’s just like – whoa – wait a minute –  
16. this is not going the way that I thought it would go –  
 
Stanza 5: I just never imagined it this way 
 
17. I think about it all the time – I can’t believe 
18. that this is how things have gone for me  
19. cause I just never imagined it this way. 
 




20. I was like thinking about emotional pain –  
21. and I don’t know if I have a separate issue with 
22. I probably have a separate issue with dealing with everything but 
 
Stanza 7: All this stuff you get used to – your body copes 
 
23. Back to where I was talking about in the beginning 
24. how I feel like my life is so different from how I ever expected it to be 
25. has probably been like –  
26. all this stuff you get used to – your body copes 
 
Stanza 8: These types of things are short 
 
27. The pleurisy is one thing –  
28. if I had to deal with that all the time then it starts to really –  
29. that would be like – interfering – you know –  
30. these types of things are short –  
 
Stanza 9: What I feel like CF has limited me to do has been the hardest thing 
 
31. I don’t feel like they interfere with my life completely – yet – 
32. my physical pain –  
33. But dealing with what I feel like CF has limited me to do  




As she talks, Brittany relates the loss of developmental milestones, the loss of 
independence, and the loss of the life she was anticipating or hoping for.  
As participants became sicker, stories around developmental milestones were part of 
every narrative and each included pain. As they became sicker, their relationships to pain 
appeared to change. With only one exception, participants were more affected by 
emotional pain than physical pain in these earlier recollections of disease progression. 
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That is not to say they were unaffected by physical pain, but physical pain did not appear 
to cause as much distress as emotional pain.  
In Box 8, Brittany is used to physical pain, but in her statement “I don’t feel like they 
interfere with my life completely yet” she anticipates increased physical pain in the 
future. She views physical pain as transient, but emotional pain as more permanent. In 
line 15, her use of the word “whoa” reflects her desire to slow the progression of her CF, 
a sentiment echoed by other participants. However, instead of slowing down, most 
participants told stories of getting much worse.  
5.2.4 Disease progression: Advanced illness 
Stories told about advanced stages of CF were markedly different than earlier stories. Not 
only were participants needing more therapy, but it was no longer working. For these four 
participants, CF was now so severe that even weeks in the hospital did not help. These 
stories were marked by resignation that nothing could be done and a sense of 
hopelessness. While other participants with advanced disease were still living it, Amanda 
recalled the months prior to having received a lung transplant.  
Box 9 
 
Stanza 4: The next morning when you wake up everything’s back in your lungs again 
 
1. The treatments that you would do from sunup to sundown 
3. and then the next morning when you wake up – 
4. everything’s back in your lungs again – 
5. to start over from zero – 






Even when Amanda spent three or four weeks in the hospital, she still did not get better. 
Box 10 
 
Stanza 1: Getting discharged feeling the same exact way 
 
1. As I’ve gotten older it would really suck 
2. when you’d go in for a tune up and you’d be prepared to 
3. okay I’m gonna fight whatever’s going on  
4. and I’m gonna feel so good when I get out of the hospital 




Amanda tried to remain optimistic, but even this was not enough as she was discharged 
three or four weeks later feeling the same as at admission. This disappointment of 
expecting one outcome and experiencing another was reminiscent of earlier stories, 
when participants became sick despite adhering to therapies. This was yet another bitter 
disappointment for them. 
Pain was approaching a crescendo in these stories of advanced illness. Pain of all types 
was expressed, but physical pain was most present in advanced illness. Participants didn’t 
just talk about physical pain more often but described it as more severe and seeming to 
permeate all aspects of their lives.  
Participants rarely talked about pain in isolation of their overall experience with CF. As 
seen in Box 11 as Amanda described late stage CF, participants linked physical pain with 
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emotional pain. Where physical pain was mentioned, other types of pain were described 
or implied within close proximity. Comparison of the hospital to prison might also 
describe the lack of escape from CF. 
Box 11 
 
Stanza 2: Refracturing old ribs just from the coughing 
 
5. With all the rib fractures before transplant 
6. I was getting maybe 3 – possibly 4 a year 
7. and refracturing old ribs – from just the coughing 
8. that was really painful too 
 
Stanza 3: You have to cough to get the stuff up 
 
9. You have to cough to get the stuff up  
10. and when you’re breathing  
11. it would hurt to take a deep breath.  
 
Stanza 4: In the hospital the pain is more intense 
 
12. And it seems like a lot of times 
13. like when you’re in the hospital 
14. it seems like the pain is more intense 
15. because you’re stuck 




Participants referred to “emotional pain” as the most painful, as seen in Amanda’s story 
below. When not overtly labelling pain as emotional, participants described it as one of 
the most painful parts of their experience. Emotional pain included fear, anxiety, 





Stanza 1: More emotional pain than anything 
 
1. I think with CF 
2. You have a lot of 
3. Like more emotional pain than anything 




Participants expressed resignation that nothing could be done, a sense of helplessness 
that was not as prominent in the earlier narratives. This is not to say only participants 
with advanced illness expressed resignation or helplessness; others expressed similar 
feelings, but the degree of resignation and helplessness in advanced illness was greater. 
Similar to most others, Ashley appeared exhausted, with frequent sighs and sagging 
shoulders, as though the weight of the world were physically upon her as she shared her 
resignation that nothing could be done. 
Box 13 
 
Stanza 1: There’s not anything they can do 
 
1. I pretty much literally laid in bed and suffered 
2. I mean – there’s not really much you can do 
3. there’s not anything they can do 
 
Stanza 2: With CF you just kinda roll with the punches 
 
4. a lot of times with CF you just kinda roll with the punches  
5. and take it as it comes you know 





In telling these stories of progression, most participants were in the midst of the 
experience. That is, they were not only recalling events from the past and retelling them 
but were still experiencing them. These stories were less rehearsed, and participants were 
more emotional when sharing them. Pain was present, but not necessarily neatly labelled, 
and they began to recognise their limited life expectancy. These stories of limited life 
expectancy were most concentrated in stories about progression of CF. 
5.2.5 Limited life expectancy 
As the narratives of emerging awareness were shared chronologically, most evolved 
towards awareness of limited life expectancy or death. This was acutely emphasised when 
one person died before their interview, and another died after the interview, before 
thesis submission.  
Life expectancy was the only topic related to lung function, in that the two participants 
with the highest lung function (Michael and Christopher) were the only ones who did not 
mention limited life expectancy. The only exception was Amanda, who had high lung 
function, but had previously been close to death before transplant.  
Some participants only spoke of limited life expectancy in regard to others, while others 
talked about themselves. Several knew someone with CF who had died. Being a genetic 
disease, some had experienced a sibling’s death from CF; others spoke of friends from the 
hospital or clinic who had died.  
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Ashley and Amanda were older than other participants and talked about being the only 
ones left of their original CF friend groups. As children, they were not discouraged from 
being around others with CF as happens today due to infection concerns, and they 
seemed to have more friends with CF than younger participants did. These social 
relationships were clearly meaningful and their loss painful. As seen in others, when 
describing their most painful moments, both laughed when quietly saying they were the 
only ones left. Amanda’s story is a good example of this social pain present in all 
participants’ stories.  
Box 15 
 
Stanza 3: When I first met people it was being in the hospital 
 
10. You know – I didn’t really know a lot of CF-ers in my early years 
11. when I first met people it was being in the hospital  
12. I remember there was like eight of us together one time 
13. and so we sat out in the hall – and it was just like a big group of us 
 
Stanza 4: Most of them have died 
 
14. Well – it kind of sucks 
15. but most of them have died 
16. I’m trying to think of – well – one is still around – he just got married 
17. I don’t really talk to him all that much. 
 
Stanza 5: I haven’t really gotten close to anybody 
 
18. but it’s like everyone has died and you know honestly 
19. I haven’t really gotten close to anybody 






As Amanda concludes this part of her story, she admits she has not “really gotten close to 
anybody”, appearing to rationalise her reluctance to get close to others now. 
While some participants limited their discussion of death to stories about friends with CF 
who had died, others reflected on their own mortality. In Brittany’s interview there was 
no gradual build up or subtle mention; rather, the listener and reader are thrust into the 
chaos of her story from the first moments. While this story was also told in a chronological 
form, it differed in that she introduced awareness of her limited life expectancy earlier in 
her narrative.  
Box 16 
 
Stanza 1: I remember having this like realisation moment when I was like 10 
 
1. I remember having this like – realisation moment –  
2. you know what I mean –  
3. when I was like – maybe I was like 10 or something.  
4. I don’t know. 
 
Stanza 2: I asked them “could I die from this”? 
 
5. I think I asked –  
6. oh actually my parents told me this recently  
7. and I completely forgot about this –  
8. I had no idea this happened –  
9. but I guess I asked them –  
10. could I die from this –  
 
Stanza 3: When do you tell your kid? 
 
11. I don’t think they ever told me – like – straight out –  
12. because it’s kind of like  
13. when do you tell your kid –  
14. especially because I wasn’t getting medication –  
15. I was taking antibiotics – like oral antibiotics –  




Stanza 4: What does this mean? 
 
17. So – I wasn’t ever hospitalised when I was really young –  
18. so I didn’t really – I don’t know –  
19. I was just kinda like –  
20. okay I have an illness and I take medication for it –  
21. but like what does this mean? 
 
Stanza 5: Does this mean that it could kill me eventually? 
 
22. Does this mean that it’s gonna get harder? 
23. Does this mean that it could kill me eventually? 
24. and I guess I asked them one day and they had to tell me –  
25. this will kill you one day. 
 
Stanza 6: I do remember when it just kind of clicked 
 
26. They remember it perfectly –  
27. I couldn’t remember it –  
28. I don’t know why –  
29. I was like “Oh I don’t remember asking you that” 
30. but I do remember when it just kind of clicked –  




Brittany, at about ten years old, was already searching for meaning, something she seems 
to still be doing years later. Throughout her interview, she seemed to be inquiring as much 
about existential meaning as she was about the potential of dying itself. Her questioning 
“but like what does this mean” was as relevant on the day of the interview as it was for 
her ten-year-old self. Throughout her interview she described a search for answers about 
the future. This existential pain implied by others was explicit in Brittany’s story.  
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Limited life expectancy was more prominent in the stories of people who had more 
advanced disease and no participant demonstrated this throughout their story more than 
Matthew.  
Matthew confronted pain as his CF worsened and he became increasingly aware of his 
limited life expectancy. This is demonstrated in Box 17 where, faced with worsening CF, 
he and his wife rushed to get married and have children.  Their rush was evident as 
Matthew recalled this time, noticeably out of breath as he talked faster and faster, his 
pace of speech matching his description.  
Box 17 
 
Stanza 1: I try not to think about CF 
  
1. We tried to like – just live a normal life 
2. I try not to think about CF  
3. Sometimes the disease 
4. because when we had plans – like – we had plans together. 
 
Stanza 2: Then I started getting the disease more 
 
5. like I’m gonna finish my studies  
6. and then after that we would get married and then have a kid 
7. and then I started getting the disease more. 
 
Stanza 3: We wanted to rush everything 
 
8. We were more aggressive 
9. Yeah we were more aggressive,  
10. so we wanted to rush everything. 
 
Stanza 4: We didn’t know how much time we had 
 
11. get married now – we want to have a daughter now 
12. We wanted to do everything at that time  






Other participants also expressed this desire to live life fully now, recognising the future 
as uncertain. This is evident in Jessica’s narrative below.  
Box 18 
 
Stanza 1: Let’s do what we can while we can 
  
1. This past summer – my daughter was out of school  
2. and it was let’s fill up – 
3. let’s do what we can –  
4. while we can kind of thing – 
 
Stanza 2: We don’t know how I’m going to feel 
 
5. like let’s go to Legoland – let’s go to the Waterpark –  
6. let’s you know – go play with our friends – let’s go to the beach –  
7. let’s do this stuff while I’m capable of doing it  
8. because we don’t know how I’m going to feel  




As Jessica talked, her voice was excited, higher pitched, and she spoke quickly, at an 
almost frenzied pace, indicative of trying to fit it all in, to live fully while she can.  As she 
continued, the pace slowed, and she took a deep breath as she appeared to reflect on the 
future.  
Although all were aware of their limited life expectancy, only Matthew expressed 
certainty around what this meant. Having already received a lung transplant and been 
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informed he was unable to receive another one, he was oxygen-dependent and 
experiencing rejection of his transplanted lungs. Matthew was sure that he did not have 
long to live, but even this proved uncertain as he was still living almost two years after his 
interview. 
These stories of diagnosis, disease progression and limited life expectancy comprised the 
emerging awareness narrative. In a chronological style, participants shared their 
experiences of pain in CF, covering the continuum from diagnosis to advanced illness and 
awareness of their limited life expectancy. As participants told these stories along their 
trajectory of CF, pain of all sorts became increasingly evident. Diagnosis and early disease 
progression stories contained mostly emotional pain. As CF became worse, physical and 
social pain became more evident, and existential or spiritual pain started to surface. As 
participants shared these experiences of pain in CF, another narrative that emerged was 
social legitimacy. 
5.3 Social legitimacy  
As participants told stories about becoming sicker and increasingly aware of the threat of 
CF, another prominent narrative arose. In this narrative, participants told of their struggle 
to maintain social legitimacy.  
Social legitimacy is defined as a “generalised perception or assumption that the action of 
an entity is desirable, proper or appropriate within some socially constructed system of 
norms, values, beliefs and definitions” (Suchman, 1995, p. 574). Tyler (2006, p. 378) 
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further explained that “people who internalise social norms and values become self-
regulating, taking on the obligations and responsibilities associated with those norms and 
values as aspects of their own motivation”. 
These cultural beliefs then inform the expectations people use to judge themselves and 
others as legitimate or not. In this quest to maintain social legitimacy, participants 
described how they “pushed through” the pain in CF. They strived to meet social 
expectations such as independence, developmental milestones and productivity, and in 
doing so sometimes ignored their symptoms, trying to avoid the hospital at almost all 
costs.  
Unlike emerging awareness, social legitimacy was not told in a chronological way. Rather 
than having a beginning (diagnosis and early years), middle (disease progression) and end 
(recognition of CF as life-limiting), these stories were less organised. While the emerging 
awareness narrative was dominated by expressions of physical and emotional pain, the 
pain seen in social legitimacy touched more on social and spiritual pain.  
5.3.1 Pushing through 
The concept of pushing through was identified in every participant’s story, and although 
it seems simple it is actually a complex experience. In its simple interpretation, pushing 
through related to such actions as completing a planned activity, such as when Jessica 
continued riding her bike despite severe joint pain in Box 19. Yet, beyond this simple 
understanding, participant’s stories described a more complex scenario of pushing 
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through in response to illness. Pushing through in this case occurred as participants 
strived to meet expectations of themselves and society. Stories of pushing through as a 
response to illness comprised the bulk of the social legitimacy narrative. 
Pushing through happened in different contexts, but the stories were all a familiar style. 
In them, participants faced an obstacle of some sort such as pain and pushed through to 
meet a certain goal. In Box 19, Jessica pushes through when she develops joint pain on a 
day that she and her husband had planned to go to the park with their daughter. In this 
scenario, Jessica confronts physical pain as she pushes through to go on the bike ride 
despite the pain.  
Box 19 
 
Stanza 1: I woke up that morning and was hurting 
 
1. We planned on taking our bikes to (the) bay 
2. I woke up that morning and was hurting and I said 
3. I’m just gonna get through it 
4. We are going to go and have fun 
5. It’s gonna be a good day… 
 
Stanza 2: I was just pushing through it 
 
6. We got down there 
7. My hands were hurting so bad 
8. But we started riding 
9. I have hand brakes 
10. So I was just pushing through it… 
 
Stanza 3: My hands started hurting so bad 
 
11. My hands started hurting so bad 
12. I couldn’t stop my bike 
13. Cause I had hand brakes 




Stanza 4: It was just too much 
 
15. It was just the worst 
16. That I think that I’ve ever felt 
17. and I think it’s because I tried to push through it 
18. It was just too much.  
 
Stanza 5: I still couldn’t move the next day 
 
19. So I came home and I laid down in bed  
20. My husband had to take over  
21. and then I called my grandma  




After pushing through, Jessica ends up in a very unwell state, unable to complete the ride 
and bedridden the following day. This scenario of feeling worse after pushing through was 
seen when other participants described similar instances of being bedridden after 
pushing through.  
Participants also pushed through in response to emotional pain. Returning to Jessica, she 
talks about pushing through following the death of her brother (from CF) and the more 
recent death of her mother (from cancer).  
Box 20 
 
Stanza 1: You just have to push through 
 
1. Losing my brother 10 years ago –  
2. losing my mom this past year –  
3. you just have to push through –  




Stanza 2: They help me get through all this stuff 
 
5. I just – like I said I have a really good support system  
6. and I have a wonderful husband  
7. and a really good kid and they just –  
8. they help me get through all this stuff –  
 
Stanza 3: CF has been the least of my concerns 
 
9. so – I feel like – yeah – mostly – I mean –  
10. I feel like in these past few years  
11. my CF has been the least of my concerns 
 
Stanza 4: Usually CF is my number one concern 
 
12. Which is weird for me –  
13. because usually my CF is my number one concern –  
14. but I feel like these past few years it’s been my mom’s health  
15. and my arthritis and just pushing through all of that stuff  




Interestingly, although arthritis is a known complication of CF, Jessica regards pain from 
arthritis as unrelated to CF, as did Michael. Throughout her narrative she sees her roles 
as mother, wife and daughter as high priorities. Striving to be successful in their multiple 
roles, participants ignored CF at times, prioritising other activities over treatment.  
Some participants were reluctant to ask for help when sick and described scenarios when 
they pushed through symptoms and delayed admission to the hospital. Brittany illustrates 
this when she needs a ride to the hospital but is reluctant to inconvenience anyone.  
Box 21 
 




10. I was texting my um cousin who’s a nurse  
11. and she was like I have a break  
12. and if you need me to come get you I will – 
13. so I waited until the next morning  
 
Stanza 4: I’ve actually experienced pain with CF my whole life 
 
14. Then my dad brought me in and that was my most – like 
15. That’s what I thought of when we were talking about this 
16. But then I was thinking about it a little more  
17. and I was like I think 
18. I’ve actually experienced pain with CF my whole life 




As Brittany reflects on her reluctance to ask for help, she realises she has experienced 
pain with CF her whole life. In her words, though, she has “become very kind of like numb 
to it”. It is not clear if Brittany is describing her physical pain during this particular episode 
or if she is talking about a broader experience of pain. However, stepping back and 
reflecting on Brittany’s story in its entirety, it seems she is experiencing all-encompassing 
pain. Through the course of telling her story, Brittany appears to develop a greater 
awareness of her pain. 
Amanda offers further insight into the lengths people with CF will go to delay admission, 
describing a friend who waited a week with severe pain before going to the hospital.  
Box 22 
 
Stanza 1: Finally, when she went to the hospital she had a collapsed lung 
 
1. I had a friend and she didn’t go here – she passed in 06 –  
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2. she had severe pain for a week and then finally, when she went to the hospital  
3. she had had a collapsed lung for a week 
 
Stanza 2: Some people just keep pushing it and pushing it 
 
4. some people just keep pushing it and pushing it  
5. thinking I’ll feel better – I’ll feel better –  
6. but I think it’s because they don’t want to go back in –  




In pushing through to delay admission, participants were responding to their illness in a 
way that felt legitimate, displaying what they perceived as strength. In most of these 
stories, participants were pushing through specific scenarios or symptoms, but Ashley 
sums it up in a more general sense, explaining that everyone with CF pushes on.  
Box 23 
 
Stanza 1: We’ve been doing it all our lives it’s all we know 
 
1. I think everyone with CF has to push on 
2. otherwise what is the point 
3. there would be nothing to live for 
4. We’ve been doing it all our lives 




These stories of pushing through provide an initial glimpse of social legitimacy. Comments 
about pushing through seemed to relate to cultural expectations of an illness response, 
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in which the most appropriate response to illness is to “push through”. A related concept 
that arose in the narratives of social legitimacy was that of independence. 
5.3.2 Productivity and independence 
Stories of productivity, defined as participating in activities of value to the self or society, 
were included in the narrative of social legitimacy for all participants (Hay, 2010).  This 
was not surprising given the moral value placed on productivity in the US (Charmaz, 1991). 
This value of productivity is pervasive throughout the US, including in those who are ill. 
Some stories about productivity seem closely related to pushing through but are different 
in an important way. The stories of pushing through are focused on the act itself, while 
the stories of productivity are focused on the outcome, with an emphasis on 
independence and perceived cultural expectations. 
While all participants valued being productive, exactly what this meant to each 
participant varied. For Amanda, this meant being independent in caring for herself, but 
her desire to be independent extended beyond this, as she also desired financial 
independence. The port she refers to in the opening line is an implantable vascular access 
device used to deliver intravenous (IV) medications for those who need frequent 
infusions, such as those with cancer or other illnesses including CF. 
Box 24 
 
Stanza 1: I just wanted to be independent 
 
1. I used to access my own ports 
2. because I didn’t want to have to rely on going to the hospital 
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3. what if I’m too sick to drive and I need – I just wanted to be independent 
4. not financially – I can never do that. 
 
Stanza 2: I’d always do it myself 
 
5. but – when it came to all my meds and doing everything I needed to do 
6. even with my IVs – I never got any help from anybody – ever 
7. I did everything – I’d wake up no matter how late I had to infuse and how early 
8. I’d always do it myself. 
 
Stanza 3: I couldn’t control the disease so I could control that 
 
9. Like a sense of power – like something I could control 
10. because I couldn’t control the disease – so I could control that  
11. and I wanted to learn how to do everything I could to help myself 
12. I just didn’t want to rely on anybody – I couldn’t. 
 
Stanza 4: I’m still on the system and I hate it 
 
13. I don’t like the fact that this disease is really expensive – It’s very expensive  
14. and if you know your future spouse has good insurance that’s fabulous  
15. but if he doesn’t or you can’t get insured you have to stay on the system  
16. Which I’m still on the system and I hate it – even though they pay for everything. 
 
Stanza 5: It feels like I don’t contribute to society 
 
17. that’s the thing is that I don’t make much money every month 
18. but the medical is fantastic – it’s fantastic – but it’s humiliating 
19. I’m on Medicare and MediCal – well isn’t Medicare for old people?  




Participants such as Amanda who did not view themselves as independent and productive 
members of society expressed anxiety in these social legitimacy narratives. Social pain 
was present throughout, with participants expressing embarrassment, humiliation, and 
an overall lack of self-worth.  
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Christopher was embarrassed when perceived as “feeble” in social situations. The cultural 
perception of a man as strong and protective was at the forefront, and clearly informed 
his perception of social legitimacy, or lack thereof.  
Box 25 
 
Stanza 3: Feel like you’re being perceived as feeble 
 
9. Yeah – the social thing and also just the – the feeling of 
10. of being with your wife out some place and you have these awful spasms  
11. that make you feel like you’re being perceived as feeble 
12. I guess you would say – you just 
13. you don’t feel like – Superman – anymore. 
 
Stanza 4: That’s kinda the Superman – the protector and all that stuff 
 
14. Yeah – that’s kinda the Superman 
15. like nothing can stop me 
16. when you feel like you’re the man 
17. you’re the one that – stands up for 
18. the protector and all that stuff. 
 
Stanza 5: Then you’re bent over coughing into a bucket 
 
19. and then you’re bent over coughing into a bucket 
20. you don’t really like that person 
21. it makes me feel great when I’m able to be that person 
22. that’s a feeling that makes me feel really good 




Christopher’s role identity is challenged when he falls short of his perception of what a 
man and a husband should be. In his mind, he should be “Superman”, “the protector”, 
and “the everything”. This is a high expectation for anyone, but especially for someone 
with CF, and he expressed surprise when realising during the interview the pain this was 
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causing him. He remarked that at the beginning of his interview he thought it would only 
last ten minutes, but he was now starting to recognise the extent of his pain. This 
expression of surprise at the depth of pain was not limited to Christopher, as three other 
participants made similar remarks after the interview concluded. 
Also linked with productivity was achieving developmental milestones, closely related to 
the stories of independence and role identity. All participants spoke in some way about 
what they were supposed to be doing. For Christopher, this was centred around being a 
man and husband. For Brittany, it was a desire to be independent. Where Brittany’s 
narrative differed from others was the depth of pain she expressed and the situation of 
her narrative in the present.   
Box 26 
 
Stanza 1: Having to stay at my parents’ house 
 
1. Having to stay at my parents’ house for so long 
2. not hard because I love them and they are like totally okay with me staying there 
3. but like just as a personal goal and feeling successful 
4. or feeling like I’m an adult. 
 
Stanza 2: Being there has been really hard 
 
5. being there – yeah – milestones that we work towards 
6. being there has been really hard 
7. painful for me like emotionally to deal with 
8. and I’m wondering like how the rest of my life is going to go. 
 
Stanza 3: I get paralysed by anxiety 
 
9. I get paralysed with like anxiety 
10. like thinking about my body issues – my physical state 
11. and trying to address it and manage it  
12. and then still think about everything else that I need to be doing  
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13. and creating a life and happiness and things that make me happy  
14. and – doing those things when I’m like consumed by this like – problem  
15. that kind of looms over me. 
  
Stanza 4: My brain cannot tackle these things that I need to be tackling right now 
 
16. Do people talk about this paralysed feeling?  
17. Maybe they don’t use that word but I use that word 
18. it’s like – oh my god – where do I start?  
19. Oh my gosh I can’t tackle 




Brittany overtly labels her experience as painful emotionally. Social pain is evident in her 
account of feeling paralysed and unable to meet the milestones she perceives are 
expected of her. In parallel is her expression of existential pain.  
The concept of existential pain is often used interchangeably with the concept of spiritual 
pain (this practice is not without critics, but addressing this controversy is beyond the 
scope of this thesis). Although multiple definitions of existential and spiritual issues are 
found in the literature, common themes exist among their definitions (Boston, Bruce, & 
Schreiber, 2011). In this thesis, existential and spiritual issues are understood through the 
search for meaning or purpose in life, questions about what happens after death, feeling 
connected to others, hope and hopelessness, and fear (Boston et al., 2011). All 
participants struggled with at least some aspects of existential pain, but for Brittany this 
experience seemed to consume her.  
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These stories of pushing through and independence reflect the cultural expectation, 
especially in the US, that individuals should contribute to society. Aspiring to 
independence is not necessarily negative but may not always be possible, especially as CF 
progresses and individuals get sicker. Less straightforward than the narratives of 
emerging awareness, these social legitimacy narratives elucidate more nuanced 
experiences with pain, especially the experiences of social and spiritual or existential pain. 
Closely linked, but distinct from the quest for social legitimacy, is the experience of 
invisibility. 
5.4 Invisibility  
Along with the narratives of disease progression and social legitimacy, all participants told 
narratives of invisibility. The phenomenon of invisible illness or invisibility has been 
described as an illness without a clear or visible outward sign, and has been closely linked 
with social legitimacy (Dow, Roche, & Ziebland, 2012; Hay, 2010). Pain, a highly subjective 
experience, and usually with no outward sign of illness or disability, is often included 
when discussing invisible illness. A close review of these narratives reveals a greater 
complexity surrounding invisibility than is suggested in the straightforward definition of 
an illness without a visible sign. In these narratives, invisibility is present when people feel 





5.4.1 Feeling misunderstood 
Several participants spoke about feeling misunderstood, or that people do not 
understand the extent to which CF affects them and others. Other participants felt that 
even friends and family did not understand the unpredictability of CF. For instance, 
Michael had recently stopped working full-time at a grocery store because of attendance 




Stanza 1: The hard part of people understanding the pain with the CF 
 
1. The hard part of people understanding the pain with the CF stuff –  
2. cause they think – the CF they think lungs  
3. they don't think the other stuff 
 
Stanza 2: They look at CF lungs not CF everything else 
 
4. which is part of a stressful part  
5. with you trying to look at help for whatever like that –  
6. they don't – they look at CF lungs –  
7. not CF everything else so –  




Michael’s words suggest that he feels invisible and misunderstood when others regard CF 
as only a lung disease. He appeared to think he would receive more empathy and 
accommodation if his symptoms were instead related to his lungs.  
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Feeling misunderstood for non–lung related symptoms was also expressed by Ashley, 
Amanda, Samantha, and Brittany. Symptoms described as misunderstood by these 
participants included abdominal pain, joint pain and fatigue. In addition to the physical 
symptoms, these participants also experienced social pain due to the conflicts that arose 
as a result of feeling misunderstood by others around them. 
Lack of understanding when others looked at CF as primarily affecting the lungs was not 
limited to co-workers, friends and family, as participants also described similar 
experiences in CF clinic.  
Box 28 
 
Stanza 1: The focus has always been lung function 
 
1. You know what 
2. at the clinics it’s very 
3. the focus has always been lung function 
4. Or am I gaining weight 
 
Stanza 2: Lung function and weight 
 
5. lung function and weight 
6. these are the two questions that I focus on 
7. what is my weight – has my weight changed, good or bad appetite 
8. lung function – can I exercise 
  
Stanza 3: Is there something else I need to be talking about? 
 
9. that’s what I focus on 
10. So, I guess when I go to clinic  
11. I’m not really thinking – like 
12. is this something that I need to be talking about 






From Brittany’s perspective, the focus of CF clinic was on lung function and weight, and 
these were therefore her primary focus as well. With this focus on only lungs and weight, 
Brittany did not report other symptoms that arose, including joint pain. Although joint 
pain did not appear to have a significant adverse effect on Brittany’s quality of life, others 
(Jessica, Michael, Ashley, and Samantha) described severe joint pain, and yet only Jessica 
had discussed it during CF clinic. Interestingly, although Jessica reported joint pain and 
was receiving care from a rheumatologist, even she did not relate her joint pain to CF, 
although it is a known complication. When participants did not report joint pain, it 
remained invisible even to their healthcare team.  
A common theme in discussions about invisibility is illness without outward visible 
symptoms. With a disease like cancer, people often lose their hair or have some other 
visible sign that they are ill. This is often not the case with CF, as many people do not have 
any outward signs of illness until advanced stages when oxygen is required. Pain is also 
often associated with invisible illness. Visible signs of illness communicate to others in 
society that the person is ill, and accommodation is warranted, but when visible signs of 
illness are not present, others may judge the person negatively. In Box 30, Amanda 
laments the loss of friends due to invisibility in CF. 
Box 29 
 
Stanza 1: I’ve lost a lot of friends over it 
 
1. The thing with CF is you can feel fine one day  
2. and then the next day be totally done 
3. Just feel like you can’t do anything –  
4. I’ve lost a lot of friends over it  
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5. Cause they don’t understand  
 
Stanza 2: “Well you looked fine yesterday” 
 
6. Because before you’re wearing oxygen you look so normal 
7. I’ve had so many say “Well you looked fine yesterday – you were fine”  
8. That used to happen quite a bit –  




Amanda was not the only one to lose friends or feel judged by others because they did 
not look “sick”. Only one participant (Matthew) did not describe such a scenario, perhaps 
because he had severe lung disease, was oxygen-dependent, and used a wheelchair due 
to severe shortness of breath. Matthew’s illness was therefore visible and those around 
him may have excused him from expectations or responsibilities.   
5.4.2 Invisibility as a choice 
Another perspective is that of invisibility as a choice. Rather than thinking about 
invisibility from the perspective of others, from this view the person with CF is making a 
choice to be invisible.  
Invisibility as a choice is demonstrated clearly, albeit sadly, at the end of Amanda’s 
narrative about the death of her friends with CF (Box 15). As discussed previously in 
section 5.3.5 about mortality, she says, “It’s like everyone has died and you know honestly 
I haven’t really gotten close to anybody – I don’t know any new CF-ers here.”  
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In this situation, Amanda is making a choice to remain invisible to others with CF. While 
they may know that she has CF, she seems to be hiding her inner self. This is even more 
interesting considering that she does a lot of work in public awareness of CF and lung 
transplant, so is publicly visible but at the same time choosing to be invisible. 
Other participants never formed relationships with others who have CF. Some expressed 
they did not feel a need to get to know others with CF (Christopher and Michael), while 
others avoided the pain, they believed would accompany these relationships. In Box 30, 
Samantha describes her reactions as she became aware of what CF meant in her life. 
Box 30 
 
Stanza 1: I mean it was hard – I cried a lot 
 
1. I mean it was hard – I cried a lot 
2. I went through like a pretty depressed phase 
3. I hung out at home a lot 
4. I quit my job 
5. I stopped going to school. 
 
Stanza 2: I don’t have relationships with any other CF patients 
 
6. I don’t have any relationships with any other CF patients 
7. I’ve never tried to be part of like a community – with the CF patients 
8. because we can’t be around each other 
9. and then everything else is just like  
10. well you could do online relationships 
11. and that was just never appealing. 
 
Stanza 3: Maybe end up with a very tragic result 
 
12. Of course there’s always the knowledge  
13. They’re dealing with something very serious and terminal 
14. So it also feels weird to start up that kind of relationship 
15. Knowing that you’re both gonna deal with a lot of the same things  






As the reality of having CF set in, Samantha withdrew from virtually all social relationships, 
quit both school and work and made herself invisible.  
Participants tried to protect themselves by not forming relationships and avoiding being 
a witness to others’ decline. This ensured they were invisible not only to others, but also 
themselves. 
Several participants talked about choosing whether to reveal their CF to friends or not. 
Continuing with Amanda’s narrative around invisibility, she talks about being diagnosed 
with CF during adolescence. In describing her adolescence, the pain of not fitting in is 
evident. She decided in adolescence not to reveal her diagnosis, although from her 
narrative it is clear that there were indeed visible signs of her CF, signs that others 
attributed to smoking which seemed preferable to Amanda over CF. 
Box 31 
 
Stanza 1: Teens were really awkward 
 
1. Teens were really awkward 
2. Because it was high school 
3. I always made a big scene with the coughing  
4. people thought I was a smoker 
 
Stanza 2: My stepmother made me feel ashamed of it 
 
5. I was almost embarrassed of it 
6. My stepmother made me feel ashamed of it 
  
 111 
7. I didn’t really tell any of my friends about it 
 
Stanza 3: I was just really embarrassed by it 
 
8. I didn’t want to tell any guys about it because I used to think 
9. I don’t want them to know when they’re kissing me that I spit up this really ugly stuff 
10. it’s so gross and I was just really embarrassed by it 




The decision of whether or not to reveal their diagnosis was a difficult one for most 
participants. Although as an adult Amanda now reveals her diagnosis, she keeps others 
with CF at a distance in an effort to avoid pain in the event of their death.  
In another nuance of invisibility, some participants rationalised not talking about their 
pain because others had it worse.  
Box 32 
 
Stanza 2: That’s how I get through things 
 
1. Deep breath in – you just gotta focus  
2. and you gotta know that it’s not gonna be like that forever – 
3. That’s how I get through things –  
4. and I always think that somebody else has it far worse than I do – 
5. that’s what I did before the transplant –  
 
Stanza 3: There are so many people far worse that I am 
 
6. I’m like there are so many people far worse that I am –  
7. and then I look at all of my friends that have died –  
8. look at their circumstances and just think –  





This reluctance to express pain because others have it worse may be mediated by 
appreciation for all participants do have, or may be due to a cultural expectation to be 
tough and not complain. Regardless of the reasoning behind not expressing pain, it results 
in invisibility where the pain may not be recognised, understood or treated. This 
recognition that others have it worse recurred in several narratives.  
Some made a choice to remain invisible by choosing not to talk about their pain. Michael 
equated talking about pain to a reminder of CF.  
Box 33 
 
Stanza 1: I’m tired of doing this all the time 
 
1. Growing up I used to have no problems telling people what’s going on 
2. but I’m tired of doing this all the time 
3. The CF, the pain, everything 
4. I had no problem talking about it because 
5. it didn’t bother me as much as much as it does now 
 
Stanza 2: I’m just tired of talking about it 
 
6. Now it drains me a little bit here 
7. and then the pain and everything  
8. and I’m just like tired of talking about it  
9. to remind me about everything going on. 
 
Stanza 3: It’s out of mind and I don’t deal with it 
 
10. Out of thought – out of mind 
11. or whatever you know 
12. instead out of sight out of mind 






As participants continually became sicker, having CF was increasingly overwhelming. Not 
talking about it was yet another way they remained invisible, even to themselves. At times 
it was simply more than they could deal with. 
5.4.3 When the invisible becomes visible 
Sometimes participants who previously chose to be invisible became visible. Visibility 
emerges then as a somewhat fluid state, changing in different situations. In some 
circumstances invisibility can be beneficial. For example, disclosing a diagnosis of CF may 
hinder employment or social relationships. However, efforts to remain invisible might 
also be harmful, as seen in Jessica’s narrative in Box 34.  
Box 34 
 
Stanza 4: I don’t know why I let it go so long 
 
1. I feel like there was one pneumonia that I had that I didn’t even know I had –  
2. I think my daughter was still a baby –  
3. maybe one – and I don’t know why –  
4. I don’t know why I let it go so long but I was in pain – and I had a fever 
 
Stanza 5: Feeling like I was drowning 
 
5. I started waking up in the middle of the night  
6. feeling like I was drowning –  
7. like I – literally could not take – I could not breathe.  
 
Stanza 6: I don’t know why I waited so long 
 
8. And I’d get out of bed and I’d go sit in the bathroom  
9. and I would just be like struggling to breathe –  
10. and I don’t know why I waited so long –  
11. I don’t know why I didn’t go in sooner 
 




12. but by the time that I went in I had pneumonia  
13. and I think that was the time I had the pleural effusion – 
14. and my fevers were really – really high 
 
Stanza 8: That was the most pain that I can remember 
 
15. so it was just – that was the most pain that I can remember being in with pneumonia.  
16. And I think it lasted probably about a 
17. week – a good week – that I couldn’t sleep –  
18. and I was you know – I was in the hospital for a week and a half or two weeks I think. 
 
Stanza 9: Why did I wait so long? 
 
19. I look back on it and I’m like –  
20. why did I wait so long –  
21. how did I not know –  
22. that there was something wrong –  
 
Stanza 10: I can’t imagine ever letting it get to that point again 
 
23. I remember laying on the floor at my house  
24. with the fan on and an ice pack on my forehead because I was so hot –  
25. and I don’t know why I waited so long 
26. Cause I can’t imagine ever letting it get to that point again 
 
Stanza 11: I had a little one and I didn’t want to admit that something was wrong 
 
27. I had a little one and I –  
28. I didn’t want to admit that 
29. something was wrong  




Jessica was not the only participant with narratives about delaying or avoiding the 
hospital. This was also described by Ashley, Amanda and Brittany, but Jessica’s story 
illustrated her thoughts and feelings around this in a way that is more informative than 
other narratives. It might be that Jessica wanted to be invisible to the hospital; it is not 
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entirely clear in her narrative. Her selection of words at line 36 is important. She said, “I 
didn’t want to have to be in the hospital.” This is different than not wanting to go to the 
hospital. She does not want to have to go. Perhaps her real meaning is that she does not 
want to have CF and is attempting to make the illness invisible. The meaning may not be 
clear, but the pain she feels as she lies on the bathroom floor, feeling as if she is drowning, 
is tangible. 
In a slightly different perspective, Matthew talks about his struggle to express emotional 
pain in Box 34. When pain is kept inside, the person may be invisible, with those around 
them not knowing the extent of their suffering.  
Box 35 
 
Stanza 1: I didn’t used to cry 
 
1. I think it’s more like emotional pain – like for me 
2. Like – she (wife) taught me like it’s okay to cry 
3. cause I didn’t used to cry 
4. I used to just like keep everything inside of me  




Unlike other participants, Matthew’s narrative did not contain many elements of 
invisibility. The exact reason for this is not clear, but it may be because Matthew was near 
the end of his life. As previously described, he had been told that he could not receive a 
second lung transplant and was facing death. Matthew seemed to take pride in having 
come to terms with his prognosis, showing his emotion and talking openly with his family 
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about dying. Connected to oxygen continuously and needing a wheelchair, he was clearly 
not invisible.  
When participants began talking about invisibility it was similar to an iceberg. Beneath 
the whole of the experience of having CF was this great iceberg of suffering that others 
didn’t see. Clinic staff may have seen the tip of the iceberg, and friends and family just a 
bit more, but the world around them, their workplaces and schools, likely saw even less. 
To the outside world, their lives were largely invisible, but in telling their experiences for 
this research, the depth of their pain and suffering became more transparent. If one story 
seemed to most succinctly represent participant experiences with pain in CF, it was 
Brittany’s retelling of a conversation she had with a co-worker.  
Box 36 
 
Stanza 4: Someone asked me like how does CF make you feel? 
 
13. Someone asked me 
14. a dorky guy at my work asked me 
15. he was like what do you feel about 
16. like how does CF make you feel? 
 
Stanza 5: Do you really want to know? 
 
17. and I was like okay do you really want to know? 
18. really want to know –  
19. I could go there do you really want to know? 
20. and he was like yeah tell me  
 
Stanza 6: It’s just suffering, I can’t explain it any other way 
 
21. and I was like  
22. it’s just a lot of suffering 
23. it’s all just suffering 







This chapter has explored pain in CF through participant narratives of emerging 
awareness of having CF, social legitimacy and invisibility. These narratives included 
physical, emotional, social and spiritual (existential) pain.  
In the narrative of emerging awareness, participants began by relaying stories of pain 
related to their diagnosis of CF. Following in chronological order were stories of disease 
progression and worsening symptoms, including pain. These stories of disease 
progression dominated the emerging awareness narrative and seemed to have great 
significance to the participants’ experiences. As CF progressed and reality of what this 
meant set in, pain became more evident, especially spiritual or existential pain. Pain of all 
types was seen through this emerging awareness narrative, along the continuum of 
disease, from diagnosis, through early stages of disease progression, to advanced and 
more severe disease.  
The narrative of social legitimacy was seen in stories of pushing through and 
independence. Stories of pushing through revealed the response to illness when cultural 
expectations encourage one to keep going at all costs. Closely related were stories 
demonstrating the cultural value of productivity, of being productive whether for the self 
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or society.  Dominating the social legitimacy narrative were experiences of social and 
spiritual (existential) pain.  
Finally, the narrative of invisibility permeated all interviews. When CF was invisible to 
others, participants felt misunderstood. Sometimes they chose to remain invisible, both 
to the outside world and even to themselves.  
In Chapter Six, the participant narratives of emerging awareness, social legitimacy and 
invisibility are discussed in relation to existing knowledge through the lens of Saunders’ 




Chapter 6: Discussion 
In the findings, reported in Chapter Five, participants communicated their experience of 
pain through three key narratives: emerging awareness, social legitimacy and invisibility. 
Emerging awareness was a gradual unveiling of what having CF meant to participants. 
Multiple types of pain were present along the entire continuum as participants developed 
this awareness and struggled to be independent and maintain or achieve social 
legitimacy, sometimes sharing stories of feeling invisible.  
This chapter begins with reflection on developing an understanding of pain as 
multidimensional and situated within the whole experience of living with CF.  Next, a pain 
theory that will best facilitate understanding of study findings was sought and selection 
of total pain as a theoretical lens described. Findings are then discussed in relation to the 
literature presented on cystic fibrosis and pain in Chapters Two and Three, the broader 
literature around pain, living with CF and other chronic illnesses and palliative care.  
Through the research process, an initial understanding developed of pain as multifaceted 
and important in participants’ experience of living with CF. As seen in the findings, 
participants described their pain as primarily “emotional”.  It is not that participants did 
not talk about physical pain; indeed, they did, and it was evident that physical pain had 
always been a part of their lives. However, they described pain that was 
multidimensional, nuanced and complex. 
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 Further illuminated in the setting of CF was that pain is integral to the lived experience 
of CF and cannot be extracted or carved out of the whole experience of living (Good, 
Brodwin, Good, & Kleinman, 1994). The interviews provided an opportunity for 
participants to share their experience with pain and when they did, they shared their 
overall experience of living with CF. However, these stories about pain were shared within 
the greater experience of living with a chronic and life-limiting illness, supporting the 
argument for studying pain in context of the overall life trajectory rather than in isolation 
(Good et al., 1994).  
6.1 Theory to illuminate pain in CF 
With pain in CF recognized as a multidimensional, complex experience occurring within 
the context of living with a chronic illness, a theory was needed that could illuminate and 
promote understanding.  In exploring the theoretical bases of pain literature described in 
Chapter Two, none seemed sufficiently focused on the multiple facets of pain as 
experienced within the context of the whole person living with CF. Returning to the pain 
literature, the biopsychosocial model is now considered. 
6.1.1 Biopsychosocial model 
The biopsychosocial model of health and illness (Figure 4) by Engel (1977) has also been 
applied to the pain experience, encompassing physical, emotional and social elements of 
pain (Gatchel, Peng, Peters, Fuchs, & Turk, 2007). Engel (1977) argued that the biomedical 
model of health and illness alone is insufficient and proposed that psychological and social 
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factors should also be considered. With a perspective of pain as not strictly physical or 
biomedical, but rather a complex experience involving many contributing aspects, the 
biopsychosocial model has been increasingly adopted in medicine (Bevers, Watts, Kishino, 
& Gatchel, 2016; Gatchel et al., 2007).  Of note, while acknowledging aspects of pain 
beyond the physical, Engel still saw pain as situated in the physician’s realm, and 
advocated the biopsychosocial model to be used by physicians with psychiatrists 
addressing the non-physical aspects of pain (Engel, 1977). 
 
Figure 4. Venn diagram illustrating Engel (1977) theory for biopsychosocial model. 
While the biopsychosocial model may come close, a theory with more emphasis on the 
person as a whole was desired. This endeavour led towards the palliative care literature 
and the theory of total pain by Saunders (1965). 
6.1.2 Total pain 
Introduced in the 1960s and evolving over the following decades, the concept of total 
pain includes physical, emotional, social and spiritual components (Clark, 2018a; 
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Saunders, 1965). In this model, the elements of total pain are interactive, as depicted 
visually in Figure 5. Saunders’ theory of total pain greatly influenced the field of palliative 
care, which still strives to address physical, emotional, social and spiritual needs (Clark, 
2018a).  
 
Figure 5. An interactive model of total pain. Reprinted from ‘Understanding of the concept of "total pain": 
A prerequisite for pain control’ by Mehta and Chan (2008, p. 30).  
6.1.3 Development of total pain theory 
Although Saunders introduced the concept of total pain in the 1960s, there is evidence of 
its beginnings in her earlier writings (Clark, 2018a). Conceptualised through her unique 
combination of experiences as a nurse, social worker (almoner), physician and scholar, 
total pain was a turn away from the previous notion of pain as chiefly physical (Clark, 
2018a; Graham & Clark, 2008). For Saunders, total pain was comprised of not only 
physical pain, but emotional, social and spiritual pain as well. In developing the theory of 
total pain, Saunders spent extensive time with patients, listening and talking with them, 
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recording conversations and drawing on these narratives as she developed her theory. 
Saunders (2006b) valued these stories and their context within an individual’s life and 
found it extraordinary that patients did not expect a physician to be interested in their 
stories of pain. In contrast, Saunders saw these stories as key to understanding multiple 
dimensions of suffering, and would likely support the narrative medicine movement 
today (Clark, 2018a).  
6.1.4 Domains of total pain  
The theory of total pain, having developed gradually through Saunders’ work, continued 
to evolve over her lifetime (Clark, 2018a). Recognising that this division into domains may 
seem somewhat artificial, Saunders (1995, p. 45) nevertheless felt the domains would 
“enlighten us as we endeavour to understand the suffering of each patient and to help 
both them and their families”. In other words, total pain provides a lens to view each 
individual, taking into consideration the many dimensions of their experience with pain 
and suffering, without which the clinician (or researcher) may miss an important aspect 
of their pain experience. Along with the physical, the other domains of total pain are 
emotional, social and spiritual. 
Physical pain is often the primary focus of pain assessment and treatment. Saunders’ 
perspective of physical pain was strongly influenced by the cancer population that made 
up most of her patient base. Types of physical pain included pain related to cancer itself, 
as well as pain related to debilitation (such as pressure ulcers and constipation), and pain 
related to treatment (such as surgery and radiation-induced esophagitis). Alongside 
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development of total pain theory, Saunders strived to improve treatment of physical pain, 
advocating for medication to be given routinely to prevent rather than only treat pain 
(Clark, 2018a). Additionally, Saunders viewed physical pain as inextricably linked to other 
domains of pain (Saunders et al., 1995). 
Emotional pain, also referred to as mental pain and psychological pain by Saunders and 
others, encompasses a broad range of experiences (Clark, 2018a; Krawczyk & Richards, 
2018; Saunders et al., 1995; Seymour, Clark, & Winslow, 2005). Depression, anxiety, 
uncertainty and even anger are all part of the manifestation of emotional pain. Fears 
about the future and worry about what will happen to friends and loved ones contribute 
to emotional pain. Isolation, encompassing the domains of both emotional and social 
pain, may cause some of the most severe suffering (Saunders, 2006b). 
Saunders, following a period of questioning and self-proclaimed atheism, was a devout 
Christian and this undoubtedly influenced her to include spiritual pain as she developed 
total pain theory (Clark, 2018a). Despite her own personal views, however, Saunders 
recognised the importance of supporting the ill in their own beliefs rather than pushing 
them to adopt Christianity. Within total pain, spiritual pain may or may not have a 
religious dimension, depending on the beliefs of the ill person.  
The search for meaning or a feeling of meaninglessness may be expressions of spiritual 
pain, as may regret and despair. Hope is often associated with spirituality, and when 
absent may cause deep suffering. Saunders felt that spiritual pain may cause the deepest 
suffering of all domains (Saunders, 2006b). She saw listening as critical in addressing 
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spiritual pain, even when the practitioner has no answers or the right words to say 
(Saunders et al., 1995).  
Saunders’ perspective of social pain primarily concerned the family of the ill person (Seale, 
1998).  In the context of family, social pain may include financial burdens experienced by 
a person and their family, or feelings of the ill person not wanting to be a burden to others 
or the real burdens of caregiving on the family. Saunders also saw grief as a form of social 
pain, beginning around diagnosis and continuing throughout the course of illness and into 
bereavement following death (Saunders et al., 1995). In the years since Saunders 
developed total pain theory, the notion of social pain is sometimes expanded to include 
not only the family, but the expanded social network of friends, work, community and 
society, discussed further in 4.2.3 Critique of total pain theory (Goebel et al., 2009; 
Gunaratnam, 2012; Krawczyk & Richards, 2018).  
A sometimes overlooked aspect of social pain, is pain in clinicians who care for people 
with serious illness.  Saunders and Baines (1983) contended that focus on total pain, on 
the whole person, also benefits clinicians. Pain was seen as an expected part of work with 
people who are dying, and Saunders advocated for both formal and informal support of 
medical staff, especially those new to the work (Saunders, 2006c; Saunders et al., 1995). 
A life outside of work was considered essential to longevity in the field, as was finding 
meaning in caring for the seriously ill and dying.  In the years since total pain emerged 




6.1.5 Critique of total pain theory 
Enduring as a central focus in palliative care, total pain has become a foundational 
concept for many in hospice and palliative care (Krawczyk & Richards, 2018; McCaffery & 
Ferrell, 1997; Saunders, 2001).  Despite being a central focus in palliative care, there is 
little research about the theory.   Furthermore, total pain has primarily been applied in 
case studies or as a general recommendation, rather than the subject of study itself 
(Krawczyk, Wood, & Clark, 2018).  This may be, at least in part, due to confusion around 
definitions of total pain, what it is and what it does (Krawczyk & Richards, 2018).  Turning 
to how total pain has been applied and discussed in the literature will provide at least 
some information to begin to answer these questions. 
As Saunders was developing her theory of total pain, she was aware of potential pitfalls 
in operationalising such a broad concept. She recognised the ideal of seeing the whole 
person but remained concerned that critical parts of suffering might be missed without a 
framework. Her vision of total pain was as much a philosophy, a way to see someone in 
deep suffering, as it was a guide for assessment and treatment. Her choice of the words 
‘total pain’ in describing the theory is not without critics. Proudfoot (1976) criticised 
Saunders for using the word pain to describe mental, social and spiritual suffering, 
concerned that it implied these feelings should be avoided or medicated (Saunders, 
2006c, p. 148).  Saunders et al. (1995, p. 45) addressed this herself when she argued that 
these types of pain “should usually be faced rather than merely blotted out”, cautioning 
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that use of the word pain should not imply that all domains of total pain require treatment 
with medication.  
Strang, Strang, Hultborn, and Arnér (2004) similarly reported that it was suggested that 
total pain is not congruent with the widely accepted International Association for the 
Study of Pain (IASP) definition, relating concern about possible confusion regarding 
whether it refers to physical pain or to other types of suffering. Yet, Krawczyk et al. (2018) 
see the definition as congruent with total pain, perhaps because it is enveloped within 
“emotional experience” of the definition (Merskey et al., 1994, p. 210).  Saunders (2006c) 
herself relates that her choice of the word pain in describing these facets of suffering was 
an intentional decision to guide the clinician’s gaze to these sometimes overlooked but 
important parts of the dying experience. Krawczyk et al. (2018) add to the rationale for 
use of the word pain when they remind readers that the word pain is already used 
figuratively by many people when they speak of illness and is therefore appropriate in the 
context of total pain. 
There are multiple ways of understanding total pain, as seen in the numerous ways it has 
been conceptualized in the literature (Krawczyk & Richards, 2018). For example, Kendrick, 
Hudgell, Hellman, and Weaver (2019) applied total pain in a case study of a boy with 
Juvenile Huntington’s Disease.  Their application had a predominantly biomedical focus, 
however in social pain they extended the theory to encompass the healthcare system and 
community, identifying a gap in available respite providers that prompted legislative 
advocacy (Kendrick et al., 2019).  Warlow and Hain (2018) examine the literature and their 
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own anecdotal experiences to consider total pain in children with neurological 
impairment.  Also emphasising the biomedical, they use the term “psychosocial” but 
social pain itself was unexplored.  In contrast, Warlow and Hain (2018) thoughtfully attend 
to the domain of spiritual pain in children with neurological impairment, with an emphasis 
on attachment and relationship.  Goebel et al. (2009) explored total pain and its 
application in heart failure, with more emphasis on the history of total pain and its 
situation amongst other pain theory.  These authors demonstrate total pain applied in a 
straight-forward but limited manner, with symptoms delineated within the associated 
domains, but without critical review or engagement with the theory itself.    
Although often applied simply, some researchers are engaging with total pain more 
critically such as Gunaratnam (2012), a sociologist who researches and teaches in the 
areas of race, ethnicity, and migration.  Gunaratnam’s work with total pain helps expand 
the theory into the broader context of community, society and culture.  Social pain in this 
broader context may be challenging for people to express, thus total pain theory may 
serve to facilitate recognition of an otherwise invisible phenomenon (Gunaratnam, 2012). 
A prolific researcher on Saunders and total pain theory, Clark (1999) has considered the 
theory from multiple social and philosophical perspectives and continues to interrogate 
the theory today. In one of his many writings on total pain, Clark (1999, p. 734) presents 
the idea of total pain as a “paradox” that can both help and harm, as an extension of the 
“clinical gaze”, promoting a position of power.  In this sense, total pain not only extends 
the realm of pain into the domains of the emotional, social and spiritual but also extends 
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the reach of the clinician’s treatment into these areas.  This essentially places the clinician 
in a position to both create and solve a problem, giving power to the clinician rather than 
the person in pain, in other words total pain is given by the physician, albeit 
unintentionally.  Addressing this paradox, Clark claims, comes in viewing total pain as 
“lived” instead of “inscribed” (Clark, 1999, p. 734).  In this shift of perspective, total pain 
allows one to embrace the position of another, to facilitate understanding of a complex 
experience, which Clark (1999) asserts was Saunders intention with the theory. 
Krawczyk and Richards (2018) call attention to some of the challenges surrounding total 
pain.  For example, the delineation of experience into the domains of total pain may 
artificially compartmentalize these aspects of experience.  In a multidisciplinary team, this 
may serve to divide focus into these domains and actually diminish focus on the whole 
person.  Saunders, with her training as a nurse, social worker and physician, and her 
wartime experience with the dying, was highly unusual (Clark, 2018a). Having such a 
unique combination of training and experience in a single person gave her a clinician’s 
gaze unlikely matched by others who may not look past what they see as their specialty 
area.  Krawczyk and Richards (2018) surmise that some of this confusion may stem from 
the original application of total pain theory in cancer at end of life and later expansion to 
the entire continuum of experience in serious illness, an expansion that not all health 
systems can support.    
There are several examples of this expansion of total pain in other diseases, although 
similar to oncology it is most often applied in case studies (Goebel et al., 2009; Klepping, 
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2012; Mehta & Chan, 2008; Middleton-Green, 2008; Phenwan, 2018; Rao, 2016; Satija, 
Singh, Kashyap, & Bhatnagar, 2014; Warlow & Hain, 2018). Reflecting on the evolution of 
palliative care, including total pain, Saunders herself viewed the focus on primarily cancer 
as a failure, but acknowledged limitations as she added: “But how do we balance need, 
skills and resources?” (Saunders, 2001, p. 432). Since the time that Saunders wrote that 
article, answers to this question have been at least in part found in a delivery model 
recognising primary palliative care as the domain of all clinicians, with specialists 
delivering specialty palliative care in more complex cases. 
Also contributing to lack of uptake may be the disparity between Saunders’ ideal and the 
realities of modern healthcare systems (Krawczyk & Richards, 2018; Krawczyk et al., 
2018). The healthcare system during Saunders’ time and the fragmented healthcare 
system today are arguably quite different. With increasing health care costs and increased 
demands of electronic health records, clinicians today  are expected to see increasing 
numbers of people in less time (Irving et al., 2017). Medical care in the US has become 
more complex, and people are living longer with more complications and comorbidities 
(Krawczyk & Richards, 2018; McPhail, 2016).  
Further developing the evidence base, Krawczyk then joins with Clark as they look to 
further understanding and utilization of total pain.    Krawczyk et al. (2018) consider that 
lack of understanding of the definition and operationalization in total pain may be limiting 
formal application of the theory.  To further current understanding, Krawczyk et al. (2018, 
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p. 9) consider total pain theory in the context of a “bio-ecological” perspective.  Krawczyk 
et al. (2018, p. 9) explain that:  
“In this framing, who we are—the combined physical, emotional, and social 
aspects of being human—emerges as an embodied consequence of existing 
within, and being able to act on, dynamic individual (micro), community (meso), 
and structural (macro) environments that together make up a complex and always 
changing ecosystem”.  
In this positioning of total pain all domains are equal in importance, rather than the often 
predominance of the biomedical, and total pain is seen not just as an experience that 
happens in or to an individual patient, but as an experience that occurs within a complex 
system that includes patients, clinicians, health systems, and communities, relationships 
between all of these entities, as well as all of the many values and priorities inherent in 
each one and the system as a whole (Krawczyk et al., 2018).  
There is something aspirational about total pain as a guiding concept in palliative care, 
seeking understanding of the whole person, within their complex social networks.   Total 
pain guides people to look beyond the patient and see a whole person, it facilitates a style 
of care, and indeed a style of research, with the person at the centre.  With the person at 
the centre, connected not only to their care team, but also within social networks, care 
and research move beyond doing for and are better situated as simply part of the social 
world.    
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Although any of the pain theories described here and in Chapter Two would likely move 
the almost exclusively quantitative body of research forward, the way Saunders 
conceptualised total pain seems most appropriate for this study. Total pain theory, with 
its inclusion of spiritual, emotional and social pain (in addition to physical pain), offers an 
opportunity to conceptualise these other dimensions of pain. With total pain selected as 
the theoretical lens for this study, now the findings are discussed in relation to the 
literature on pain and living with CF. This discussion begins with the continual evolution 
of emerging awareness, with emphasis on the temporal experience in CF.   This is followed 
by a discussion on total pain and suffering.  Next, the discussion explores social legitimacy 
and invisibility in relation to the literature.  
6.2 Continual evolution of emerging awareness 
Findings reported in Chapter Six highlight that participants underwent continual change 
as they both lived with illness and searched for meaning, echoing previous research in 
chronic illness (Charmaz, 1983; A. W. Frank, 2002). This continual evolution has been 
reported in both chronic and life-threatening illness, as well as illnesses that fall 
somewhere in between (Bruce et al., 2014).  
For participants, not only was their experience with CF changing as they became sicker, 
they were changing in relation to it. This is at least in part because the illness experience 
itself is considered to be socially constructed, reflected in the way people come to 
understand and navigate daily life in the context of their illness (Conrad & Barker, 2010). 
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These changes created a sense of movement or progression, and the significance of what 
it means to have CF continually evolved. 
6.2.1 Experiencing time differently 
As the meaning of having CF unfolded, participants seemed to experience time 
differently, a phenomenon consistent with previous studies of people who are ill (Gergel, 
2013; Good et al., 1994). Participants experienced a shift from the linear sense of time 
(past, present and future), to a more pendulum-like experience of time, as described in 
chronic illness research (Charmaz, 1991; Marini & Stebnicki, 2018). Participants seemed 
to simultaneously live in the memory of the past by remembering a time they felt 
healthier, or even remembering trauma or pain, while at the same time coping with 
present physical and emotional stressors, all in the setting of anticipating future events 
and uncertainty. This is reminiscent of Bruner (2002, p. 93), who said, “Through narrative, 
we construct, reconstruct, in some ways reinvent yesterday and tomorrow. Memory and 
imagination fuse in the process.” Heaton (2015) characterizes a similar depiction of 
people with CF looking back and forth between their past, present, and future selves as 
“temporal comparison” of the self, a term introduced by Albert (1977).  In a “temporal 
comparison” the individual seeks to make sense of the experience. These examples 
illustrate the ability of narrative to demonstrate how meaning changes over time. As they 





6.2.2 Milestones as markers of change  
Signalling progression from diagnosis to advanced disease, participants described 
milestones in their illness, resonant with Charmaz (1991) description of “time markers” 
or “turning points”. These milestones created signs along a road map of participants’ lives. 
Milestones provide more than a marker of time; they help to create meaning as people 
reflect on past events to understand the present (Charmaz, 1991). Milestones or turning 
points described by participants signalled transition or movement along the continuum 
of illness. Some milestones were discrete events such as diagnosis of CF, first hospital 
admission or lung transplant, with a clear change in the experience that followed. 
Regardless of what the event was, the meaning to participants seemed to evolve, 
demonstrating the changing meaning over time (Charmaz, 1991). 
Some milestones, rather than being a distinct event, occurred over a less defined period, 
as when participants were getting sicker, not responding to treatment, or developing new 
symptoms. Although Jessup and Parkinson (2010, p. 356) did not use the terms milestones 
or turning points, their description of “watersheds” leading to a “stark moment of the 
actual reality of having CF” is similar, and their emphasis on fear caused by these 
moments was echoed in participant narratives. Palser, Rayner, Leighton, and Smyth 
(2016) also echo the significance of milestones in their qualitative study of the first 
pseudomonas infection in CF. Palser et al. (2016, p. 4) in their descriptions of the first 
infection with pseudomonas (and other ‘firsts’, such as needing oxygen) as a “turning 
point in people’s relationship with CF” and marking a transition from one stage to 
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another. Similar transitions have been discussed by others researchers in CF as well  
(Dellon, Robinson, & Klick, 2011; Schmid-Mohler, Caress, Spirig, Benden, & Yorke, 2019). 
These milestones signalled a significant event, transition or turning point, and were often 
accompanied by fear or pain. In this study on pain in CF, laughter was especially 
prominent around milestones when participants were discussing their deepest pain, thus 
illuminating the key role that milestones may play in identifying total pain.  
Milestones also supplied form and direction to the flow of emerging awareness. 
Participants looked back, reflecting on these milestones, and forward, anticipating future 
changes, becoming increasingly aware of what CF meant in their lives. Meaning shifted as 
they were continually in a different location along the trajectory of illness. That is, as 
Cassell stated, “Meanings also flow. Like the value or importance invested within them, 
meanings are not static, even if they often remain stable for long periods.”(E. Cassell, 
2005, p. 309).  
6.2.3 Between sickness and health 
Although participants generally shared stories in a chronological form, their location along 
the narrative at any given point had an element of flexibility, a liminal quality. This 
phenomenon of liminality was present throughout the full spectrum of emerging 
awareness. In early illness, participants had CF but did not necessarily view themselves as 
sick, even though they still required hours of treatment every day.   
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When recalling earlier phases of illness, “healthy” became a relative term. Participants 
referred to themselves as healthy, while at the same time recalling the burden of 
treatments and symptoms.  Participants were in a fluid state, moving between sick and 
not sick, with the definition of “sick” seen in retrospect of how they felt previously 
compared to how they feel now.  What was considered sick one day may be health later. 
Along this continuum, participants moved from hope for a normal state of health, into 
the recognition that they would never have this. This notion of health echoes Lowton and 
Gabe (2003) in their work in adults with CF, where perception of health was found to be 
a relative and dynamic state, related to the participant’s status of illness and treatments, 
as well as the general context in which they live their lives.  Similarly, Huyard (2008, p. 
543) in her study of adults with CF, described a transformation from the perception of 
oneself as healthy to that of ill as an “illness career” in her study of adults with CF.  She 
found that participants viewed their life in two distinct phases.  The first phase was 
relatively straightforward and in this phase, participants did not consider themselves to 
be ill.  The second phase was more convoluted, and it was in this phase that participants 
started viewing themselves as ill.  As Huyard (2008, p. 539) describes, recognizing self as 
ill is a learning process that occurs over a period of time and awareness  “generally 
emerges with a sudden worsening of the condition”.  Milestones described in 6.2.2 echo 
this description of the shift that occurs with an abrupt change in condition, and the 
corresponding shift in recognition of self as ill is seen in Box 6 as Samantha begins 
“learning the depth of what the illness did”. 
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Badlan (2006) noted a similar ambiguity between being healthy and unhealthy in her 
study of young people with CF. In her study, she found that the CF treatment regimen 
seemed to influence the perception of self in young people, noting that this process can 
be painful and may affect acceptance of their illness (Badlan, 2006).  Badlan (2006) 
emphasized the importance of CF team members understanding the temporality of the 
experience of being sick and recognizing that people with CF usually spend time in several 
other roles in addition to a sick role. This supports the goal of viewing a person in their 
wholeness, a goal supported in this study through use of total pain as a lens to consider 
the experience of pain in CF.  
6.2.4 Death always looming 
For participants, death was always in the background, lurking even when not the focus of 
the story. Increasing realisation of living less well meant that death became less 
hypothetical and more real. Participants were no longer able to keep it in the background 
as they became increasingly short of breath and spent more time in the hospital. There 
was a delicate balance of living life fully now, with increasing awareness of dying from CF.  
It was this particular liminal space, between living and dying, where emerging awareness 
led. At its core, emerging awareness was not about becoming aware of what it means to 
have CF in regard to medications or facts about the disease, but a journey towards 
recognising that death is looming, that it is getting closer with each milestone. This 
recognition of mortality in CF. Uncertainty and fear were prominent along the continuum 
`as participants became increasingly aware that they would eventually die from CF.  
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All participants talked about having outlived their life expectancy.  People with CF often 
grow up with the thought that they are always at or close to the end of their life, perhaps 
first told they may live to about 12 years, later extended to 20 and still later to 30 and so 
forth, with death always looming not far off in the distance (Schubert & Murphy, 2005). 
As seen in this and other studies, for example Badlan (2006) and Jessup and Parkinson 
(2010), deaths of friends or even siblings from CF becomes a somewhat common 
occurrence in life and participants expressed a great deal of emotional and social pain 
with these experiences. This experience, with death always looming near but continually 
moving just a bit more into the future, constitutes a particular type of uncertainty. 
At times, uncertainty presented in more practical ways, such as when participants felt 
they were unable to make plans for vacations or even dinner for fear that they would get 
sick and have to cancel. This is characterised as just one of many losses that occur in 
serious illness (A. W. Frank, 1995, 2002). Participants also shared other concerns about 
uncertainty within illness including uncertainty about diagnosis, severity of illness, 
treatment, and implications for life and future plans (Mishel, 1988, 1990). These were 
seen in narratives around diagnosis, treatment no longer working as well, school and 
work, and worrying about romantic rejection.  
The deepest fears and uncertainties were seen as participants faced the reality of getting 
sicker and dying, and struggled to find meaning, as noted in Chapter Six when they 
whispered and laughed when relaying these concerns. Other researchers have suggested 
that uncertainty and unpredictability diminish the construction of meaning in the illness 
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experience (Charmaz, 1991; Marini & Stebnicki, 2018; Mishel, 1988, 1990). In a study 
examining symptom burden and unmet existential needs, adults with CF reported needs 
for additional support around fears of worsening CF, uncertainty, and fears of death, 
elements of emotional and spiritual pain (Trandel et al., 2019). In people with more severe 
disease, Trandel et al. (2019) found even more reported unmet existential needs. 
In the face of uncertainty, participants were challenged to revise expectations, goals for 
the future, and even identity. Although uncertainty has often been presented as an 
experience to be feared, it may also evolve over time, leading to recognition of 
uncertainty as an expected state and even to personal growth, such as when participants 
talked about uncertainty being normal or living fully while they still could (Mishel, 1990).  
6.2.5 Biographical disruption in cystic fibrosis 
Echoes of the evolution of emerging awareness can be seen in the body of research on 
biographical disruption, yet there are differences in the experience in CF. In his work on 
biographical disruption in rheumatoid arthritis (RA), Bury (1982) aimed to speak with 
people early, identifying potential participants as they were referred to a rheumatologist. 
In both RA and CF, symptoms are often gradual in onset. However, CF diagnosis usually 
occurs in the first two years of life, and most people with CF (even children as seen in 
Brittany’s narrative) are aware of their terminal diagnosis. Furthermore, although 
symptoms might increase gradually, the treatment regimen, or “lifestyle” as Christopher 
called it, is perceived as a burden by participants even in the apparent absence of 
progression in early disease. In CF, then, the experience of biographical disruption is likely 
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different than in RA. Indeed, Williams et al. (2009) also found biographical disruption in 
CF to be different than when described in RA.  In interviews with young people diagnosed 
with CF, they described the experience to be more of a “continual biographical revision” 
as opposed to distinct disruption, appearing to overlap with the description in this study 
(section 7.1.1) of experiencing time differently, with participants continually reflecting on 
their past and anticipating their future (Williams et al., 2009, p. 1453).  Although there is 
not space in this discussion for a thorough examination of biographical disruption in the 
context of CF, there was a glimpse in the narratives when Ashley said, “We’ve been doing 
it all our lives, it’s all we know.”  
Considering emerging awareness as a whole, participants were clearly still in the midst of 
this continuum. Even as participants recalled past events, their relationships to these 
events had evolved over time. This evolution occurred in the setting of changing meaning, 
worsening illness, and changing cognition as they became adults and had increasing 
capacity for understanding. All stories of emerging awareness involved this sense of 
movement, change, and an ever-increasing presence of total pain and suffering. 
Total pain, as a theory, makes sense of emerging awareness by providing the context to 
view this narrative within the wider experience of living with cystic fibrosis. Without the 
lens of total pain, the emerging awareness narrative may have been overlooked as 
unimportant and simply the timeline upon which pain is described, rather than an integral 
and illuminating component of the experience of pain in CF.  
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Figure 6 illustrates a conceptual model for the continual evolution of emerging 
awareness. It shows the gradual increase in awareness as participants began to recognise 
what having CF meant in their lives. Bidirectional movement, often pendulum-like, is 
displayed along the continuum. Milestones represent events that signify change and are 
depicted by signs along the evolution of awareness. The figure shows death as present, 
lurking in the background of participants’ stories as they became increasingly aware of its 
presence.
 
Figure 6. Emerging awareness in cystic fibrosis. 
6.3 Total pain in cystic fibrosis: “It’s all just suffering” 
As seen in the literature review, presented in Chapter Two, studies of pain in CF have been 
centred on physical pain, which is common (Havermans, Colpaert, De Boeck, Dupont, & 
Abbott, 2013). Locations of physical pain in the findings were consistent with the 
literature review.  However, while all narratives included discussion of physical pain, their 
focus was on other types of pain, most often dubbed “emotional pain” by participants. 
Participants interpreted pain in CF broadly, albeit reluctantly, asking hesitantly if 




The quantitative nature of previous studies on pain in CF provided little more than a 
glimpse of the “emotional pain” described by participants, seen in the studies that 
examined potential relationships between pain and psychological correlates for quality of 
life using the CFQ-R  (Blackwell & Quittner, 2014; Hayes et al., 2011; Kelemen et al., 2012; 
Munck et al., 2012; Palermo et al., 2006). In this narrative study, participants shared much 
more detailed and rich descriptions about their experience with pain in CF. 
6.3.1 Emotional pain more than anything 
Although participants usually began with describing physical pain, they quickly moved on 
to descriptions of emotional pain, which then encompassed much of their pain 
experience. The stories of physical pain served as a kind of entry point into discussion of 
emotional pain, and this in turn revealed a deeper and far more complex experience than 
previously understood. Participants referred to any pain that was not physical as 
emotional pain but did not label it more specifically. Amanda said it best: “It’s emotional 
pain more than anything.” 
Participant descriptions of their experiences with emotional pain were more diverse than 
the label emotional pain would suggest. Emotional pain for participants included pain 
with loss of friendship, loss of jobs, death of friends and family, grief associated with loss 
of physical abilities with increased severity of CF, loss of an imagined future self or 
meaning, fear and uncertainty, to name just a few of the scenarios described as emotional 
pain. Although participants did not label their experiences beyond “emotional pain”, a 
language and framework are found in the general pain and palliative care literature.  
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As noted in the literature review, historical definitions of pain have been fundamentally 
about physical pain. While some definitions included the psychological response and 
social context of physical pain, they fell short of acknowledging emotional pain as pain in 
and of itself. Saunders, in recognising physical, emotional, social and spiritual pain, 
bridges this gap in understanding. Participant narratives well represent Saunders’ concept 
of total pain as affecting physical, emotional, social and spiritual realms, allowing pain to 
be considered in different ways. If pain is understood as an experience other than just 
physical, total pain then supplies a framework and language to communicate about it.  
Although different domains of pain in Saunders’ theory provide a framework to talk and 
think about pain, the findings in this thesis suggest that separation into distinct domains 
may not recognise the importance of the relationship between domains of total pain as 
experienced in a whole person living with chronic illness. In other words, despite the 
theory’s usefulness, the concept of total pain may risk reductionism. As described in 
Chapter Four, Saunders recognised this risk of reductionism and in her earlier writing 
described the risk of overlooking the whole person when focusing on separate domains. 
Heeding Saunders’ caution to listen to the individual’s story and their experience as they 
describe it may improve the risk of reductionism. 
In initial consideration and analysis of data for this study, pain was indeed visualised in 
distinct categories, envisioned as more or less separate experiences. The findings, 
however, show that total pain is much more complex than just a distinct category 
depending on which part of the body or mind is affected. In CF, total pain is part of 
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everyday living with emphasis across the domains changing in relation to time and 
context. Pain cannot be carved out of the overall experience of living with CF. Total pain 
is a complex of the whole being in pain, a totality that is much more nuanced than just 
being in different domains on different days.  
Understanding pain in CF requires considering how it infuses every part of people’s lives, 
their relationships and their whole being. Total pain theory furthers understanding of the 
experience of pain in CF, but if viewed only within distinct categories damage to the entire 
person may not be fully appreciated. To deepen this understanding, an exploration 
follows of the concept of suffering as part of the CF pain experience. 
6.3.2 Suffering 
Despite controversy, as outlined by  A. W. Frank (2001), about whether suffering can truly 
be studied at all, and with minimal representation in the literature on pain in CF, it is 
relevant in this thesis to include a discussion about suffering, as most participants referred 
to their own experience as suffering. The use of narrative appeared to facilitate the 
identification of suffering in CF as a constant experience throughout people’s lives,   
Narrative  interviews, for instance, can allow participants the space to share rich accounts 
of experience that may span their everyday lives   and express their suffering, even 
described as giving voice to suffering (Kleinman, 1988; Loeser, 2005).  
Participants spoke of suffering in the context of living with CF, supporting A. W. Frank 
(2004) that like pain, suffering is best explored in the context of the illness experience. 
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Similarly, Cassell stated that “suffering is experienced by persons, not merely by bodies, 
and has its source in challenges that threaten the intactness of the person as a complex 
social and psychologic entity” (1982, p. 639).  
As participants shared stories about their illness, they were not merely sharing facts about 
their illness or treatment but revealing what it was like to suffer. Even when not overtly 
labelling it, participants expressed suffering through sadness or a sense of unfairness. 
Sometimes suffering was expressed in a pained expression or body language, and made 
clear through metaphors, a powerful use of language common in those who suffer (J. 
Bourke, 2014; Good et al., 1994). Christopher’s metaphor of pain in CF as “kind of like 
how a drop of water on your forehead isn’t uncomfortable until the 100,000th drop that 
lands on your forehead” brings the listener closer to his experience. Suffering is also found 
in the participants’ search for meaning or in asking the same, unanswerable questions, 
illustrated by Brittany as she wonders what CF “means for my life” (Charmaz, 1983). 
Although all participants were searching for meaning, Brittany returned to this question 
of meaning repeatedly in her interview and had a sense of desperation not seen in the 
other stories.   
Suffering, closely linked with loss in the literature, is seen in the narratives as participants 
describe numerous losses of control, self, health, friends, future dreams or plans, and life 
as they know it (Ferrell, 2008).  Through their stories, participants communicated that 
much more is going on under the surface than shared with others in their lives, including 
family and friends, and even more than they themselves may appreciate. Participants 
  
 146 
who seemed well from outside appearances and described themselves initially as doing 
well revealed that they were in fact, often in their own words, suffering. For instance, 
participants described pain in all its forms, from becoming aware of what having CF meant 
in their lives, to striving to be independent and feel successful, to feeling invisible and 
misunderstood, getting sicker, and wondering when their life would end, while life as they 
knew it was already changing. None of these experiences occurred in isolation; they 
converged and affected the whole being. When viewed as a whole, it was evident that 
their experience was all-encompassing. Suffering seemed indistinguishable from the 
experience of illness and total pain, supporting the notion that it is best understood in the 
experience of the whole person (Ferrell, 2008; Good et al., 1994).  
This understanding of suffering in CF as the expression of total pain, where the two are in 
essence one experience, is a key contribution to knowledge about the all-encompassing 
nature of pain in CF. Illustrating the experience of total pain and suffering in CF, Figure 7 
builds on the earlier depiction of the continual evolution of emerging awareness. Total 
pain and suffering encompass the domains of total pain described by Saunders (2006a), 
and are shown as a singular experience occurring within a whole person living with CF, 




Figure 7. Total pain and suffering in the context of the whole person living with cystic 
fibrosis. 
6.3.3 Finding meaning in suffering  
Much has been written about finding meaning and purpose in suffering (Charmaz, 1983, 
1999, 2008; Frankl, 2004; Kleinman, 1988). Some may find suffering to have positive 
consequences, such as valuing life more, striving to live more fully or finding deeper 
meaning in life. The participants in this study spoke of doing things while they still could, 
such as Matthew getting married and he and his wife having a child sooner than planned. 
Therefore, to say that participants are suffering does not lessen the meaning some may 
find through the experience.  
Suffering was present in all participant narratives, but that is not to say that the 
participants were complaining or had a victim mindset. Indeed, while some participants 
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seemed to experience spiritual pain as they searched for meaning in their experience, 
suffering for others may have had some positive aspects. Some researchers have 
described narratives of suffering as integral in coming to terms with and understanding a 
changed or changing life (Charmaz, 1999). Suffering may lead to a more evolved self 
(Kearney, 2000). In CF and other life-threatening chronic illnesses, a search for meaning 
may lead to transcendence as people navigate their way through the experience of 
worsening illness, disability and death.  When Canda (2001) interviewed 16 people with 
CF many of them described a heightened interest in meaning attributed to awareness of 
their own mortality. However, he noted that this path of transcendence was not an easy 
one, stating that participants “described times of great physical discomfort, emotional 
stress, intellectual quandary, and social relational impediment” (Canda, 2001, p. 122). The 
focus of his research is clearly centred on the spiritual, but this sentence gives a hint of a 
potentially broader experience not unlike total pain.  Returning to the experience of 
Brittany and her desperate search for meaning, perhaps she is on a path towards 
transcendence but at the time of the interview she was, in her own words, suffering.  
The scope of this study does not support an in-depth evaluation of the benefits of 
suffering in CF, but further investigation by those interested in exploring this 
phenomenon may be warranted. Although there may be some benefits in suffering, for 
many, pain and suffering in the context of chronic, life-limiting illness can seriously 




6.4 Social legitimacy 
Thus far in discussing the experience of pain in CF, this thesis has explored the emerging 
awareness of what it is like to have CF, and the experience of total pain and suffering. It 
has drawn from the literature on chronic illness, pain, suffering and palliative care to help 
make sense of the participant narratives in the context of existing knowledge.  
In examining the narratives, the depth of suffering expressed by some participants was 
astonishing, but not entirely unexpected. The close link of social legitimacy to the 
experience of living in CF, however, was not expected yet affected all participants. It was 
in looking through the lens of total pain, the wholeness that included emerging awareness 
of what it means to live with CF, pain and suffering, that the critical role of social 
legitimacy was identified. Indeed, the place of social legitimacy in the experience of pain 
in CF is a key contribution of knowledge emerging from this thesis. For participants, after 
a lifetime of emerging awareness of what it means to have CF, as pain in all its facets led 
to suffering, nowhere was the deeper impact of living with CF more obvious then when 
they felt that they had no social legitimacy as people. 
Social legitimacy first presents in the participant narratives as a response to illness, a 
coping mechanism. As people emerge into awareness of this chronic, life-limiting disease, 
this is part of how they deal with it, by striving to achieve or maintain social legitimacy. 
This was clear in all participants in their aim towards independence. It was also a driving 
force behind striving to achieve or maintain a desired social role, seen when participants 
“pushed through” to attend a social event when in pain or sick, or when they dedicated 
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significant effort to maintain employment despite worsening illness. Similar to the 
participants in this study, Saldana, Pomeranz, and Young (2018) found that people with 
CF may continue to work even with quite severe disease.  Other studies in CF reported 
severe lung disease is not in and of itself an indicator of work disability, finding that 
flexible work and other accommodations, along with psychological and educational 
factors are more closely associated with work status (Burker, Sedway, & Carone, 2004; 
Hogg, Braithwaite, Bailey, Kotsimbos, & Wilson, 2007).  Good et al. (1994) even described 
work as a respite from pain.  
Social roles for participants mirrored those seen in the general public, such as friend, 
spouse or partner, parent, child, caregiver, employee and volunteer. Pain, suffering, 
chronic illness and disability have been studied in relation to social roles, strategies used 
to maintain functioning, and disruption that results from lost ability to maintain these 
roles (Good et al., 1994).  
6.4.1 Sociocultural conditioning 
The striving for social legitimacy seen in participant narratives reflects points described in 
the literature on sociocultural conditioning. In western society, value is placed on hard 
work, productivity, accomplishment, financial success and independence (Charmaz, 1983; 
Hay, 2010; Marini & Stebnicki, 2018). This perception of social legitimacy may be difficult 
to reconcile with an illness such as CF, and despite understanding CF as life-threatening, 
progressive and unpredictable, society often reinforces these expectations of hard work 
and productivity. Even when those around them are understanding and accommodating, 
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people with CF may still place similar expectations on themselves, illustrating self-
regulation of societal norms. 
Western societies often place high value on this model of pushing through illness, 
including their healthcare systems (Hay, 2010). For participants in this study, their society, 
including family, friends and even clinicians, reinforced this style of coping through praise 
and admiration, often elevating the person to hero status. For example, Ashley is talking 
about this very admiration when she describes her experience pushing through in CF, and 
how this has inspired her friends and family. This is so ingrained in the expected way of 
coping with illness that participants did not identify with any other way of living with CF, 
best demonstrated by Ashley’s remark: “I think everyone with CF has to push on… it’s all 
we know”.  
This social model is also seen through using language of battle and war when talking about 
people who are ill. They are encouraged to fight, illness is framed as a battle or a war, and 
they are said to have “lost” their battle when they die. Especially prevalent when talking 
about cancer, this language of battle is also common in CF and is present throughout the 
narratives.  
6.4.2 Trying to be independent  
The desire to be independent was also influenced by the high value placed on 
independence in western society (Hay, 2010). This was especially prominent in Amanda’s 
case as she said that she wanted to be independent, take care of herself and be financially 
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self-supporting, but because financial independence was not possible given her CF, she 
was “on the system” and felt humiliated. Given the diagnosis and associated medical 
expenses and disability, people with CF can be caught in a cycle of receiving assistance 
through Supplemental Security Income (SSI) and then being subject to the limitations on 
employment required to maintain their coverage, an experience not unique to CF in the 
US (Marini & Stebnicki, 2018). The social cost of being trapped in this system manifests in 
social pain as seen in feelings of shame and worthlessness, illustrated so clearly in 
Amanda’s story. 
As they became increasingly aware of what it meant to have CF, participants continually 
strived for social legitimacy, pushing through to be “normal” and independent. Present 
even in children, D'Auria, Christian, and Richardson (1997, p. 106) described participants 
ages six to twelve years trying to “keeping up” with their peers.  This is a part of usual 
growth and development, but in CF it is interrupted at best and may be impossible in the 
face of a burdensome treatment regimen and worsening illness. Some with CF report that 
they are often faced with skipping daily treatments so that they do not miss social events 
(Gjengedal, Rustoen, Wahl, & Hanesta, 2003).  Striving for social legitimacy, pretending 
not to be sick, and trying to be normal and independent is often impossible in the face of 
worsening illness. Even basic social outings may be skipped due to sheer exhaustion and 
embarrassment related to social judgement (Cordeiro, Jesus, Tavares, Oliveira, & Merighi, 
2018).  Striving for social legitimacy may at times be beneficial, but can be physically 
exhausting and unsustainable, and when unable to keep up the effort people may lose 
their sense of identity and self-worth, thus experiencing social pain (Hay, 2010).  
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6.4.3 Working harder 
As these participants with CF became sicker, they explained how they had to work harder 
to maintain earlier levels of function. Inevitably there came a time when regardless of 
increased effort they could no longer keep up.  
As in the earlier discussion about liminality, participants were situated somewhere along 
the continuum between the societal role expectations of the healthy and of the sick. 
Society expects those considered healthy to conform to expectations discussed earlier. 
Those in a sick role, excused from these societal expectations, may have other obligations 
now placed on them. These obligations require the sick person to want to get better as 
soon as possible and to seek and comply with medical advice (Hay, 2010; Larkin, 2011). 
However, what happens when a person does not fit neatly into either role?  
Narratives for participants clearly caught in the middle of these two roles had an element 
of chaos that was not as prominent in the others. This is seen throughout the entire 
narrative for Brittany as she struggles with maintaining social legitimacy, exclaiming 
repeatedly that she does not know how to do all the things she is supposed to be doing 
in her life. The chaos depicted in Brittany’s narrative may, at least in part, stem from the 
pattern of constant change related to illness, leading to starting and stopping school, 
moving out and back in to her parents’ house, a pattern described by Saldana et al. (2018, 
p. 431) in participants with more advanced CF as “disruption and interruption”.  As 
participants became more dependent on others as illness progressed, they viewed this as 
negative and expressed embarrassment about it. Although adults, like Brittany, may 
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express embarrassment or frustration about being somewhat dependent on others for 
help with therapies and activities of daily living, assistance from others is common in 
adults with CF, especially assistance from parents (Edwards & Boxall, 2012; Lowton, 
2002b; McGuffie, Sellers, Sawicki, & Robinson, 2008).  
6.4.4 Losing social legitimacy 
As participants were moving away from the healthy role and towards the sick role, they 
experienced numerous losses, from social role, identity and independence, to hopes for 
a life previously known or hoped for. As these losses began to mount, they contributed 
to total pain and suffering and decreased social legitimacy. Some participants, in response 
to these changes, also described becoming more socially isolated (Charmaz, 1983). 
Friends stopped inviting them to social events when they repeatedly said no or had to 
cancel at the last minute, as shown in Amanda and Ashley’s stories. Participants 
sometimes lost friendships over these events. Other times, as seen in several participants’ 
stories, the increased focus and energy required to deal with worsening CF meant they 
no longer had the energy for keeping social relationships and became even more isolated. 
Some were marginalised on the fringe of society, becoming increasingly isolated as illness 
progressed, and barely taking part in social processes, such as when Amanda described 
doing treatments from sunup to sundown. Isolation, marginalisation and lack of social 




6.4.5 Gradual descent towards invisibility 
As illustrated in Chapter Six, stories depicting invisibility were prominent in the findings. 
Saunders (2006b) spoke of invisibility as a source of great suffering, and indeed as these 
stories repeatedly surfaced, the depth of participants’ social pain, suffering and loss of 
social legitimacy started to appear. This finding of invisibility led to identification of social 
legitimacy. The extent of total pain and suffering beneath the surface is key to 
understanding the experience of total pain in CF.  
Participant narratives were filled with reports of feeling misunderstood and judged by 
friends, family, colleagues and even the CF team. The phenomenon of feeling 
misunderstood and feeling the need to remind  or prove to others that they had a chronic 
illness is not unique to CF. Researchers studying invisibility in chronic illness have written 
about people with invisible symptoms who are unable to be productive feeling devalued, 
misunderstood and judged by others about the legitimacy of their illness (Charmaz, 2002, 
2008; Hay, 2010; Larkin, 2011; Marini & Stebnicki, 2018). Similar experiences have been 
reported in other chronic lung diseases, including COPD and pulmonary hypertension 
(Fraser, Kee, & Minick, 2006; Gysels & Higginson, 2008; Yorke, Armstrong, & Bundock, 
2014).  
Invisibility can be problematic in those who are unable to conform to societal 
expectations, but has also been described as beneficial when people want to hide or 
minimise the effects of illness (Charmaz, 2008; Hay, 2010). There are several possible 
explanations about why someone with CF might choose to be invisible. Some participants 
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explained that they keep suffering out of view of others, sometimes to protect them or in 
response to an earlier loss of moral status. This concern about being stigmatised or not 
wanting to be labelled as sick and treated differently also led participants to choose to be 
invisible by not disclosing their diagnosis of CF. Broekema and Weber (2017) found that 
participants carefully weighed the risks and benefits of disclosure after previously 
experiencing negative reactions in friends. Lowton (2004) also described a careful 
consideration of risks and benefits in disclosing a CF diagnosis, adding that fear 
surrounding disclosure was related to the level of risk. Less risk was present in casual 
encounters with the greatest risk present in discussions with potential partners or 
employers, as seen in this thesis, with Samantha’s fear of disclosing to boyfriends.  Even 
children struggle with whether to tell others about their diagnosis and fear the negative 
social consequences of disclosure (D'Auria et al., 1997). At times this hiding or silence can 
become a habit and perpetuate invisibility, as when participants sometimes isolated 
themselves when unable to fulfil social roles in the way they wanted (Charmaz, 2002). 
This was seen in participants who chose to stay home more often and no longer spent 
time with friends or quit their jobs when they felt devalued.  
Similarly, participants avoided seeking treatment for worsening symptoms, thereby being 
invisible to their clinical team, although this may have been more of a way to exert some 
degree of control over their illness than an adherence or avoidance issue.  
In this study’s findings, recall Jessica lying on the floor, unable to breathe and feeling that 
she was drowning, but refusing to go to the hospital. In her story, she was unsure why 
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she did not go to the hospital and wondered aloud if this was because she had a baby and 
did not want to leave her. But her statement about not wanting to have to go suggested 
a feeling of loss of control over her illness, magnified in the setting of being a new parent. 
Fear and existential threat around loss of control has been previously described in 
pulmonary exacerbations in CF, chronic obstructive pulmonary disease (COPD), and 
asthma and also compared to the experience of Post-Traumatic Stress Disorder (PTSD) 
(Schmid-Mohler et al., 2019). In an ethnographic study in CF, Maynard (2010) viewed 
situations like Jessica’s as a pursuit to be normal while living with CF, measured through 
comparison with individuals perceived as healthy. This constant comparison of self to 
others and trying to be normal led people to try and make CF invisible, sometimes leading 
to a “dysfunctional interpretation of the true risks confronting them” (Maynard, 2010, p. 
196). Seeing this as set in the greater social context of what a mother should be, Maynard 
(2010) sees this as more limited by society’s ableist narrative of what being a mother 
should be, rather than a limitation born of CF itself.   
Participants sometimes felt clinicians reinforced invisibility by conditioning people in what 
is proper to discuss in their clinical visits, albeit unintentionally. This was clear when all 
participants commented that clinic visits are all about lungs and weight. Despite the 
longstanding presence of a multidisciplinary care model in CF, people still felt that teams 
focused on just lungs and weight. With so much focus on these aspects, pain and suffering 
often remain invisible. Participants adjusted to what they thought was expected of them. 
In this way, the healthcare community encourages people to view illness, in this case CF, 
from a biomedical perspective and this has contributed to invisibility.  
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Viewing the social legitimacy and invisibility narratives through the lens of total pain 
illuminated participants experiences, highlighting connections between the narratives 
and how they contribute to the experience of pain in CF. In Figure 8, social legitimacy and 
invisibility are now added to the conceptual model of total pain and suffering in CF. This 
illustrates how total pain and suffering occur not only in the whole person living with CF, 
but also within the expectation of social legitimacy. Invisibility is depicted within the 
individual as a consequence to loss of social legitimacy and may be present throughout 
the life course.  
 
Figure 8. Social legitimacy, invisibility and their relationship to total pain in cystic fibrosis. 
The nature of invisibility is that it is not usually seen by those surrounding the person with 
CF in their social circle. This presents challenges in learning more about the experience, 
but given these interviews, people with CF are willing to share their stories when given 
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the opportunity. Although the study was not seeking knowledge about the experience of 
invisibility, it was overtly present in the narrative and seemed closely related to total pain 
and suffering. Invisibility seemed to both come out of and cause total pain and suffering, 
which calls for further investigation. 
6.5 Conclusion 
This chapter has discussed the experience of pain in CF, in context of the overall 
experience of living with illness. Literature in pain, palliative care, and living with chronic 
illness helped to make sense of the findings in relation to existing knowledge. Findings 
reinforced the assertion that researchers should study the experience of pain in relation 
to the overall experience of living, as when asked about pain, participants told their 
stories in this context.  Focusing on the person as a whole has been a goal throughout the 
study, essential to both research and clinical practice in pain and palliative care. Total pain 
has helped this study to move towards accomplishing this goal.  
Participants shared their stories along a narrative of emerging awareness where across 
their lives, they gradually became aware of what having CF meant. Findings suggested 
that participants lived in a liminal space of always being “in between”, existing between 
sick and not sick, health and illness, living and not living. Total pain was present in various 
forms across the entire spectrum of emerging awareness, but especially impactful to 
participants was the uncertainty and fear found in these liminal spaces.  
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The findings show that participants viewed the experience of pain in CF as more than just 
physical pain, with emotional pain dominating their narratives. Using the lens of total pain 
to help guide interpretation, all domains of total pain were present within the narratives. 
However, participants also spoke of suffering, so it was beneficial to turn to palliative care 
literature on suffering to further understanding.  
After considering suffering in relation to total pain theory and as affecting the whole 
person, understanding of total pain and suffering in this study evolved to a view of total 
pain and suffering as a singular experience. Participants described suffering in CF, and 
through their stories suffering was like an iceberg, with only a glimpse visible above the 
surface and great depths of suffering below. This study supplied a narrative opportunity 
for participants to communicate this suffering.  
This study argues that total pain in the context of living with CF threatens social 
legitimacy. Efforts of participants to maintain societal expectations often hide the pain 
and suffering from even those closest to them, including family, friends and clinical teams. 
Eventually, when pain and suffering persist, participants may lose social legitimacy and 
subsequently feel invisible. These findings highlight the importance of studying the 




Chapter 7: Conclusions and recommendations 
This chapter presents a summary of the study and original contribution to knowledge. It 
also includes a discussion of study limitations as well as strengths. Implications for clinical 
practice and a self-reflection follows, and the chapter concludes with opportunities for 
future research.  
7.1 Summary of the study 
In this thesis, I sought to gain a deeper understanding of the experience of pain in CF. This 
narrative study, set within a social constructivist epistemological framework, enabled me 
to explore the experience of pain in CF through interviewing nine adults with CF. I 
analysed the interview transcripts using a method of narrative analysis by Gee (1991), 
which presents the findings in stanzas, as a poetic form that aims to preserve the voice of 
the narrator. Essential to research in pain and palliative care, focus on the person as a 
whole was maintained throughout the study. The findings were then interpreted through 
the lens of total pain theory. Through these findings I have come to understand total pain 
in CF as a complex of interrelated elements occurring within the whole person. It is 
through these narratives of emerging awareness, social legitimacy and invisibility that I 
came to appreciate the nuances and complexity of total pain in CF.  
The emerging awareness narrative, occurring across participants’ lives, was the gradual 
increasing awareness of what it means to have CF. A crescendo effect of increasing total 
pain and suffering occurred alongside the continuum of emerging awareness. This effect 
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was part of an overarching sense of movement or fluidity and continual change. Signals 
or key indicators described by participants along this narrative supported the notion of 
milestones described by Charmaz (1991). Discussion of these milestones was prominent 
in emerging awareness as participants referred back to key moments such as diagnosis, 
first hospitalisation, transplant, moving back home and other recollections of key 
moments. In sharing these milestones, participants told stories revealing their 
experiences with physical, emotional, social and spiritual pain, the domains of total pain. 
Descriptions of these milestones also revealed another key feature across participant 
stories, liminality, which was seen in the experience of living in between, between health 
and illness, living and dying. Liminality and milestones appeared to be closely related to 
uncertainty and fear, expressions of emotional and spiritual pain. Uncertainty and fear 
appeared to cause a great deal of distress for participants. 
Total pain in CF permeated across all narratives. Despite participants not using the precise 
words “total pain”, total pain was at the centre of their stories. The typologies or domains 
of total pain (physical, social, emotional and spiritual), were instead labelled as either 
physical pain, emotional pain or suffering by participants. For participants, total pain was 
experienced by their whole person in the larger context of living with illness, rather than 
as a distinct experience. Taken as a whole, the experience of total pain and the experience 
of suffering were indistinguishable from one another. This understanding moves away 
from E. Cassell (1982) understanding of pain as happening to bodies and suffering as 
happening to persons, an understanding perhaps better placed in the context of physical 
pain than total pain. Instead, my understanding of total pain and suffering in CF sees them 
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as a singular experience happening to a whole person, encapsulating their very being. This 
understanding is one of the key contributions to knowledge arising out of this thesis. 
In an unexpected finding and another key contribution to knowledge stemming from this 
study, social legitimacy held a critical role in the experience of total pain in CF. Social 
legitimacy appears in the stories as a struggle to maintain independence, as participants 
tried to meet societal expectations. As participants became sicker and were no longer 
able to maintain these social expectations, the changes they experienced such as in social 
role, job, relationships and independence were experienced as losses. Echoing previous 
knowledge, the stories reflected values in western society of hard work, productivity, 
accomplishment, financial success and independence, and participants shared how 
difficult these were to achieve or maintain when living with a serious illness (Hay, 2010). 
Total pain was ever-present in these stories, and when participants were isolated, 
marginalised and lost social legitimacy they felt invisible.  
Nowhere was total pain and the impact of living with CF more obvious than when 
participants felt invisible. This is another key contribution to knowledge in this thesis. It 
was within these stories of invisibility that the true depth of pain and suffering was 
revealed. An iceberg was a useful analogy to visualise this phenomenon, as participants 
revealed in their stories that much more was going on under the surface than was known 
even to those closest to them. This recognition of the loss of social legitimacy related to 
total pain and suffering, and eventually leaving participants feeling invisible, is key to 
understanding the experience of pain in CF.  
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A narrative approach to this study provided an opportunity for participants to tell their 
individual stories. In this unstructured style of interview, participants chose which stories 
to tell and which to keep within. In other words, this was their story, told in their way, 
albeit ultimately a product of interaction between interviewer and participant. This 
approach helped maintain focus on the whole person while exploring the experience of 
pain in CF, striving to study pain not in isolation but in the context of living with CF. 
7.2 Original contribution to knowledge 
This thesis presents original empirical research into the experience of pain in CF, as 
examined through the lens of total pain. In seeking to examine pain in the context of the 
whole person living with CF, the thesis draws together knowledge in an original way from 
the fields of palliative care, chronic illness, pain, and sociology. Drawing from these varied 
perspectives enabled identification and exploration of the closely related concepts of 
pain, suffering, living with serious illness, social legitimacy and invisibility in a way that 
has not been previously described in CF.  
This study offers unique insight into how pain is experienced along a continuum of 
emerging awareness, as people gradually become aware of what having CF means in their 
lives. Through examining total pain along this continuum, pain is visualised as an 
evolution, as a movement or process, rather than an event. This enhances understanding 




A key contribution to knowledge is visualisation of total pain and suffering in CF as a 
singular experience. This is in direct contrast to the depiction of pain happening to bodies 
and suffering to persons, possibly because E. Cassell (1982) may have been speaking 
primarily of physical pain, as opposed to total pain. Through the narrative design, 
participants told the stories of pain they felt were important, and through these stories, 
revealed pain and suffering to be a singular experience.   Telling these stories in their own 
words also illuminated their shared language, as all participants told stories of total pain, 
but the words used to describe various domains were almost always emotional pain and 
suffering.  
Another important contribution of the thesis in understanding the concept of pain in CF 
is the revelation that when participants experience total pain, it threatens social 
legitimacy and leads to invisibility. Invisibility, both resulting from and causing pain, was 
where the depth of pain in CF was most evident. In examining the role of social legitimacy 
within the experience of pain, the concept of total pain was considered in relationship to 
societal dimensions rather than as only situated within the individual. 
Demonstrating that total pain is applicable in CF, the study provides evidence that total 
pain is generalizable not only in CF but across other non-cancer illnesses as well.  Finally, 
while total pain theory was developed more than five decades ago, this study shows that 
it is still as relevant today as when Saunders introduced it in the 1960’s. 
In summary, this study is a move forward in deepening understanding of pain in CF.  
Through adoption of total pain as a theoretical lens, discourse has been taken beyond 
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primarily physical pain, where there is a tendency to view pain as a symptom for clinicians 
to manage, to a broader understanding of pain as a phenomenon to engage with more 
existentially. 
7.3 Implications for clinical practice  
This thesis supports the importance for healthcare practitioners to see the patient as a 
whole person and in relation to their broader social world. Knowledge gained through 
this study leads to several practical recommendations that can be operationalised. Other 
recommendations require more of a philosophical shift in how clinicians practice and view 
the role of healthcare. 
The close relationship of social legitimacy and invisibility with total pain and suffering 
suggests that paying attention when clinicians hear these may yield greater 
understanding of pain in CF. People may speak of challenges in their various roles such as 
parents, partners, friends, students, employees or even patients. Talk of embarrassment, 
judgement, feeling misunderstood, change or loss may be heard in conversations, as they 
were heard from participants in this study. These are often invitations to explore if 
attention is paid to hear them. Recognising stories of invisibility may be especially 
important, as it seemed associated with the deepest pain. 
All participants spoke of milestones as important markers of change, and attention to 
these milestones may help busy clinicians recognise when a person might benefit from 
additional support. Attending to these milestones echoes previous recommendations to 
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recognise certain events as potential “triggers” for the need for palliative care in CF 
(Dellon et al., 2016). Similarly, laughter seemed to be paired with the most painful 
experiences and therefore may serve as an indicator for pain or a cue to explore further. 
Providing opportunities for people with CF to share their stories may provide insight into 
the experience of pain. Listening to the stories people tell, acknowledging and honouring 
their meaning, and acting on these stories is the hallmark of narrative medicine, a practice 
advocated by Charon (2001). Particularly relevant to findings coming out of this thesis is 
the assertion of Charon (2017) that through narrative medicine clinicians are able to see 
suffering and, as understood in this thesis, total pain. Carvalho et al. (2018, p. 970; 972) 
argued, from an ethical perspective, that narrative medicine is not only a “logical 
pathway” for addressing pain, but an ethical imperative, part of a “comprehensive 
paradigm of pain management that recognises the complexity of pain as a ‘total’ 
phenomenon and experience”. A closer look at narrative medicine may provide 
interested clinicians support in ways to develop their narrative competence.  
Embracing care of the whole person need not entail dissolution of the team approach, 
indeed the team approach is a valuable component of CF care. It is important to 
recognise, however, that the relationship between a person with CF (or any illness) and 
their doctor is often regarded as sacred. The challenge is to maintain focus on the whole 
person living with illness within the context of the team approach. Subtleties in approach 
matter. Referring to a social worker or psychologist at the first mention of emotional pain 
may unintentionally imply this is not my department or I only care about your lungs, even 
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though unintended. The ability to hear suffering, to sit with it, even if only for a few 
moments before bringing in another team member, shows that the person is seen as a 
whole, complex being.  
To embrace these recommendations may mean a shift for some in how they view the key 
role of healthcare. This shift, away from an understanding of healthcare as only concerned 
with the physical, towards healthcare as concerned with the full experience of illness, 
means caring for the whole person, including the complexity of total pain and suffering 
(Kearney, 2000).  
Accepting this broader view of healthcare requires accepting a role in addressing total 
pain and suffering. Participant Ashley, who “laid in bed and suffered” because “there’s 
not anything they can do”, may have been right if the only treatment considered was a 
pill, procedure, or whatever the care map says to do. However, in this broader view of 
healthcare there is more to be done, there is a place to listen, room for silence, and to 
simply be with a person, to accompany them. With much of the focus in healthcare on 
fixing, it may be difficult to appreciate the value in simply listening or being with someone 
in silence. It is less about what to do and more about how to do it, with what Frank called 
“generous medicine” (A. W. Frank, 2004; A. W. Frank, 2008). In the foreword for the book 
Mortally Wounded by Kearney (1996, pp. 11-12), Saunders described this as “the way care 
is given can reach the most hidden places”, and A. W. Frank (2005, p. 296) said this is “a 
way of doing things – a spirit of practice – and many of those things have to be done 
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anyway”. With this in mind, the recent trend towards personalised medicine to treat 
disease may be just as fitting to treat the whole person living with serious illness. 
7.4 Limitations of the study 
There are several limitations to this study which should be acknowledged. Some critics of 
narrative research argue that the participant’s voice can be lost in the act of retelling the 
story (Polkinghorne, 2007). While it should be acknowledged that the narrative is created 
in the interaction between participant and researcher, the decision to represent the 
stories in a poetic style aims to better preserve the essence of the participants’ stories. 
Attention to body language, verbal utterances, silence, and expressions of emotion such 
as laughter also help to preserve the voice of the participant, as did cross-checking the 
transcripts and stanzas with participants as described in Chapter Five.  
Another potential limitation is that all of the participants attended the same accredited 
CF centre and experiences from other centres may have been different. In recognition of 
this concern, recruitment included people who were new to the program and these 
efforts yielded two participants who had only recently transferred to the centre. These 
were also the only two participants who had not met me prior to the day of the interview. 
Strategies to address potential issues for “insider research” or power imbalances were 
described in Chapter Five.  
There was also a possibility of bias, as the researcher has been working within the 
specialty of CF for more than ten years and has been integrally involved in efforts to 
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advance palliative care in CF. This experience and interest may have led the researcher to 
pay more attention to some parts of stories than others and may have affected the 
selection of which stories to include in the thesis narratives. Some participants were likely 
aware of the researcher’s interest in these areas and this may have affected participant 
choices of which stories to tell and which to keep silent.  
7.5 Future research 
During the literature review phase of this study, almost all published studies about pain 
in CF were quantitative. While this study provides insight into the experience of pain in 
CF, more qualitative research is needed. The scope of the narratives that participants 
shared about their experiences with pain in CF and the nuances contained within these 
stories suggest that pain in CF is best explored through methods that focus on the whole 
person and can support this degree of complexity. Using other qualitative methods in 
addition to narrative may also provide further insight. A similar study to learn more about 
the experience of people with CF that regularly take pain medication (prescribed or illicit) 
would also be insightful. 
Recognising the strong biomedical positioning of the field in CF, a mixed method study 
may be best readily received by CF specialists and findings from this study could be used 
to inform study development. I advocate, however, that mixed method research not 
replace qualitative study but rather may be considered in addition as an effort to build a 
comprehensive knowledge base on pain in CF. 
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As mentioned in Chapter Four, total pain seems to have been either operationalised in 
individual case studies or used as a recommendation or discussion point in a theoretical 
discussion rather than the research process itself. This study applied total pain theory on 
a slightly larger scale (nine participants) and application on a larger scale may be 
beneficial. Researchers will need to consider the challenge of applying total pain on a 
larger scale with the importance of studying in the whole person. Carrying forward with 
a contemporary view of total pain, future research should examine total pain from the 
perspective of a dynamic, evolving experience with dimensions beyond the individual 
(Clark, 2018b).  
Invisibility held a powerful place in participant narratives and seemed to both come out 
of, and cause, suffering. The challenge with invisibility, however, is that it is by nature 
invisible. This study is an indication that if people with CF are provided an opportunity to 
share their experiences, and those around them value and listen to them, there is an 
opportunity through these stories to advance knowledge further in this area of research.  
Finally, the findings in this study may cause some degree of concern for CF clinicians who 
understandably wonder how they can possibly address this magnitude of scope within an 
allotted visit, even in the context of multidisciplinary care. This is an important concern 





7.6 Concluding remarks 
At the end of this thesis, I reflect again on the events that culminated in my research 
about pain in CF. Rounding out this string of events was someone asking if others with CF 
also have pain every day, so this project has been influenced by the voices of those who 
live with CF from the start and for these voices I am grateful.  
  Reflecting on my status as an insider, in these final words of the thesis, I was almost 
hyper aware of my positioning as an insider and took seriously the responsibility to 
conduct ethical research, as noted in Chapter Five (5.4.4).  While I spent a considerable 
amount of time thinking about risks and cautions in conducting insider research, there 
are strengths as well.  In many cases, participants themselves independently highlighted 
the strengths, both before and after the interviews. Importantly, they stated that because 
they had known me for long time, they trusted me and felt safe sharing their stories.  This 
was demonstrated in the depth of sharing by participants, especially evident in the rich 
stories of their experiences. From a practical standpoint, insider status also helped 
facilitate contact with participants for cross checking findings. 
I have been honoured that those I spoke with so generously shared their stories and time 
with me. I have been taken aback by how little I knew about their experiences before 
taking the time to listen to their stories and surprised by the emotional and at times 
tearful gratitude expressed to me simply because I asked about their pain. This 
unexpected gratitude of participants reminds me of Saunders, who said, “Often we are 
merely called on to show that we are trying to understand, even though we have few 
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answers to give and no comfort that can take away the pain we stay alongside” (Saunders, 
1990, p. 2). I do hope that this research has provided a few more answers about pain in 
CF, although I suspect it may have raised as many questions as answers.  
In closing, I cite Saunders (2000, p. 9) account of her patient Mrs Hinson, who captured 
the essence of total pain when she said to Saunders, “It seems that all of me is wrong”. 
The narratives participants shared through this study illuminate the experience of total 
pain in those living with CF.  Like Mrs Hinson many years ago, Brittany captured the 
essence of total pain in CF when she exclaimed, “It’s all just suffering” as described in 
Chapter Six. In this study, total pain, captured so clearly by Mrs Hinson, seems as relevant 
in CF today as it was in terminal cancer 55 years ago. The challenge now is to move 
forward with the new knowledge from this study in a way that meaningfully informs 
clinical care and research in CF and other serious illness. As I look towards the next phase 
of my career, I see this as an important and exciting challenge. 
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Appendix A: Database Summary 
 
Database Search Terms References Comments 
AMED For AMED database, 
searched with AB “cystic 




CINAHL Using “CINAHL headings” 
searched for cystic 
fibrosis and pain as major 
concept.  
12  
PsycINFO For PsycINFO database, 
searched using AB “cystic 













Web of science does not have a thesaurus.   
Did not limit search to title as decision made 
that relevant articles might be missed; 
therefore, search is done by topic (search in 
title, abstract is not available in WOS). 
























Design Participants Data Collection/Outcome Measures Key Findings Limitations Quality 
Score 
Allgood, SJ et al. 
2018 
US 
Descriptions of the pain 
experience in adults and 











5 females; 5 males 
Population: adolescent and adult 
Age: no mean or median available, 
range 13-46 years 
FEV1:  23.5%-102% 
Site:  single centre 




Differences in pain experience for 
adolescents and adults.  Pain adversely 
affects all aspects of life.  Adolescents report 
decreased socialization due to pain.  Adults 
report more emotional pain than 
adolescents.  While adolescents feel 
supported by clinical team, adults feel 
unsupported. 
No mention of theory 
 
31 




Daily pain in adolescents 
with CF:  Effects on 
adherence, psychological 
symptoms, and health-











59 females; 36 males 
Population:  adolescent 
Age: mean 15.8 years 
FEV1: mean 80% 






Initial visit followed by 6-day online diary 
Demographics and Medical characteristics 
Prospective  
Daily Pain Assessment Questionnaire for 
Cystic Fibrosis (DPAQ-CF) 
Retrospective 
Hospital Anxiety and Depression Scale 
(HADS) 
Medication Possession Ratio (MPR) 
Cystic Fibrosis Questionnaire 
Revised (CFQ-R) 
74.5 % participants reported pain, average 
2.1 out of 10 (mild). Pain associated with 
decreased adherence to CF treatment 
regimen, decreased HRQOL, and increased 
psychological distress. 
Limitations 
average 4.34 diaries 
completed (out of 6)  
Small sample size  
HRQOL, CFQR-R, HADS only 
completed on day 1 
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Epker, J A, et al. 
1999 
US 
Pain and pain-related 








37 females; 38 males 
Population:  adults 
Age: mean 26.8 years 
FEV1: not reported 
Site:  single centre 
 
MPI (Multidimensional Pain Inventory) 
Shwachman index 
“Nurse perception scale” 
65.7 % reported mild pain.  Significant 
relationship between age and pain related 
interference, did not find significant 
relationship between disease severity and 
pain, nurses rated patients pain higher than 
patients rated themselves. 
Only included outpatients so 
may not be as sick. 
Only included 2 nurses. 




Festini, FS, et al. 
2004 
Italy 
Prevalence of pain in adults 







125 females; 114 males 
Population: adults 
Age: mean 26.1 years 
Median FEV1: 56.71% 
Site: 15 centres 
 
Demographics and medical information 
 
6 item questionnaire developed for this 
study 
Study reported high incidence of pain for 
intensity and frequency.  59.8 % report pain 
as adversely affecting life.  Only 42.6% 
participants discussed with CF clinical team.  







Flume, PA et al. 
2009 
US 
Patient reported pain and 
impaired sleep quality in 








23 females; 27 males 
Population: adults 
Age: median 31.1 years 
FEV1: mean 58.4% 
Site:  single centre 
 
Brief Pain Inventory (BPI) 
Pittsburgh Sleep Quality Index 
Demographics 
More than half participants reported recent 
pain and issues with sleep quality.  Pain was 




Hayes, M et al. 
2011 
US 
Pain is a common problem 
affecting clinical outcomes 




Retrospective   
 
n=83 
47 females; 36 males 
Population:  adults 
Age: median 29.3 years 
FEV1: median 63.6% 
Site:  single centre 
Brief Pain Inventory (BPI) 
CFQ-R 
 
Hospital Anxiety and Depression Scale 
 
Pain Catastrophizing Scale 
82% participants reported pain in last 
month.  Pain negatively impacted general 
activities, mood and work.  Pain associated 
with decreased quality of life, depression 
and anxiety.  Pain associated with increased 
pulmonary exacerbations and death. 
Selection bias (61% response 
rate), single centre, recall bias, 
BPI not validated in CF. 
 
29 
Hubbard, PA et al. 
2005 
US  
Pain, coping, and disability 
in adolescents and adults 








12 females; 6 males 
Population: adults 
Age: 67% older than 23 years 
FEV1-not reported 
Site: all US centres 
Demographics 
Pain Disability Index (PDI) 
Pain response inventory (adapted) 
 
Pain reported to be common with about 
50% participants reporting daily pain.  Pain 
adversely affected recreational activities, 
work and social life.  Common coping 
strategies were both active and 
accommodative. 
Very low participation 




Kelemen, LA, et al. 
2012 
Australia 
Pain impacts on quality of 
life and interferes with 












35 females; 42 males 
Population: adults  
Age: mean 30 years 
FEV1: 60.5% (unknown whether 
mean or median) 
Site: single centre 
CFQ 
Brief Pain Inventory (BPI) 
Pain Catastrophizing Scale (PCS) 
Body outline 
Demographics 
Pain was not associated with severity 
disease severity but did adversely affect 
treatment adherence.  Mild pain reported by 
89% stable participants. 
Recall bias 
Only patients who attended CF 
clinic were eligible 
27 
Koh, JL et al. 
2005 
US 
Assessment of acute and 
chronic pain symptoms in 







24 females; 22 males 
Population: children 
Age: mean 12.9 years (8-17) 
FEV1: mean 80% 
Site: 3 centres 
FACES pain intensity scale 
Self-report questionnaire (homegrown, not 
validated) 
McGrath tool (measures degree pain 
caused emotional upset) 
VAS for perceived functional limitation 
Body outline for location 
Demographics 
46% of children reported pain at least 
weekly, usually mild.  11% reported 
moderate intensity of pain.  Chest pain 
associated with increased disease severity.  
70% children reported pain caused 
emotional upset. 
Outpatient only 
Retrospective for last 4 weeks 




Munck, AA et al. 
2012 
France 
Recurrent abdominal pain in 
children with cystic fibrosis:  






2 females; 6 males 
Population: children 
Age: mean 13.6 years 
FEV1: mean 85% 
Site:  single centre 
Eland Pain location  
Faces Pain Scale-Revised (FPS-R) 
 Mc Gill emotional status  
R-CMAS anxiety score  
Health-related quality of life (CF-QOL) 
A 28-day daily pain diary 
Reported low prevalence (6%) of abdominal 
pain in children with CF.   
2 of 8 participants withdrew 
from the study 
Descriptive results only due to 




longitudinal evaluation of 
characteristics and 
management 
Palermo, TM et al. 
2006 
US 
Effect of disease-related 
pain on the health-related 
quality of life of children 







24 females; 22 males 
Population:  children and 
adolescents 
Age: mean 12.9 years (8.1-17.8) 
FEV!: mean 80.2% 
Site: single centre 
CFQ-R 
Retrospective pain interview  
Faces pain scale 
Body outline 
Demographics 
Pain reported to negatively impact quality of 
life in physical functioning, role functioning, 
CF treatment regimen, and physical 
symptoms.  






Ravilly, S et al. 
1996 
US 




n=78 (58 deceased, 23 alive) 
25 females; 30 males (deceased) 
11 females; 12 males (alive) 
Population: adults 
Age: mean 26 years (deceased); 
mean 23 years (alive) 
FEV1: mean 58% 
Site: single centre 
No tool mentioned or referenced 
 
Pain increased in last 6 months of life.  
Headaches and chest pain were most 
common.  53% received opioids for pain in 
last 6 months of life.  
Only descriptive statistics 
used. 
Defined pain episode as event 
requiring medical intervention 
and study based on chart 
review so based on other 
study results with less than ½ 
reporting to MD this may limit 
results significantly. 




Sermet-Gaudelus JP, et al.  
2009 
France 
Pain in children and adults 






n=73 children; 110 adults 
36 females; 37 males (children) 
62 females; 48 males (adults) 
Population:  children and adults 
Age: mean 10.2 years (children, 1-
18); mean 28.5 years (adults, 18-52) 
FEV1: mean 70% (children); 50% 
(adults) 
Site:  2 centres 
Ad hoc questionnaire 
Body outline 
Children and adults experienced similar rate 
of pain but adults reported increased 
intensity and duration of pain than did 
children.  Pain associated with decreased 
physical activity.  Mean intensity of pain was 
moderate. Authors reported pain as 
common and undertreated.  
Study is retrospective only, 
parent reported pain in 
children <8 years, QOL not 
fully explored,  
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management of pain, 





n=64 children; 59 adults 
71 females; 52 males 
Population:  children and adults 
Age: mean 19.9 years (7-60) 
FEV1:  
     40% with FEV1>81% 
     29% FEV1 61-80% 
     22% FEV1 41-60% 
     4% FEV1 <40 
     5% UNK 
Site: 3 centres 
Demographics 
Questionnaire (ad hoc) 
Dalhousie Dyspnea Scale (DDS) 
 
84% participants reported pain, head and 
abdomen most frequent locations of pain.  
64% reported dyspnea, 83% cough.   




























Articles for Inclusion Articles for Exclusion 
Focus on participants of all ages with CF Focus on multiple diagnoses where evidence 
specific to CF is not disaggregated 
Focus on experience of pain in CF Empirical studies that fail to address topic 
(pain in CF is mentioned but not the primary 
focus of the article, primary focus on specific 
intervention (i.e. acupuncture) or diagnostic 
criteria rather than the experience of pain), 
pharmacological randomised controlled trials 
(RCTs). 
Published in English Non-English studies 
Empirical papers reporting primary 
research 
Conference abstracts, opinion or editorial 
papers, reviews, letters. 
  
 182 
Appendix E: Interview Guide 
 
Interview Topic Guide for Unstructured Interviews 
 
• Researcher introduction of self and study 
• Reminder re:  confidentiality 
• Reminder regarding right to decline question or end interview 
• Thank you for participating 
• Ask verbal permission to record and take notes 
• Initial questions to establish comfort, help the participant to be more comfortable  
o Please tell me about yourself 
o What has your day been like so far today? 
o How would you describe your CF? 
• Possible topics to explore 




o Pain disbelief 
o Barriers to relief 
o Beliefs about cause 
o Effect on QOL 
o Daily activities 
o Reporting pain/seeking assistance/communicating about pain 







o Treatment regimen 




o CF team 
• Strategies for researcher 
o LISTEN 
o Open-ended questions 
o Ask questions about what they have said 
o Summarize/Echo back, “What I hear you saying is…” 
o Silence is okay 
o Ask participant to “Tell me more” or “Then what happened?” 






































Appendix H: Participant Information Sheet 
VOLUNTEERS NEEDED FOR 
RESEARCH STUDY ON  
PAIN IN CYSTIC FIBROSIS 
 
We are looking for volunteers to participate in an 
interview about pain in cystic fibrosis (CF). 
Participants must be at least 18 years of age, have 
CF, and have experience with pain (now or in the 
past).  As a participant in this study, you will be 
asked to talk about your life history and experience 
of pain. The interview will take approximately 1-1 ½ 
hours for you complete.  
 
If you are interested, please contact: 
 
Jessica Goggin, MAS, RN 
Principle Investigator 
Telephone (858) 657-7073 
Email:  jlgoggin@ucsd.edu 
Thank you!  
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Appendix I: Example Initial Stage Analysis (Atlas.ti) 
Appendix I:  Initial Stage A nalysis (Mind-mapping) 
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P05 [Yeah-and then-but even after that-I-people would ask me-like-oh they saw 
me taking my enzymes-or-all my friends knew about my vest-and they would 
all try it on-laughs-and um-and men um-so I Rad to do all those things­
�e but other than that I would just be kind of like-oh it's
'tothmg-you know-it doesn't really-I felt like it didn't really affect my life a
whole lot.
) 
- - -- --- - - ---
JG Hmm 
P05 Cause I just did what I had to do-I still had fun-and it� ettin to the 
�oin1 where it was like interfering with my life-- - --- - ,..""'-'-' ·•-..:.,- .- ,., 
JG Okay 
P05 Until I was like 18-or 17-
JG And how old are you now? 
P05 I am 26. Um-yeah-I should probably mention that I'm 26-laughs-um-so-um­
and-so when I turned 17 I had my first hospitalization-my first IV-my PICC 
line-and after that-it ·ust ot harder and harder for me to sta healthy-um-
so ever since then 1t s just een m o - e progression 1s Just-you now how 




Have you always lived at home? . Qe\/, 1.fY� ;_ \ e'.:>¾�





No I moved out a year and a half ag9 whic.h...was_a Bl.G...thin _ for me-because '(vl"D 
when I was 18 I always thought I would be out-like- a ways wanted to be \r--ov-JL.>
very-very independent-I graduated school-I got my um diploma early 
Mmhmm-oh early-you got it early 
Yeah-well know-actually they gave me my diploma- I walked with 2008 but I 
finished all my courses-um-the summer before the 2008 school year started 





Appendix J: Example Interview Excerpt and Related Stanza 
JG Have you through the years-have you had support from other people with CF aside from 
transplant-so just in general-have you like social network wise- 
P06 You know-I didn’t really know a lot of CF-ers in my early years--when I first met people-it 
was being in the hospital (lists names)--I remember there was like eight of us together 
one time--and so we sat out in the hall-and it was just like a big group of us-- 
JG Unofficial support group 
P06 Yes!  Yes!  Yes-that was pretty cool-that was pretty cool-um-yeah- 
JG In more recent years do you still have any sort of friends with CF 
P06 Well-it kind of sucks--but most of them have died--yeah-(voice trails off)-I’m trying to 
think of-well-(male with CF) is still around-he just got married--I don’t really talk to him 
all that much--but it’s like everyone has died (whispers)-and you know honestly--it’s 
ooh-I haven’t really gotten close to anybody--I don’t know any new CF-ers here--I mean 
like there is a (hospital) CF chat group-I know (female with CF)-we are friends-we’ve 
done some stuff together-(female with CF)-we went to (female with CF) thing (funeral)-
we saw (CF MD) there-um-I don’t really-I mean it’s like they’ve all died (whispers) 
Box 15 
 
Stanza 3: When I first met people-it was being in the hospital 
 
10. You know – I didn’t really know a lot of CF-ers in my early years 
11. when I first met people it was being in the hospital  
12. I remember there was like eight of us together one time 
13. and so we sat out in the hall – and it was just like a big group of us. 
 
Stanza 4: Most of them have died 
 
14. Well – it kind of sucks 
15. but most of them have died 
16. I’m trying to think of – well – one is still around – he just got married 
17. I don’t really talk to him all that much. 
 
Stanza 5: I haven’t really gotten close to anybody 
 
18. but it’s like everyone has died--and you know honestly 
19. I haven’t really gotten close to anybody 











the quality of adolescent relationships. We chose to 
focus on adolescents, as developmentally they are likely 
to experience opportunities to disclose their CF inde- 
pendently as their general level of independence increas- 
es (6) and their ability to understand and effectively 
express disease processes to others develops. 
We hypothesize that adolescents who have disclosed 
their diagnosis will have families with more favorable 
attitudes towards disclosure, greater social support, and 
less perceived stigma. 
Adolescents between the ages of 12-18 were recruited 
for the current study. Inclusion criteria require confirmed 
diagnosis of CF with pancreatic insufficiency, current 
prescription of pancreatic enzyme replacement therapy 
(PERT), access to the internet, and proficiency in reading 
English. Exclusion criteria include diagnoses of develop- 
mental delay or intellectual disability, history of a lung 
transplant, or a diagnosis of CF-related diabetes. Partic- 
ipants meeting inclusion/exclusion criteria are mailed a 
recruitment letter and a flyer describing the study along 
with a return addressed, stamped “do not contact” post- 
card that they can return requesting not to be contacted. 
All families for whom a postcard is not received within 
10 days of mailing are contacted by phone or at their 
next clinic visit by study personnel to explain more about 
the study, assess the family’s interest in participation in 
the study, and schedule a study visit. Adolescent partic- 
ipants complete baseline self-report measures assessing 
disease disclosure behaviors (Cystic Fibrosis Disclosure 
Scale [CFDS]) (2), family attitudes towards sharing pri- 
vate information (Family Privacy Orientation [FPO]) 
(7), perceptions of stigma (Social Impact Scale [SIS]) 
(8), and relationship quality (Network of Relationships 
Inventory [NRI]) (9). Participants’ caregivers also com- 
plete the FPO. Participants’ demographic and health data 
(ie, body mass index and FEV1 percent predicted) are 
obtained via medical record review. 
Recruitment is ongoing with an anticipated final sam- 
ple size of 20 participants. In our presentation, we will 
discuss patterns of disease disclosure behaviors among 
adolescents with CF as well as associations between 
disease disclosure behaviors and other psychosocial 
variables. Findings have implications for anticipatory 
guidance and recommendations provided to patients 
with CF and their families with regard to potential health 
implications of disclosure and access to emotional and 
practical social support. 
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Pediatr Nurs. 1997;12(1):3-12. 
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and health outcomes. J Cyst Fibros. 2016;15(5):696-702. 
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S07.3 
INVISIBILITY AND THE EXPERIENCE OF PAIN IN CF 
Jessica L. Goggin, MAS 
Pulmonary, University of California San Diego, San Diego, CA, USA 
Background: As treatment and clinical care have 
improved, people with cystic fibrosis (CF) are living lon- 
ger and CF, although still life-limiting has emerged as a 
chronic disease (1). This improved life expectancy often 
occurs alongside an increased symptom burden resulting 
from disease progression and co-morbidities (2). One of 
the common symptoms in CF is pain. 
In a literature review, pain in CF was found to be a 
common phenomenon (3). The location of pain in CF  
is most commonly reported to be head, chest, back, and 
stomach (3). Pain has been associated with lower qual- 
ity of life, decreased adherence, increased pulmonary 
exacerbations and decreased survival (4-6). Despite 
indications that pain in CF is common and associated 
with negative outcomes, only 50% of CF patients who 
endorse pain report it (3). The phenomenon of invisible 
illness or invisibility has been described as an illness 
without a clear or visible outward sign (7,8). Pain, a 
highly subjective experience, and usually with no out- 
ward sign of illness or disability is often included when 
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